<SEC-DOCUMENT>0001553350-22-000849.txt : 20221103
<SEC-HEADER>0001553350-22-000849.hdr.sgml : 20221103
<ACCEPTANCE-DATETIME>20221102203014
ACCESSION NUMBER:		0001553350-22-000849
CONFORMED SUBMISSION TYPE:	8-K
PUBLIC DOCUMENT COUNT:		14
CONFORMED PERIOD OF REPORT:	20221029
ITEM INFORMATION:		Entry into a Material Definitive Agreement
ITEM INFORMATION:		Unregistered Sales of Equity Securities
ITEM INFORMATION:		Material Modifications to Rights of Security Holders
ITEM INFORMATION:		Financial Statements and Exhibits
FILED AS OF DATE:		20221103
DATE AS OF CHANGE:		20221102

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			DUOS TECHNOLOGIES GROUP, INC.
		CENTRAL INDEX KEY:			0001396536
		STANDARD INDUSTRIAL CLASSIFICATION:	SERVICES-PREPACKAGED SOFTWARE [7372]
		IRS NUMBER:				650493217
		STATE OF INCORPORATION:			FL
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		8-K
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	001-39227
		FILM NUMBER:		221355833

	BUSINESS ADDRESS:	
		STREET 1:		7660 CENTURION PARKWAY
		STREET 2:		SUITE 100
		CITY:			JACKSONVILLE
		STATE:			FL
		ZIP:			32256
		BUSINESS PHONE:		904-296-2807

	MAIL ADDRESS:	
		STREET 1:		7660 CENTURION PARKWAY
		STREET 2:		SUITE 100
		CITY:			JACKSONVILLE
		STATE:			FL
		ZIP:			32256

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	DUOS TECHNOLOGY GROUP, INC.
		DATE OF NAME CHANGE:	20150710

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	INFORMATION SYSTEMS ASSOCIATES, INC.
		DATE OF NAME CHANGE:	20070416
</SEC-HEADER>
<DOCUMENT>
<TYPE>8-K
<SEQUENCE>1
<FILENAME>duot_8k.htm
<DESCRIPTION>CURRENT REPORT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="utf-8"?>
<html xmlns="http://www.w3.org/1999/xhtml" xmlns:xs="http://www.w3.org/2001/XMLSchema-instance" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:xbrldi="http://xbrl.org/2006/xbrldi" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" xmlns:iso4217="http://www.xbrl.org/2003/iso4217" xmlns:ix="http://www.xbrl.org/2013/inlineXBRL" xmlns:ixt="http://www.xbrl.org/inlineXBRL/transformation/2015-02-26" xmlns:ixt-sec="http://www.sec.gov/inlineXBRL/transformation/2015-08-31" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:dei="http://xbrl.sec.gov/dei/2022" xmlns:ref="http://www.xbrl.org/2006/ref" xmlns:us-gaap="http://fasb.org/us-gaap/2022" xmlns:us-gaap-supplement="http://fasb.org/us-gaap-sup/2022q3" xmlns:srt-supplement="http://fasb.org/srt-sup/2022q3" xmlns:us-roles="http://fasb.org/us-roles/2022" xmlns:country="http://xbrl.sec.gov/country/2022" xmlns:srt="http://fasb.org/srt/2022" xmlns:DUOT="http://duostech.com/20221029">
<head>
     <title></title>
<meta http-equiv="Content-Type" content="text/html" />
</head>
<!-- Field: Set; Name: xdx; ID: xdx_02B_US%2DGAAP%2D2022 -->
<!-- Field: Set; Name: xdx; ID: xdx_034_DUOT_duostech.com_20221029 -->
<!-- Field: Set; Name: xdx; ID: xdx_046_20221029_20221029 -->
<!-- Field: Set; Name: xdx; ID: xdx_058_edei%2D%2DEntityCentralIndexKey_0001396536 -->
<!-- Field: Set; Name: xdx; ID: xdx_059_edei%2D%2DAmendmentFlag_false -->
<!-- Field: Set; Name: xdx; ID: xdx_06B_USD_1_iso4217%2D%2DUSD -->
<!-- Field: Set; Name: xdx; ID: xdx_062_Shares_2_xbrli%2D%2Dshares -->
<!-- Field: Set; Name: xdx; ID: xdx_06D_USDPShares_3_iso4217%2D%2DUSD_xbrli%2D%2Dshares -->
<body style="font: 10pt Times New Roman, Times, Serif">
<div style="display: none">
<ix:header>
 <ix:hidden>
  <ix:nonNumeric contextRef="From2022-10-29to2022-10-29" name="dei:EntityCentralIndexKey">0001396536</ix:nonNumeric>
  <ix:nonNumeric contextRef="From2022-10-29to2022-10-29" name="dei:AmendmentFlag">false</ix:nonNumeric>
  </ix:hidden>
 <ix:references>
  <link:schemaRef xlink:href="duot-20221029.xsd" xlink:type="simple" />
  </ix:references>
 <ix:resources>
    <xbrli:context id="From2022-10-29to2022-10-29">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001396536</xbrli:identifier>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2022-10-29</xbrli:startDate>
        <xbrli:endDate>2022-10-29</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:unit id="USD">
      <xbrli:measure>iso4217:USD</xbrli:measure>
    </xbrli:unit>
    <xbrli:unit id="Shares">
      <xbrli:measure>xbrli:shares</xbrli:measure>
    </xbrli:unit>
    <xbrli:unit id="USDPShares">
      <xbrli:divide>
        <xbrli:unitNumerator>
          <xbrli:measure>iso4217:USD</xbrli:measure>
        </xbrli:unitNumerator>
        <xbrli:unitDenominator>
          <xbrli:measure>xbrli:shares</xbrli:measure>
        </xbrli:unitDenominator>
      </xbrli:divide>
    </xbrli:unit>
  </ix:resources>
 </ix:header>
</div>


<p style="margin: 0">&#160;</p>

<p style="margin: 0"></p>

<p style="font: 12pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>&#160;</b></p>

<!-- Field: Rule-Page --><div style="margin-top: 1pt; margin-bottom: 1pt; width: 100%"><div style="border-top: Black 0.25pc solid; font-size: 1pt">&#160;</div></div><!-- Field: /Rule-Page -->

<!-- Field: Rule-Page --><div style="margin-top: 1pt; margin-bottom: 1pt; width: 100%"><div style="border-top: Black 1pt solid; font-size: 1pt">&#160;</div></div><!-- Field: /Rule-Page -->

<p style="font: 12pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>UNITED STATES<br />
SECURITIES AND EXCHANGE COMMISSION</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>Washington, D.C. 20549</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>&#160;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;</p>

<p style="font: 12pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>&#160;</b></p>

<p style="font: 12pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>FORM <span id="xdx_90B_edei--DocumentType_c20221029__20221029_zg9Iex3iRmNa"><ix:nonNumeric contextRef="From2022-10-29to2022-10-29" name="dei:DocumentType">8-K</ix:nonNumeric></span></b></p>

<p style="font: 12pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>&#160;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>CURRENT REPORT</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>&#160;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>Pursuant to Section 13 or 15(d) of the Securities
Exchange Act of 1934</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>&#160;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>Date of Report (Date of earliest event reported):
<span id="xdx_90C_edei--DocumentPeriodEndDate_c20221029__20221029_zc06vkPXFjsi"><ix:nonNumeric contextRef="From2022-10-29to2022-10-29" format="ixt:datemonthdayyearen" name="dei:DocumentPeriodEndDate">October 29, 2022</ix:nonNumeric></span></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</p>

<p style="font: 16pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b><span id="xdx_904_edei--EntityRegistrantName_c20221029__20221029_zDhJkeLBCUW4"><ix:nonNumeric contextRef="From2022-10-29to2022-10-29" name="dei:EntityRegistrantName">Duos Technologies Group, Inc.</ix:nonNumeric></span></b></p>

<p style="font: 8pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><i>(Exact name of registrant as specified in its
charter)</i></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="vertical-align: top">
    <td style="width: 34%; text-align: center"><b><span id="xdx_908_edei--EntityIncorporationStateCountryCode_c20221029__20221029_zMESdA4GP9b4"><ix:nonNumeric contextRef="From2022-10-29to2022-10-29" format="ixt-sec:stateprovnameen" name="dei:EntityIncorporationStateCountryCode">Florida</ix:nonNumeric></span></b></td>
    <td style="width: 33%; text-align: center"><b><span id="xdx_900_edei--EntityFileNumber_c20221029__20221029_zrKa2uujUeej"><ix:nonNumeric contextRef="From2022-10-29to2022-10-29" name="dei:EntityFileNumber">001-39227</ix:nonNumeric></span></b></td>
    <td style="width: 33%; text-align: center"><b><span id="xdx_904_edei--EntityTaxIdentificationNumber_c20221029__20221029_zSy14qWRmfY6"><ix:nonNumeric contextRef="From2022-10-29to2022-10-29" name="dei:EntityTaxIdentificationNumber">65-0493217</ix:nonNumeric></span></b></td></tr>
  <tr style="vertical-align: top">
    <td style="text-align: center"><span style="font-size: 8pt"><i>(State or Other Jurisdiction</i></span></td>
    <td style="text-align: center"><span style="font-size: 8pt"><i>(Commission</i></span></td>
    <td style="text-align: center"><span style="font-size: 8pt"><i>(I.R.S. Employer</i></span></td></tr>
  <tr style="vertical-align: top">
    <td style="text-align: center"><span style="font-size: 8pt"><i>of Incorporation)</i></span></td>
    <td style="text-align: center"><span style="font-size: 8pt"><i>File Number)</i></span></td>
    <td style="text-align: center"><span style="font-size: 8pt"><i>Identification No.)</i></span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b><span id="xdx_908_edei--EntityAddressAddressLine1_c20221029__20221029_ziZHlbgRIJ25"><ix:nonNumeric contextRef="From2022-10-29to2022-10-29" name="dei:EntityAddressAddressLine1">7660 Centurion Parkway</ix:nonNumeric></span>, <span id="xdx_908_edei--EntityAddressAddressLine2_c20221029__20221029_zrveIqLzBPzd"><ix:nonNumeric contextRef="From2022-10-29to2022-10-29" name="dei:EntityAddressAddressLine2">Suite 100</ix:nonNumeric></span>, <span id="xdx_90F_edei--EntityAddressCityOrTown_c20221029__20221029_zdHPGZux6Ide"><ix:nonNumeric contextRef="From2022-10-29to2022-10-29" name="dei:EntityAddressCityOrTown">Jacksonville</ix:nonNumeric></span>,
<span id="xdx_900_edei--EntityAddressStateOrProvince_c20221029__20221029_zBv8wxvtnq73"><ix:nonNumeric contextRef="From2022-10-29to2022-10-29" format="ixt-sec:stateprovnameen" name="dei:EntityAddressStateOrProvince">Florida</ix:nonNumeric></span> <span id="xdx_901_edei--EntityAddressPostalZipCode_c20221029__20221029_z5TFWfWRqkH9"><ix:nonNumeric contextRef="From2022-10-29to2022-10-29" name="dei:EntityAddressPostalZipCode">32256</ix:nonNumeric></span></b></p>

<p style="font: 8pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><i>(Address of Principal Executive Offices) (Zip
Code)</i></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b><span id="xdx_900_edei--CityAreaCode_c20221029__20221029_ziUjMoesY709"><ix:nonNumeric contextRef="From2022-10-29to2022-10-29" name="dei:CityAreaCode">(904)</ix:nonNumeric></span> <span id="xdx_900_edei--LocalPhoneNumber_c20221029__20221029_zooU9ycOVUme"><ix:nonNumeric contextRef="From2022-10-29to2022-10-29" name="dei:LocalPhoneNumber">296-2807</ix:nonNumeric></span></b></p>

<p style="font: 8pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><i>(Registrant&#8217;s telephone number, including
area code)</i></p>

<p style="font: 8pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><i>&#160;</i></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0pc">Check the appropriate box below
if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0pc"><span style="font-family: Segoe UI Symbol,sans-serif"><span id="xdx_900_edei--WrittenCommunications_c20221029__20221029_zTNKCX9l8bG6"><ix:nonNumeric contextRef="From2022-10-29to2022-10-29" format="ixt:booleanfalse" name="dei:WrittenCommunications">&#9744;</ix:nonNumeric></span></span>
Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0pc"><span style="font-family: Segoe UI Symbol,sans-serif"><span id="xdx_904_edei--SolicitingMaterial_c20221029__20221029_ztG9gpp4QAug"><ix:nonNumeric contextRef="From2022-10-29to2022-10-29" format="ixt:booleanfalse" name="dei:SolicitingMaterial">&#9744;</ix:nonNumeric></span></span>
Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0pc"><span style="font-family: Segoe UI Symbol,sans-serif"><span id="xdx_901_edei--PreCommencementTenderOffer_c20221029__20221029_zgugqtBb7e93"><ix:nonNumeric contextRef="From2022-10-29to2022-10-29" format="ixt:booleanfalse" name="dei:PreCommencementTenderOffer">&#9744;</ix:nonNumeric></span></span>
Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0pc"><span style="font-family: Segoe UI Symbol,sans-serif"><span id="xdx_90B_edei--PreCommencementIssuerTenderOffer_c20221029__20221029_zrLXLULRj4qe"><ix:nonNumeric contextRef="From2022-10-29to2022-10-29" format="ixt:booleanfalse" name="dei:PreCommencementIssuerTenderOffer">&#9744;</ix:nonNumeric></span></span>
Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Securities registered pursuant to Section 12(b) of the Act:</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="vertical-align: bottom">
    <td style="border-bottom: black 1pt solid; width: 32%; text-align: center"><span style="font-size: 8pt"><b>Title of each class</b></span></td>
    <td style="width: 2%; text-align: center">&#160;</td>
    <td style="border-bottom: black 1pt solid; width: 32%; text-align: center"><span style="font-size: 8pt"><b>Trading Symbol(s)</b></span></td>
    <td style="width: 2%; text-align: center">&#160;</td>
    <td style="border-bottom: black 1pt solid; width: 32%; text-align: center"><span style="font-size: 8pt"><b>Name of each exchange on which registered</b></span></td></tr>
  <tr style="vertical-align: top">
    <td style="text-align: center"><span id="xdx_902_edei--Security12bTitle_c20221029__20221029_zsOT5KaNuJre"><ix:nonNumeric contextRef="From2022-10-29to2022-10-29" name="dei:Security12bTitle">Common Stock (par value $0.001 per share)</ix:nonNumeric></span></td>
    <td>&#160;</td>
    <td style="text-align: center"><span id="xdx_90E_edei--TradingSymbol_c20221029__20221029_zuJ51HLCAI9k"><ix:nonNumeric contextRef="From2022-10-29to2022-10-29" name="dei:TradingSymbol">DUOT</ix:nonNumeric></span></td>
    <td>&#160;</td>
    <td style="text-align: center"><span id="xdx_90E_edei--SecurityExchangeName_c20221029__20221029_znxqBAedFmPf"><ix:nonNumeric contextRef="From2022-10-29to2022-10-29" format="ixt-sec:exchnameen" name="dei:SecurityExchangeName">The Nasdaq Stock Market LLC</ix:nonNumeric></span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Indicate by check mark whether the registrant
is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (&#167;230.405 of this chapter) or Rule 12b-2 of the
Securities Exchange Act of 1934 (&#167;240.12b-2 of this chapter).</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Emerging growth company <span style="font-family: Segoe UI Symbol,sans-serif"><span id="xdx_90B_edei--EntityEmergingGrowthCompany_c20221029__20221029_zq9X3LIQoXSj"><ix:nonNumeric contextRef="From2022-10-29to2022-10-29" format="ixt:booleanfalse" name="dei:EntityEmergingGrowthCompany">&#9744;</ix:nonNumeric></span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">If an emerging growth company, indicate by check
mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting
standards provided pursuant to Section 13(a) of the Exchange Act.&#160;<span style="font-family: Segoe UI Symbol,sans-serif">&#9744;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<!-- Field: Rule-Page --><div style="margin-top: 1pt; margin-bottom: 1pt; width: 100%"><div style="border-top: Black 1pt solid; font-size: 1pt">&#160;</div></div><!-- Field: /Rule-Page -->

<!-- Field: Rule-Page --><div style="margin-top: 1pt; margin-bottom: 1pt; width: 100%"><div style="border-top: Black 0.25pc solid; font-size: 1pt">&#160;</div></div><!-- Field: /Rule-Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>


<!-- Field: Page; Sequence: 1 -->
    <div style="margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="width: 100%"><tr><td style="text-align: center; width: 100%">&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="width: 100%"><tr><td style="text-align: center; width: 100%">&#160;</td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 8pt; text-align: justify"><span style="letter-spacing: 0.4pt"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 8pt; text-align: justify"><span style="letter-spacing: 0.4pt"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><b></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><b>Item 1.01. Entry into a Material Definitive Agreement</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 3pc">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 3pc">On October 29, 2022, Duos Technologies Group, Inc. (the
<span style="font-family: Arial Unicode MS,serif">&#8220;</span>Company<span style="font-family: Arial Unicode MS,serif">&#8221;</span>)
entered into a Securities Purchase Agreement (the <span style="font-family: Arial Unicode MS,serif">&#8220;</span>Purchase Agreement<span style="font-family: Arial Unicode MS,serif">&#8221;</span>)
with an existing investor in the Company and two other accredited investors (collectively, the <span style="font-family: Arial Unicode MS,serif">&#8220;</span>Purchasers&#8221;).
&#160;Pursuant to the Purchase Agreement, the Purchasers purchased an aggregate of 83,667 shares of common stock and 300 shares of a previously-authorized
Series D Convertible Preferred Stock (the &#8220;Series D Preferred Stock&#8221;), and the Company received aggregate proceeds of $551,001.
&#160;The common stock was sold at $3.00 a share and the Series D Preferred Stock was sold at $1,000 a share.. Northland Securities, Inc.
acted as Placement Agent and will receive fees in an amount up to 7% of the gross transaction amount.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 3pc">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 3pc">The Purchase Agreement contains the same provisions as
the purchase agreement previously entered into by the Company on September 30, 2022 and described in the Form 8-K filed with the Securities
and Exchange Commission on October 3<sup>rd</sup>, 2022 (the &#8220;Prior Form 8-K&#8221;) In particular, the Purchase Agreement requires
the Company to hold a shareholders meeting to receive shareholder approval (the &#8220;Stockholder Approval&#8221;) for the issuance of
shares of common stock upon conversion of the Series D Preferred Stock under Nasdaq rules and as described in the Prior Form 8-K. Prior
to the receipt of the Stockholder Approval, no shares of common stock may be issued upon conversion of the Series D Preferred Stock.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 3pc">In connection with the Purchase Agreement, the Company
also entered into a Registration Rights Agreement with the Purchasers. &#160;Pursuant to the Registration Rights Agreement, the Company
shall file with the SEC a registration statement covering the resale by the Purchasers of the 83,667 shares of common stock issued as
well as the shares of common stock into which the shares of Series D Preferred Stock are convertible. &#160;Subject to certain conditions,
the Company must cause the registration statement to be declared effective by 90 days after closing (or in the event of a full review
by the SEC, by 120 days). &#160;The Registration Rights Agreement contains the same provisions as the registration rights agreement previously
entered into by the Company on September 30, 2022 and described in the Prior Form 8-K.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 3pc">The forgoing descriptions of the Purchase Agreement and
the Registration Rights Agreement do not purport to be complete and are subject to, and qualified in their entirety by, such documents,
forms of which are attached as exhibits to this Current Report on Form 8-K and incorporated herein by reference.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><b>Item 3.02 Unregistered Sales of Equity Securities</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 3pc">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 3pc">The information set forth in Item 1.01 of this Current
Report on Form 8-K is incorporated by reference into this Item 3.02.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 3pc">The issuances of the shares of common stock and the Series
D Preferred Stock were not registered under the Securities Act of 1933, as amended (the &#8220;Securities Act&#8221;), but qualified for
an exemption under Section 4(a)(2) of the Securities Act and by Rule 506 of Regulation D promulgated thereunder as transactions by an
issuer not involving a public offering.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><b>Item 3.03. Material Modification to Rights of Security Holders</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 3pc">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 3pc">The information set forth in Item 1.01 of this Current
Report on Form 8-K is incorporated by reference into this Item 3.03. The preferences, rights and limitations of the Series D Preferred
Stock are as described in the Prior Form 8-K.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><b>Item 9.01. Financial Statements and Exhibits.</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><b>(d) Exhibits</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<table cellspacing="0" cellpadding="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr>
    <td style="border-bottom: black 1pt solid; vertical-align: bottom; width: 62px"><span style="font-size: 8pt"><b>Exhibit No.</b></span></td>
    <td style="vertical-align: top; width: 10px">&#160;</td>
    <td style="border-bottom: black 1pt solid; vertical-align: bottom"><span style="font-size: 8pt"><b>Description of Exhibit</b></span></td></tr>
  <tr style="vertical-align: top; background-color: rgb(204,238,204)">
    <td style="text-align: justify"><span style="font-size: 10pt">10.1</span></td>
    <td>&#160;</td>
    <td style="text-align: justify"><span style="font-size: 10pt"><a href="duot_ex10z1.htm">Form of Securities Purchase Agreement</a></span></td></tr>
  <tr style="vertical-align: top; background-color: White">
    <td style="text-align: justify"><span style="font-size: 10pt">10.2</span></td>
    <td>&#160;</td>
    <td style="text-align: justify"><span style="font-size: 10pt"><a href="duot_ex10z2.htm">Form of Registration Rights Agreement</a></span></td></tr>
  <tr style="vertical-align: top; background-color: rgb(204,238,204)">
    <td style="text-align: justify"><span style="font-size: 10pt">104</span></td>
    <td>&#160;</td>
    <td style="text-align: justify"><span style="font-size: 10pt">Cover Page Interactive Data File (formatted as Inline XBRL and contained in Exhibit 101)</span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 8pt; text-align: justify"><span style="letter-spacing: 0.4pt"><b></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 8pt; text-align: justify"></p>


<!-- Field: Page; Sequence: 2 -->
    <div style="border-bottom: Black 1pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="width: 100%"><tr><td style="text-align: center; width: 100%">&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="width: 100%"><tr><td style="text-align: center; width: 100%">&#160;</td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>&#160;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>SIGNATURES</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>&#160;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0pc">Pursuant to the requirements of the Securities Exchange
Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned, hereunto duly authorized.</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 3pc">&#160;</p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="vertical-align: top">
    <td>&#160;</td>
    <td colspan="2"><b>DUOS TECHNOLOGIES GROUP, INC.</b></td></tr>
  <tr style="vertical-align: top">
    <td style="width: 55%">&#160;</td>
    <td style="width: 6%">&#160;</td>
    <td style="width: 39%">&#160;</td></tr>
  <tr style="vertical-align: top">
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td></tr>
  <tr style="vertical-align: top">
    <td>Dated: November 2, 2022</td>
    <td>By:&#160;&#160;</td>
    <td style="border-bottom: Black 1pt solid">/s/&#160;<i>Adrian Goldfarb</i></td></tr>
  <tr style="vertical-align: top">
    <td>&#160;</td>
    <td>&#160;</td>
    <td rowspan="2">
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Adrian Goldfarb</p>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Chief Financial Officer</p></td></tr>
  <tr style="vertical-align: top">
    <td>&#160;</td>
    <td>&#160;</td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0pc">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0pc">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0pc">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0pc">&#160;</p>



<p style="margin: 0">&#160;</p>

</body>
</html>
<!-- Field: Set; Name: xdx; ID: xdx_08B_extensions -->
<!-- eJxFjdEKwjAMRb9g/xD6LLpORN2jQ0WcImOIr8VFKW7NSOt0n+Rf2m2IIRCSe0+uECOxpY0ukeGyylLIsapL5RAyvCGjuaJ3JLt9DH5meNfWsTKuX39gQp5Bz8zGS+XvvbPRFosYwsVETieRhFDGszmcDiLo9ITMTRdonFYlKFPAialmjU5xO3zI1ZsMVW2fdEa2mkwMchwO8geiUEZwpEa9iB8W0jQRwaivQGyZnnUX87SOKliXWPksO6D/Dr7iu0kh -->
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-10.1
<SEQUENCE>2
<FILENAME>duot_ex10z1.htm
<DESCRIPTION>FORM OF SECURITIES PURCHASE AGREEMENT
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: right"><B>EXHIBIT 10.1</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="text-transform: uppercase"><B>FORM OF</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 1pc; text-align: center"><FONT STYLE="text-transform: uppercase"><B>SECURITIES
PURCHASE AGREEMENT</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 1pc; text-align: justify; text-indent: 3pc">This Securities Purchase Agreement
(this &ldquo;<U>Agreement</U>&rdquo;) is dated as of October __, 2022, between Duos Technologies Group, Inc., a Florida corporation (the
&ldquo;<U>Company</U>&rdquo;), and each purchaser identified on the signature pages hereto (each, including its successors and assigns,
a &ldquo;<U>Purchaser</U>&rdquo; and collectively, the &ldquo;<U>Purchasers</U>&rdquo;).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 1pc; text-align: justify; text-indent: 3pc">WHEREAS, subject to the terms
and conditions set forth in this Agreement and pursuant to Section 4(a)(2) of the Securities Act of 1933, as amended (the &ldquo;<U>Securities
Act</U>&rdquo;), and Rule 506 promulgated thereunder, the Company desires to issue and sell to each Purchaser, and each Purchaser, severally
and not jointly, desires to purchase from the Company, securities of the Company as more fully described in this Agreement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 1pc; text-align: justify; text-indent: 3pc">NOW, THEREFORE, IN CONSIDERATION
of the mutual covenants contained in this Agreement, and for other good and valuable consideration, the receipt and adequacy of which
are hereby acknowledged, the Company and each Purchaser agree as follows:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 1pc; text-align: center"><FONT STYLE="text-transform: uppercase"><B>ARTICLE
I.<BR>
DEFINITIONS</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 1pc; text-align: justify; text-indent: 3pc">1.1 <U>Definitions</U>. In
addition to the terms defined elsewhere in this Agreement, for all purposes of this Agreement, the following terms have the meanings set
forth in this Section 1.1:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 1pc; text-align: justify; text-indent: 3pc">&ldquo;<U>Acquiring Person</U>&rdquo;
shall have the meaning ascribed to such term in Section 4.5.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 1pc; text-align: justify; text-indent: 3pc">&ldquo;<U>Action</U>&rdquo;
shall have the meaning ascribed to such term in Section 3.1(j).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 1pc; text-align: justify; text-indent: 3pc">&ldquo;<U>Affiliate</U>&rdquo;
means any Person that, directly or indirectly through one or more intermediaries, controls or is controlled by or is under common control
with a Person, as such terms are used in and construed under Rule 405 under the Securities Act.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 1pc; text-align: justify; text-indent: 3pc">&ldquo;<U>BHCA</U>&rdquo;
shall have the meaning ascribed to such term in Section 3.1(mm).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 1pc; text-align: justify; text-indent: 3pc">&ldquo;<U>Board of Directors</U>&rdquo;
means the board of directors of the Company.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 1pc; text-align: justify; text-indent: 3pc">&ldquo;<U>Business Day</U>&rdquo;
means any day except any Saturday, any Sunday, any day which is a federal legal holiday in the United States or any day on which banking
institutions in the State of Florida are authorized or required by law or other governmental action to close; <U>provided</U>, <U>however</U>,
for clarification, banking institutions shall not be deemed to be authorized or required by law or other governmental actions to close
due to &ldquo;stay at home,&rdquo; &ldquo;shelter-in-place,&rdquo; &ldquo;non-essential employee&rdquo; or other similar orders or restrictions
or the closure of any physical branch locations at the direction of any governmental authority so long as the electronic funds transfer
system (including for wire transfers) of banks in the State of Florida generally are open for use by customers on such day.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 1pc; text-align: justify; text-indent: 3pc">&ldquo;<U>Closing</U>&rdquo;
means the closing of the purchase and sale of the Shares pursuant to Section 2.1.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 1pc; text-align: justify; text-indent: 3pc">&ldquo;<U>Closing Date</U>&rdquo;
means the Trading Day on which all of the Transaction Documents have been executed and delivered by the applicable parties thereto, and
all conditions precedent to (i) the Purchasers&rsquo; obligations to pay the Subscription Amount and (ii) the Company&rsquo;s obligations
to deliver the Shares, in each case, have been satisfied or waived.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 1pc; text-align: justify; text-indent: 3pc">&ldquo;<U>Commission</U>&rdquo;
means the United States Securities and Exchange Commission.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 1pc; text-align: justify; text-indent: 3pc">&ldquo;<U>Common Stock</U>&rdquo;
means the common stock of the Company, par value $0.001 per share, and any other class of securities into which such securities may hereafter
be reclassified or changed.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 1pc; text-align: justify; text-indent: 3pc">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 1pc; text-align: justify; text-indent: 3pc">&nbsp;</P>


<!-- Field: Page; Sequence: 1 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%"><TR STYLE="font-size: 10pt"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->1<!-- Field: /Sequence -->&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%"><TR><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 1pc; text-align: justify; text-indent: 3pc">&ldquo;<U>Common Stock Equivalents</U>&rdquo;
means any securities of the Company or the Subsidiaries which would entitle the holder thereof to acquire at any time Common Stock, including,
without limitation, any debt, preferred stock, right, option, warrant or other instrument that is at any time convertible into or exercisable
or exchangeable for, or otherwise entitles the holder thereof to receive, Common Stock.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 1pc; text-align: justify; text-indent: 3pc">&ldquo;<U>Common Stock Shares</U>&rdquo;
means the shares of Common Stock issuable at Closing to a Purchaser pursuant to this Agreement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 1pc; text-align: justify; text-indent: 3pc">&ldquo;<U>Company Counsel</U>&rdquo;
means Shutts &amp; Bowen LLP, 200 S. Biscayne Blvd, Suite 4100, Miami, Florida 33131.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 1pc; text-align: justify; text-indent: 3pc">&ldquo;<U>Conversion Shares</U>&rdquo;
means the shares of Common Stock issuable upon conversion of the Preferred Stock.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 1pc; text-align: justify; text-indent: 3pc">&ldquo;<U>Disclosure Schedules</U>&rdquo;
shall have the meaning ascribed to such term in Section 3.1.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 1pc; text-align: justify; text-indent: 3pc">&ldquo;<U>Disqualification
Event</U>&rdquo; shall have the meaning ascribed to such term in Section 3.1(oo).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 1pc; text-align: justify; text-indent: 3pc">&ldquo;<U>Effective Date</U>&rdquo;
means the earliest of the date that (a) the initial Registration Statement has been declared effective by the Commission, (b) all of the
Common Stock Shares and Conversion Shares have been sold pursuant to Rule 144 or may be sold pursuant to Rule 144 without the requirement
for the Company to be in compliance with the current public information required under Rule 144 and without volume or manner-of-sale restrictions
or (c) following the one-year anniversary of the Closing Date provided that a holder of Common Stock Shares or Conversion Shares is not
an Affiliate of the Company, all of the Common Stock Shares and Conversion Shares may be sold pursuant to an exemption from registration
under Section 4(1) of the Securities Act without volume or manner-of-sale restrictions and Company Counsel has delivered to the Transfer
Agent for the benefit of such holders (and, if required by a holder, to such holder or such holder&rsquo;s custodian or prime broker)
a standing written unqualified opinion that resales may then be made by such holders of the Common Stock Shares and Conversion Shares
pursuant to such exemption which opinion shall be in form and substance reasonably acceptable to such holders.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 1pc; text-align: justify; text-indent: 3pc">&ldquo;<U>Environmental Laws</U>&rdquo;
shall have the meaning ascribed to such term in Section 3.1(m)</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 1pc; text-align: justify; text-indent: 3pc">&ldquo;<U>Evaluation Date</U>&rdquo;
shall have the meaning ascribed to such term in Section 3.1(s).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 1pc; text-align: justify; text-indent: 3pc">&ldquo;<U>Exchange Act</U>&rdquo;
means the Securities Exchange Act of 1934, as amended, and the rules and regulations promulgated thereunder.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 1pc; text-align: justify; text-indent: 3pc">&ldquo;<U>FCPA</U>&rdquo;
means the Foreign Corrupt Practices Act of 1977, as amended.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 1pc; text-align: justify; text-indent: 3pc">&ldquo;<U>GAAP</U>&rdquo;
shall have the meaning ascribed to such term in Section 3.1(h).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 1pc; text-align: justify; text-indent: 3pc">&ldquo;<U>Indebtedness</U>&rdquo;
shall have the meaning ascribed to such term in Section 3.1(bb).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 1pc; text-align: justify; text-indent: 3pc">&ldquo;<U>Intellectual Property
Rights</U>&rdquo; shall have the meaning ascribed to such term in Section 3.1(p).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 1pc; text-align: justify; text-indent: 3pc">&ldquo;<U>Legend Removal Date</U>&rdquo;
shall have the meaning ascribed to such term in Section 4.1(c).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 1pc; text-align: justify; text-indent: 3pc">&ldquo;<U>Liens</U>&rdquo;
means a lien, charge, pledge, security interest, encumbrance, right of first refusal, preemptive right or other restriction.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 1pc; text-align: justify; text-indent: 3pc">&ldquo;<U>Material Adverse
Effect</U>&rdquo; shall have the meaning ascribed to such term in Section 3.1(b).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 1pc; text-align: justify; text-indent: 3pc">&ldquo;<U>Material Permits</U>&rdquo;
shall have the meaning ascribed to such term in Section 3.1(m).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 1pc; text-align: justify; text-indent: 3pc">&ldquo;<U>Per Share Purchase
Price</U>&rdquo; equals $3.00 per Common Stock Share and $1,000.00 per share of Preferred Stock.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 1pc; text-align: justify; text-indent: 3pc">&ldquo;<U>Person</U>&rdquo;
means an individual or corporation, partnership, trust, incorporated or unincorporated association, joint venture, limited liability company,
joint stock company, government (or an agency or subdivision thereof) or other entity of any kind.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 1pc; text-align: justify; text-indent: 3pc">&ldquo;<U>Placement Agent</U>&rdquo;
means Northland Securities, Inc.</P>


<!-- Field: Page; Sequence: 2 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%"><TR STYLE="font-size: 10pt"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->2<!-- Field: /Sequence -->&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%"><TR><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 1pc; text-align: justify; text-indent: 3pc">&ldquo;<U>Preferred Stock</U>&rdquo;
means the preferred stock of the Company, par value $0.001 per share, designated as Series D Preferred Stock which shall have the rights,
preferences, restrictions and other matters relating to a series of preferred stock as set forth in the Certificate of Designation of
Preferences, Rights and Limitations attached as <U>Exhibit A</U> hereto (the &ldquo;<U>Certificate of Designation</U>&rdquo;).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 1pc; text-align: justify; text-indent: 3pc">&ldquo;<U>Proceeding</U>&rdquo;
means an action, claim, suit, investigation or proceeding (including, without limitation, an informal investigation or partial proceeding,
such as a deposition), whether commenced or threatened.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 1pc; text-align: justify; text-indent: 3pc">&ldquo;<U>Purchaser Party</U>&rdquo;
shall have the meaning ascribed to such term in Section 4.8.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 1pc; text-align: justify; text-indent: 3pc">&ldquo;<U>Registration Rights
Agreement</U>&rdquo; means the Registration Rights Agreement, dated as of the date hereof, among the Company and the Purchasers, in the
form of <U>Exhibit B</U> attached hereto.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 1pc; text-align: justify; text-indent: 3pc">&ldquo;<U>Registration Statement</U>&rdquo;
means a registration statement meeting the requirements set forth in the Registration Rights Agreement and covering the resale by the
Purchasers of the Common Stock Shares and the Conversion Shares.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 1pc; text-align: justify; text-indent: 3pc">&ldquo;<U>Required Approvals</U>&rdquo;
shall have the meaning ascribed to such term in Section 3.1(e).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 1pc; text-align: justify; text-indent: 3pc">&ldquo;<U>Rule 144</U>&rdquo;
means Rule 144 promulgated by the Commission pursuant to the Securities Act, as such Rule may be amended or interpreted from time to time,
or any similar rule or regulation hereafter adopted by the Commission having substantially the same purpose and effect as such Rule.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 1pc; text-align: justify; text-indent: 3pc">&ldquo;<U>Rule 424</U>&rdquo;
means Rule 424 promulgated by the Commission pursuant to the Securities Act, as such Rule may be amended or interpreted from time to time,
or any similar rule or regulation hereafter adopted by the Commission having substantially the same purpose and effect as such Rule.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 1pc; text-align: justify; text-indent: 3pc">&ldquo;<U>SEC Reports</U>&rdquo;
shall have the meaning ascribed to such term in Section 3.1(h).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 1pc; text-align: justify; text-indent: 3pc">&ldquo;<U>Securities Act</U>&rdquo;
means the Securities Act of 1933, as amended, and the rules and regulations promulgated thereunder.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 1pc; text-align: justify; text-indent: 3pc">&ldquo;<U>Shares</U>&rdquo;
means the shares of Preferred Stock and/or Common Stock issuable at Closing to each Purchaser pursuant to this Agreement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 1pc; text-align: justify; text-indent: 3pc">&ldquo;<U>Short Sales</U>&rdquo;
means all &ldquo;short sales&rdquo; as defined in Rule 200 of Regulation SHO under the Exchange Act.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 1pc; text-align: justify; text-indent: 3pc">&ldquo;<U>Stockholder Approval</U>&rdquo;
means such approval as may be required by the applicable rules and regulations of the Nasdaq Stock Market (or any successor entity) from
the stockholders of the Company with respect to the transactions contemplated by the Transaction Documents, including the issuance of
all of the Conversion Shares in excess of 19.99% of the issued and outstanding Common Stock on the Closing Date and pursuant to this Agreement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 1pc; text-align: justify; text-indent: 3pc">&ldquo;<U>Subscription Amount</U>&rdquo;
means, as to each Purchaser, the aggregate amount to be paid for the Shares purchased hereunder as specified below such Purchaser&rsquo;s
name on the signature page of this Agreement and next to the heading &ldquo;Subscription Amount,&rdquo; in United States dollars and in
immediately available funds.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 1pc; text-align: justify; text-indent: 3pc">&ldquo;<U>Subsidiary</U>&rdquo;
means any subsidiary of the Company as set forth on <U>Schedule 3.1(a)</U> and shall, where applicable, also include any direct or indirect
subsidiary of the Company formed or acquired after the date hereof.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 1pc; text-align: justify; text-indent: 3pc">&ldquo;<U>Trading Day</U>&rdquo;
means a day on which the principal Trading Market is open for trading.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 1pc; text-align: justify; text-indent: 3pc">&ldquo;<U>Trading Market</U>&rdquo;
means any of the following markets or exchanges on which the Common Stock is listed or quoted for trading on the date in question: the
NYSE American, the Nasdaq Capital Market, the Nasdaq Global Market, the Nasdaq Global Select Market, the New York Stock Exchange, OTCQB
or OTCQX (or any successors to any of the foregoing).</P>


<!-- Field: Page; Sequence: 3 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%"><TR STYLE="font-size: 10pt"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->3<!-- Field: /Sequence -->&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%"><TR><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 1pc; text-align: justify; text-indent: 3pc">&ldquo;<U>Transaction Documents</U>&rdquo;
means this Agreement, the Certificate of Designation, the Registration Rights Agreement, all exhibits and schedules thereto and hereto
and any other documents or agreements executed in connection with the transactions contemplated hereunder.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 1pc; text-align: justify; text-indent: 3pc">&ldquo;<U>Transfer Agent</U>&rdquo;
means Continental Stock Transfer &amp; Trust, the current transfer agent of the Company, with a mailing address of 1 State Street, 30<SUP>th</SUP>
Floor, New York, New York 10004, and any successor transfer agent of the Company.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 1pc; text-align: center"><FONT STYLE="text-transform: uppercase"><B>ARTICLE
II.<BR>
PURCHASE AND SALE</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 1pc; text-align: justify; text-indent: 3pc">2.1 <U>Closing</U>. On the
Closing Date, upon the terms and subject to the conditions set forth herein, substantially concurrent with the execution and delivery
of this Agreement by the parties hereto, the Company shall sell, and the Purchasers, severally and not jointly, shall purchase, up to
an aggregate of $5,000,000 of Common Stock and Preferred Stock (of which no more than $3,735,400 will be Common Stock Shares). Each Purchaser
shall deliver to the Company, via wire transfer, immediately available funds equal to such Purchaser&rsquo;s Subscription Amount as set
forth on the signature page hereto executed by such Purchaser, and the Company shall deliver to each Purchaser its respective Shares,
and the Company and each Purchaser shall deliver the other items set forth in Section 2.2 deliverable at the Closing. Upon satisfaction
of the covenants and conditions set forth in Sections 2.2 and 2.3, the Closing shall occur at the offices of Company Counsel or such other
location as the parties shall mutually agree. All share prices set forth herein are subject to automatic adjustment for any stock split
or reverse stock split occurring prior to Closing.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 1pc; text-align: justify; text-indent: 3pc">2.2 <U>Deliveries</U>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 1pc; text-align: justify; text-indent: 6pc">(a) On or prior to the Closing
Date, the Company shall deliver or cause to be delivered to each Purchaser the following:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 1pc; text-align: justify; text-indent: 9pc">(i) this Agreement duly executed
by the Company;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 1pc; text-align: justify; text-indent: 9pc">(ii) a legal opinion of Company
Counsel, substantially in the form of <U>Exhibit&nbsp;C</U> attached hereto;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 1pc; text-align: justify; text-indent: 9pc">(iii) a copy of the irrevocable
instructions to the Transfer Agent instructing the Transfer Agent to deliver, on an expedited basis, a certificate evidencing a number
of Shares purchased by such Purchaser, registered in the name of such Purchaser;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 1pc; text-align: justify; text-indent: 9pc">(iv) for each Purchaser purchasing
shares of Preferred Stock, a stamped filed copy of the Certificate of Designation, as filed with the Secretary of State of the State of
Florida; and</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 1pc; text-align: justify; text-indent: 9pc">(v) the Registration Rights
Agreement duly executed by the Company.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 1pc; text-align: justify; text-indent: 6pc">(b) On or prior to the Closing
Date, each Purchaser shall deliver or cause to be delivered to the Company, the following:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 1pc; text-align: justify; text-indent: 9pc">(i) this Agreement duly executed
by such Purchaser;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 1pc; text-align: justify; text-indent: 9pc">(ii) to the Company, such
Purchaser&rsquo;s Subscription Amount by wire transfer to the account specified in writing by the Company; and</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 1pc; text-align: justify; text-indent: 9pc">(iii) the Registration Rights
Agreement duly executed by such Purchaser.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 1pc; text-align: justify; text-indent: 3pc">2.3 <U>Closing Conditions</U>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 1pc; text-align: justify; text-indent: 6pc">(a) The obligations of the
Company hereunder in connection with the Closing are subject to the following conditions being met:</P>


<!-- Field: Page; Sequence: 4 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%"><TR STYLE="font-size: 10pt"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->4<!-- Field: /Sequence -->&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%"><TR><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 1pc; text-align: justify; text-indent: 9pc">(i) the accuracy in all material
respects (or, to the extent representations or warranties are qualified by materiality or Material Adverse Effect, in all respects) on
the Closing Date of the representations and warranties of the Purchasers contained herein (unless as of a specific date therein in which
case they shall be accurate as of such date);</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 1pc; text-align: justify; text-indent: 9pc">(ii) all obligations, covenants
and agreements of each Purchaser required to be performed at or prior to the Closing Date shall have been performed; and</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 1pc; text-align: justify; text-indent: 9pc">(iii) the delivery by each
Purchaser of the items set forth in Section 2.2(b) of this Agreement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 1pc; text-align: justify; text-indent: 6pc">(b) The respective obligations
of the Purchasers hereunder in connection with the Closing are subject to the following conditions being met:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 1pc; text-align: justify; text-indent: 9pc">(i) the accuracy in all material
respects (or, to the extent representations or warranties are qualified by materiality or Material Adverse Effect, in all respects) when
made and on the Closing Date of the representations and warranties of the Company contained herein (unless as of a specific date therein
in which case they shall be accurate as of such date);</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 1pc; text-align: justify; text-indent: 9pc">(ii) all obligations, covenants
and agreements of the Company required to be performed at or prior to the Closing Date shall have been performed;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 1pc; text-align: justify; text-indent: 9pc">(iii) the delivery by the
Company of the items set forth in Section 2.2(a) of this Agreement;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 1pc; text-align: justify; text-indent: 9pc">(iv) there shall have been
no Material Adverse Effect with respect to the Company since the date hereof; and</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 1pc; text-align: justify; text-indent: 9pc">(v) from the date hereof to
the Closing Date, trading in the Common Stock shall not have been suspended by the Commission or the Company&rsquo;s principal Trading
Market, and, at any time prior to the Closing Date, trading in securities generally as reported by Bloomberg L.P. shall not have been
suspended or limited, or minimum prices shall not have been established on securities whose trades are reported by such service, or on
any Trading Market, nor shall a banking moratorium have been declared either by the United States or Florida State authorities nor shall
there have occurred any material outbreak or escalation of hostilities or other national or international calamity of such magnitude in
its effect on, or any material adverse change in, any financial market which, in each case, in the reasonable judgment of such Purchaser,
makes it impracticable or inadvisable to purchase the Shares at the Closing.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 1pc; text-align: center"><FONT STYLE="text-transform: uppercase"><B>ARTICLE
III.<BR>
REPRESENTATIONS AND WARRANTIES</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 1pc; text-align: justify; text-indent: 3pc">3.1 <U>Representations and
Warranties of the Company</U>. Except as set forth in the Disclosure Schedules, which Disclosure Schedules are delivered under separate
cover from this Agreement, but shall be deemed a part hereof and shall qualify any representation or warranty otherwise made herein to
the extent of the disclosure contained in the corresponding section of the Disclosure Schedules to the extent that it is reasonably apparent
on its face that such disclosure is relevant to such section, the Company hereby makes the following representations and warranties to
each Purchaser as of the date hereof and as of the Closing Date (unless as of a specific date, in which case they shall be accurate as
of such date):</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 1pc; text-align: justify; text-indent: 6pc">(a) <U>Subsidiaries</U>. All
of the direct and indirect Subsidiaries of the Company are set forth on <U>Schedule 3.1(a)</U>. The Company owns, directly or indirectly,
all of the capital stock or other equity interests of each Subsidiary free and clear of any Liens, and all of the issued and outstanding
shares of capital stock of each Subsidiary are validly issued and are fully paid, non-assessable and free of preemptive and similar rights
to subscribe for or purchase securities.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 1pc; text-align: justify; text-indent: 6pc">(b) <U>Organization and Qualification</U>.
The Company and each of the Subsidiaries is an entity duly incorporated or otherwise organized, validly existing and in good standing
under the laws of the jurisdiction of its incorporation or organization, with the requisite power and authority to own and use its properties
and assets and to carry on its business as currently conducted. Neither the Company nor any Subsidiary is in violation nor default of
any of the provisions of its respective certificate or articles of incorporation, bylaws or other organizational or charter documents.
Each of the Company and the Subsidiaries is duly qualified to conduct business and is in good standing as a foreign corporation or other
entity in each jurisdiction in which the nature of the business conducted or property owned by it makes such qualification necessary,
except where the failure to be so qualified or in good standing, as the case may be, could not have or reasonably be expected to result
in: (i) a material adverse effect on the legality, validity or enforceability of any Transaction Document, (ii) a material adverse effect
on the results of operations, assets, business, prospects or condition (financial or otherwise) of the Company and the Subsidiaries, taken
as a whole, or (iii) a material adverse effect on the Company&rsquo;s ability to perform in any material respect on a timely basis its
obligations under any Transaction Document (any of (i), (ii) or (iii), a &ldquo;<U>Material Adverse Effect</U>&rdquo;) and no Proceeding
has been instituted in any such jurisdiction revoking, limiting or curtailing or seeking to revoke, limit or curtail such power and authority
or qualification.</P>


<!-- Field: Page; Sequence: 5 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%"><TR STYLE="font-size: 10pt"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->5<!-- Field: /Sequence -->&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%"><TR><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 1pc; text-align: justify; text-indent: 6pc">(c) <U>Authorization; Enforcement</U>.
The Company has the requisite corporate power and authority to enter into and to consummate the transactions contemplated by this Agreement
and each of the other Transaction Documents and otherwise to carry out its obligations hereunder and thereunder. The execution and delivery
of each of this Agreement and the other Transaction Documents by the Company and the consummation by it of the transactions contemplated
hereby and thereby have been duly authorized by all necessary action on the part of the Company and no further action is required by the
Company, the Board of Directors or the Company&rsquo;s stockholders in connection herewith or therewith other than in connection with
the Required Approvals. This Agreement and each other Transaction Document to which the Company is a party has been (or upon delivery
will have been) duly executed by the Company and, when delivered in accordance with the terms hereof and thereof, will constitute the
valid and binding obligation of the Company enforceable against the Company in accordance with its terms, except: (i) as limited by general
equitable principles and applicable bankruptcy, insolvency, reorganization, moratorium and other laws of general application affecting
enforcement of creditors&rsquo; rights generally, (ii) as limited by laws relating to the availability of specific performance, injunctive
relief or other equitable remedies and (iii) insofar as indemnification and contribution provisions may be limited by applicable law or
public policy.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 1pc; text-align: justify; text-indent: 6pc">(d) <U>No Conflicts</U>. The
execution, delivery and performance by the Company of this Agreement and the other Transaction Documents to which it is a party, the issuance
and sale of the Shares and the consummation by it of the transactions contemplated hereby and thereby do not and will not: (i) conflict
with or violate any provision of the Company&rsquo;s or any Subsidiary&rsquo;s certificate or articles of incorporation, bylaws or other
organizational or charter documents, (ii) conflict with, or constitute a default (or an event that with notice or lapse of time or both
would become a default) under, result in the creation of any Lien upon any of the properties or assets of the Company or any Subsidiary,
or give to others any rights of termination, amendment, acceleration or cancellation (with or without notice, lapse of time or both) of,
any agreement, credit facility, debt or other instrument (evidencing a Company or Subsidiary debt or otherwise) or other understanding
to which the Company or any Subsidiary is a party or by which any property or asset of the Company or any Subsidiary is bound or affected,
or (iii) subject to the Required Approvals, conflict with or result in a violation of any law, rule, regulation, order, judgment, injunction,
decree or other restriction of any court or governmental authority to which the Company or a Subsidiary is subject (including federal
and state securities laws and regulations), or by which any property or asset of the Company or a Subsidiary is bound or affected; except
in the case of each of clauses (ii) and (iii), such as could not have or reasonably be expected to result in a Material Adverse Effect.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 1pc; text-align: justify; text-indent: 6pc">(e) <U>Filings, Consents and
Approvals</U>. The Company is not required to obtain any consent, waiver, authorization or order of, give any notice to, or make any filing
or registration with, any court or other federal, state, local or other governmental authority or other Person in connection with the
execution, delivery and performance by the Company of the Transaction Documents, other than: (i) the filings required pursuant to Section
4.4 of this Agreement, (ii) the filings with the Commission pursuant to the Registration Rights Agreement, (iii) the notice and/or application(s)
to each applicable Trading Market for the issuance and sale of the Shares and the listing of the Common Stock Shares and the Conversion
Shares for trading thereon in the time and manner required thereby, and (iv) the filing of Form D with the Commission and such filings
as are required to be made under applicable state securities laws (collectively, the &ldquo;<U>Required Approvals</U>&rdquo;).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 1pc; text-align: justify; text-indent: 6pc">(f) <U>Issuance of the Shares</U>.
The Shares are duly authorized and, when issued and paid for in accordance with the applicable Transaction Documents, will be duly and
validly issued, fully paid and nonassessable, free and clear of all Liens imposed by the Company other than restrictions on transfer provided
for in the Transaction Documents. The Conversion Shares, when issued in accordance with the Preferred Stock and the Transaction Documents
will be validly issued, fully paid and non-assessable, free and clear of all Liens imposed by the Company other than restrictions on transfer
provided for in the Transaction Documents. The Company has reserved from its duly authorized capital stock the maximum number of Conversion
Shares issuable pursuant to this Agreement, the Certificate of Designation and the Preferred Stock.</P>


<!-- Field: Page; Sequence: 6 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%"><TR STYLE="font-size: 10pt"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->6<!-- Field: /Sequence -->&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%"><TR><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 1pc; text-align: justify; text-indent: 6pc">(g) <U>Capitalization</U>.
The capitalization of the Company is as set forth on <U>Schedule 3.1(g)</U>, which <U>Schedule 3.1(g)</U> shall also include the number
of shares of Common Stock owned beneficially, and of record, by Affiliates of the Company as of the date hereof. Except as set forth on
<U>Schedule 3.1(g)</U>, the Company has not issued any capital stock since its most recently filed periodic report under the Exchange
Act, other than pursuant to the exercise of employee stock options under the Company&rsquo;s stock option plans, the issuance of shares
of Common Stock to employees pursuant to the Company&rsquo;s employee stock purchase plans and pursuant to the conversion and/or exercise
of Common Stock Equivalents outstanding as of the date of the most recently filed periodic report under the Exchange Act. No Person has
any right of first refusal, preemptive right, right of participation, or any similar right to participate in the transactions contemplated
by the Transaction Documents. Except as a result of the purchase and sale of the Shares or as set forth in <U>Schedule 3.1(g)</U>, there
are no outstanding options, warrants, scrip rights to subscribe to, calls or commitments of any character whatsoever relating to, or securities,
rights or obligations convertible into or exercisable or exchangeable for, or giving any Person any right to subscribe for or acquire
any shares of Common Stock or the capital stock of any Subsidiary, or contracts, commitments, understandings or arrangements by which
the Company or any Subsidiary is or may become bound to issue additional shares of Common Stock or Common Stock Equivalents or capital
stock of any Subsidiary. The issuance and sale of the Shares will not obligate the Company or any Subsidiary to issue shares of Common
Stock or other securities to any Person (other than the Purchasers) and will not result in a right of any holder of Company securities
to adjust the exercise, conversion, exchange or reset price under any of such securities. There are no outstanding securities or instruments
of the Company or any Subsidiary that contain any redemption or similar provisions, and there are no contracts, commitments, understandings
or arrangements by which the Company or any Subsidiary is or may become bound to redeem a security of the Company or such Subsidiary.
The Company does not have any stock appreciation rights or &ldquo;phantom stock&rdquo; plans or any similar plan or agreement. All of
the outstanding shares of capital stock of the Company are duly authorized, validly issued, fully paid and nonassessable, have been issued
in compliance with all federal and state securities laws, and none of such outstanding shares was issued in violation of any preemptive
rights or similar rights to subscribe for or purchase securities. No further approval or authorization of any stockholder, the Board of
Directors or others is required for the issuance and sale of the Shares. There are no stockholder agreements, voting agreements or other
similar agreements with respect to the Company&rsquo;s capital stock to which the Company is a party or, to the knowledge of the Company,
between or among any of the Company&rsquo;s stockholders.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 1pc; text-align: justify; text-indent: 6pc">(h) <U>SEC Reports; Financial
Statements</U>. The Company has filed all reports, schedules, forms, statements and other documents required to be filed by the Company
under the Securities Act and the Exchange Act, including pursuant to Section 13(a) or 15(d) thereof, for the two years preceding the date
hereof (or such shorter period as the Company was required by law or regulation to file such material) (the foregoing materials, including
the exhibits thereto and documents incorporated by reference therein, being collectively referred to herein as the &ldquo;<U>SEC Reports</U>&rdquo;)
on a timely basis or has received a valid extension of such time of filing and has filed any such SEC Reports prior to the expiration
of any such extension. As of their respective dates, the SEC Reports complied in all material respects with the requirements of the Securities
Act and the Exchange Act, as applicable, and none of the SEC Reports, when filed, contained any untrue statement of a material fact or
omitted to state a material fact required to be stated therein or necessary in order to make the statements therein, in the light of the
circumstances under which they were made, not misleading. The Company has never been an issuer subject to Rule 144(i) under the Securities
Act. The financial statements of the Company included in the SEC Reports comply in all material respects with applicable accounting requirements
and the rules and regulations of the Commission with respect thereto as in effect at the time of filing. Such financial statements have
been prepared in accordance with United States generally accepted accounting principles applied on a consistent basis during the periods
involved (&ldquo;<U>GAAP</U>&rdquo;), except as may be otherwise specified in such financial statements or the notes thereto and except
that unaudited financial statements may not contain all footnotes required by GAAP, and fairly present in all material respects the financial
position of the Company and its consolidated Subsidiaries as of and for the dates thereof and the results of operations and cash flows
for the periods then ended, subject, in the case of unaudited statements, to normal, immaterial, year-end audit adjustments.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 1pc; text-align: justify; text-indent: 6pc">(i) <U>Material Changes; Undisclosed
Events, Liabilities or Developments</U>. Since the date of the latest audited financial statements included within the SEC Reports, except
as set forth on <U>Schedule 3.1(i)</U> or in the SEC Reports: (i) there has been no event, occurrence or development that has had or that
could reasonably be expected to result in a Material Adverse Effect, (ii) the Company has not incurred any liabilities (contingent or
otherwise) other than (A) trade payables and accrued expenses incurred in the ordinary course of business consistent with past practice
and (B) liabilities not required to be reflected in the Company&rsquo;s financial statements pursuant to GAAP or disclosed in filings
made with the Commission, (iii) the Company has not altered its method of accounting, (iv) the Company has not declared or made any dividend
or distribution of cash or other property to its stockholders or purchased, redeemed or made any agreements to purchase or redeem any
shares of its capital stock and (v) the Company has not issued any equity securities to any officer, director or Affiliate, except pursuant
to existing Company stock option plans. The Company does not have pending before the Commission any request for confidential treatment
of information. Except for the issuance of the Shares contemplated by this Agreement or as set forth on <U>Schedule 3.1(i)</U>, no event,
liability, fact, circumstance, occurrence or development has occurred or exists, or is reasonably expected to occur or exist, with respect
to the Company or its Subsidiaries or their respective businesses, properties, operations, assets or financial condition, that would be
required to be disclosed by the Company under applicable securities laws at the time this representation is made or deemed made that has
not been publicly disclosed at least 1 Trading Day prior to the date that this representation is made.</P>


<!-- Field: Page; Sequence: 7 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%"><TR STYLE="font-size: 10pt"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->7<!-- Field: /Sequence -->&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%"><TR><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 1pc; text-align: justify; text-indent: 6pc">(j) <U>Litigation</U>. There
is no action, suit, inquiry, notice of violation, proceeding or investigation pending or, to the knowledge of the Company, threatened
against or affecting the Company, any Subsidiary or any of their respective properties before or by any court, arbitrator, governmental
or administrative agency or regulatory authority (federal, state, county, local or foreign) (collectively, an &ldquo;<U>Action</U>&rdquo;)
which (i) adversely affects or challenges the legality, validity or enforceability of any of the Transaction Documents or the Shares or
(ii) could, if there were an unfavorable decision, have or reasonably be expected to result in a Material Adverse Effect. Neither the
Company nor any Subsidiary, nor, to the knowledge of the Company, any director or officer thereof, is or has been the subject of any Action
involving a claim of violation of or liability under federal or state securities laws or a claim of breach of fiduciary duty. There has
not been, and to the knowledge of the Company, there is not pending or contemplated, any investigation by the Commission involving the
Company or any current or former director or officer of the Company. The Commission has not issued any stop order or other order suspending
the effectiveness of any registration statement filed by the Company or any Subsidiary under the Exchange Act or the Securities Act.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 1pc; text-align: justify; text-indent: 6pc">(k) <U>Labor Relations</U>.
No labor dispute exists or, to the knowledge of the Company, is imminent with respect to any of the employees of the Company, which could
reasonably be expected to result in a Material Adverse Effect. None of the Company&rsquo;s or its Subsidiaries&rsquo; employees is a member
of a union that relates to such employee&rsquo;s relationship with the Company or such Subsidiary, and neither the Company nor any of
its Subsidiaries is a party to a collective bargaining agreement, and the Company and its Subsidiaries believe that their relationships
with their employees are good. To the knowledge of the Company, no executive officer of the Company or any Subsidiary is, or is now expected
to be, in violation of any material term of any employment contract, confidentiality, disclosure or proprietary information agreement
or non-competition agreement, or any other contract or agreement or any restrictive covenant in favor of any third party, and the continued
employment of each such executive officer does not subject the Company or any of its Subsidiaries to any liability with respect to any
of the foregoing matters. The Company and its Subsidiaries are in compliance with all U.S. federal, state, local and foreign laws and
regulations relating to employment and employment practices, terms and conditions of employment and wages and hours, except where the
failure to be in compliance could not, individually or in the aggregate, reasonably be expected to have a Material Adverse Effect.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 1pc; text-align: justify; text-indent: 6pc">(l) <U>Compliance</U>. Neither
the Company nor any Subsidiary: (i) is in default under or in violation of (and no event has occurred that has not been waived that, with
notice or lapse of time or both, would result in a default by the Company or any Subsidiary under), nor has the Company or any Subsidiary
received notice of a claim that it is in default under or that it is in violation of, any indenture, loan or credit agreement or any other
agreement or instrument to which it is a party or by which it or any of its properties is bound (whether or not such default or violation
has been waived), (ii) is in violation of any judgment, decree, or order of any court, arbitrator or other governmental authority or (iii)
is or has been in violation of any statute, rule, ordinance or regulation of any governmental authority, including without limitation
all foreign, federal, state and local laws relating to taxes, environmental protection, occupational health and safety, product quality
and safety and employment and labor matters, except in each case as could not have or reasonably be expected to result in a Material Adverse
Effect.</P>


<!-- Field: Page; Sequence: 8 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%"><TR STYLE="font-size: 10pt"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->8<!-- Field: /Sequence -->&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%"><TR><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 1pc; text-align: justify; text-indent: 6pc">(m) <U>Environmental Laws</U>.
The Company and its Subsidiaries (i) are in compliance with all federal, state, local and foreign laws relating to pollution or protection
of human health or the environment (including ambient air, surface water, groundwater, land surface or subsurface strata), including laws
relating to emissions, discharges, releases or threatened releases of chemicals, pollutants, contaminants, or toxic or hazardous substances
or wastes (collectively, &ldquo;<U>Hazardous Materials</U>&rdquo;) into the environment, or otherwise relating to the manufacture, processing,
distribution, use, treatment, storage, disposal, transport or handling of Hazardous Materials, as well as all authorizations, codes, decrees,
demands, or demand letters, injunctions, judgments, licenses, notices or notice letters, orders, permits, plans or regulations, issued,
entered, promulgated or approved thereunder (&ldquo;<U>Environmental Laws</U>&rdquo;); (ii) have received all permits, licenses or other
approvals required of them under applicable Environmental Laws to conduct their respective businesses; and (iii) are in compliance with
all terms and conditions of any such permit, license or approval where in each clause (i), (ii) and (iii), the failure to so comply could
be reasonably expected to have, individually or in the aggregate, a Material Adverse Effect.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 1pc; text-align: justify; text-indent: 6pc">(n) <U>Regulatory Permits</U>.
The Company and the Subsidiaries possess all certificates, authorizations and permits issued by the appropriate federal, state, local
or foreign regulatory authorities necessary to conduct their respective businesses as described in the SEC Reports, except where the failure
to possess such permits could not reasonably be expected to result in a Material Adverse Effect (&ldquo;<U>Material Permits</U>&rdquo;),
and neither the Company nor any Subsidiary has received any notice of proceedings relating to the revocation or modification of any Material
Permit.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 1pc; text-align: justify; text-indent: 6pc">(o) <U>Title to Assets</U>.
The Company and the Subsidiaries have good and marketable title in fee simple to all real property owned by them and good and marketable
title in all personal property owned by them that is material to the business of the Company and the Subsidiaries, in each case free and
clear of all Liens, except for (i) Liens as do not materially affect the value of such property and do not materially interfere with the
use made and proposed to be made of such property by the Company and the Subsidiaries and (ii) Liens for the payment of federal, state
or other taxes, for which appropriate reserves have been made therefor in accordance with GAAP and the payment of which is neither delinquent
nor subject to penalties. Any real property and facilities held under lease by the Company and the Subsidiaries are held by them under
valid, subsisting and enforceable leases with which the Company and the Subsidiaries are in compliance.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 1pc; text-align: justify; text-indent: 6pc">(p) <U>Intellectual Property</U>.
The Company and the Subsidiaries have, or have rights to use, all patents, patent applications, trademarks, trademark applications, service
marks, trade names, trade secrets, inventions, copyrights, licenses and other intellectual property rights and similar rights as described
in the SEC Reports as necessary or required for use in connection with their respective businesses and which the failure to so have could
have a Material Adverse Effect (collectively, the &ldquo;<U>Intellectual Property Rights</U>&rdquo;). None of, and neither the Company
nor any Subsidiary has received a notice (written or otherwise) that any of, the Intellectual Property Rights has expired, terminated
or been abandoned, or is expected to expire or terminate or be abandoned, within two (2) years from the date of this Agreement. Neither
the Company nor any Subsidiary has received, since the date of the latest audited financial statements included within the SEC Reports,
a written notice of a claim or otherwise has any knowledge that the Intellectual Property Rights violate or infringe upon the rights of
any Person, except as could not have or reasonably be expected to not have a Material Adverse Effect. To the knowledge of the Company,
all such Intellectual Property Rights are enforceable and there is no existing infringement by another Person of any of the Intellectual
Property Rights. The Company and its Subsidiaries have taken reasonable security measures to protect the secrecy, confidentiality and
value of all of their intellectual properties, except where failure to do so could not, individually or in the aggregate, reasonably be
expected to have a Material Adverse Effect.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 1pc; text-align: justify; text-indent: 6pc">(q) <U>Insurance</U>. The
Company and the Subsidiaries are insured by insurers of recognized financial responsibility against such losses and risks and in such
amounts as are prudent and customary in the businesses in which the Company and the Subsidiaries are engaged, including, but not limited
to, directors and officers insurance coverage at least equal to the dollar amount specified on <U>Schedule 3.1(q)</U>. Neither the Company
nor any Subsidiary has any reason to believe that it will not be able to renew its existing insurance coverage as and when such coverage
expires or to obtain similar coverage from similar insurers as may be necessary to continue its business without a significant increase
in cost.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 1pc; text-align: justify; text-indent: 6pc">(r) <U>Transactions With Affiliates
and Employees</U>. None of the officers or directors of the Company or any Subsidiary and, to the knowledge of the Company, none of the
employees of the Company or any Subsidiary is presently a party to any transaction with the Company or any Subsidiary (other than for
services as employees, officers and directors), including any contract, agreement or other arrangement providing for the furnishing of
services to or by, providing for rental of real or personal property to or from, providing for the borrowing of money from or lending
of money to or otherwise requiring payments to or from any officer, director or such employee or, to the knowledge of the Company, any
entity in which any officer, director, or any such employee has a substantial interest or is an officer, director, trustee, stockholder,
member or partner, in each case in excess of $120,000 other than for: (i) payment of salary or consulting fees for services rendered,
(ii) reimbursement for expenses incurred on behalf of the Company and (iii) other employee benefits, including stock option agreements
under any stock option plan of the Company.</P>


<!-- Field: Page; Sequence: 9 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%"><TR STYLE="font-size: 10pt"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->9<!-- Field: /Sequence -->&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%"><TR><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 1pc; text-align: justify; text-indent: 6pc">(s) <U>Sarbanes-Oxley; Internal
Accounting Controls</U>. The Company and the Subsidiaries are in material compliance with any and all applicable requirements of the Sarbanes-Oxley
Act of 2002 that are effective as of the date hereof, and any and all applicable rules and regulations promulgated by the Commission thereunder
that are effective as of the date hereof and as of the Closing Date. The Company and the Subsidiaries maintain a system of internal accounting
controls sufficient to provide reasonable assurance that: (i) transactions are executed in accordance with management&rsquo;s general
or specific authorizations, (ii) transactions are recorded as necessary to permit preparation of financial statements in conformity with
GAAP and to maintain asset accountability, (iii) access to assets is permitted only in accordance with management&rsquo;s general or specific
authorization, and (iv) the recorded accountability for assets is compared with the existing assets at reasonable intervals and appropriate
action is taken with respect to any differences. The Company and the Subsidiaries have established disclosure controls and procedures
(as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) for the Company and the Subsidiaries and designed such disclosure controls
and procedures to ensure that information required to be disclosed by the Company in the reports it files or submits under the Exchange
Act is recorded, processed, summarized and reported, within the time periods specified in the Commission&rsquo;s rules and forms. The
Company&rsquo;s certifying officers have evaluated the effectiveness of the disclosure controls and procedures of the Company and the
Subsidiaries as of the end of the period covered by the most recently filed periodic report under the Exchange Act (such date, the &ldquo;<U>Evaluation
Date</U>&rdquo;). The Company presented in its most recently filed periodic report under the Exchange Act the conclusions of the certifying
officers about the effectiveness of the disclosure controls and procedures based on their evaluations as of the Evaluation Date. Since
the Evaluation Date, there have been no changes in the internal control over financial reporting (as such term is defined in the Exchange
Act) of the Company and its Subsidiaries that have materially affected, or is reasonably likely to materially affect, the internal control
over financial reporting of the Company or its Subsidiaries.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 1pc; text-align: justify; text-indent: 6pc">(t) <U>Certain Fees</U>. Other
than the commissions and expenses payable to the Placement Agent, no brokerage or finder&rsquo;s fees or commissions are or will be payable
by the Company or any Subsidiary to any broker, financial advisor or consultant, finder, placement agent, investment banker, bank or other
Person with respect to the transactions contemplated by the Transaction Documents. The Purchasers shall have no obligation with respect
to any fees or with respect to any claims made by or on behalf of other Persons for fees of a type contemplated in this Section that may
be due in connection with the transactions contemplated by the Transaction Documents.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 1pc; text-align: justify; text-indent: 6pc">(u) <U>Private Placement</U>.
Assuming the accuracy of the Purchasers&rsquo; representations and warranties set forth in Section 3.2, no registration under the Securities
Act is required for the offer and sale of the Shares by the Company to the Purchasers as contemplated hereby. The issuance and sale of
the Shares hereunder do not contravene the rules and regulations of the Trading Market.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 1pc; text-align: justify; text-indent: 6pc">(v) <U>Investment Company</U>.
The Company is not, and is not an Affiliate of, and immediately after receipt of payment for the Shares, will not be or be an Affiliate
of, an &ldquo;investment company&rdquo; within the meaning of the Investment Company Act of 1940, as amended. The Company shall conduct
its business in a manner so that it will not become an &ldquo;investment company&rdquo; subject to registration under the Investment Company
Act of 1940, as amended.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 1pc; text-align: justify; text-indent: 6pc">(w) <U>Registration Rights</U>.
Other than each of the Purchasers, no Person has any right to cause the Company to effect a registration under the Securities Act of any
securities of the Company or any Subsidiary.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 1pc; text-align: justify; text-indent: 6pc">(x) <U>Listing and Maintenance
Requirements</U>. The Common Stock is registered pursuant to Section 12(b) or 12(g) of the Exchange Act, and the Company has taken no
action designed to terminate, or which to its knowledge is likely to have the effect of terminating, the registration of the Common Stock
under the Exchange Act nor has the Company received any notification that the Commission is contemplating terminating such registration.
Other than as disclosed in the SEC Reports, the Company has not, in the 12 months preceding the date hereof, received notice from any
Trading Market on which the Common Stock is or has been listed or quoted to the effect that the Company is not in compliance with the
listing or maintenance requirements of such Trading Market. Other than as disclosed in the SEC Reports, the Company is, and has no reason
to believe that it will not in the foreseeable future continue to be, in compliance with all such listing and maintenance requirements.
The Common Stock is currently eligible for electronic transfer through the Depository Trust Company or another established clearing corporation
and the Company is current in payment of the fees to the Depository Trust Company (or such other established clearing corporation) in
connection with such electronic transfer.</P>


<!-- Field: Page; Sequence: 10 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%"><TR STYLE="font-size: 10pt"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->10<!-- Field: /Sequence -->&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%"><TR><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 1pc; text-align: justify; text-indent: 6pc">(y) <U>Application of Takeover
Protections</U>. The Company and the Board of Directors have taken all necessary action, if any, in order to render inapplicable any control
share acquisition, business combination, poison pill (including any distribution under a rights agreement) or other similar anti-takeover
provision under the Company&rsquo;s certificate of incorporation (or similar charter documents) or the laws of its state of incorporation
that is or could become applicable to the Purchasers as a result of the Purchasers and the Company fulfilling their obligations or exercising
their rights under the Transaction Documents, including without limitation as a result of the Company&rsquo;s issuance of the Shares and
the Purchasers&rsquo; ownership of the Shares.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 1pc; text-align: justify; text-indent: 6pc">(z) <U>Disclosure</U>. Except
with respect to the material terms and conditions of the transactions contemplated by the Transaction Documents, the Company confirms
that neither it nor any other Person acting on its behalf has provided any of the Purchasers or their agents or counsel with any information
that it believes constitutes or might constitute material, non-public information. The Company understands and confirms that the Purchasers
will rely on the foregoing representation in effecting transactions in securities of the Company. All of the disclosure furnished by or
on behalf of the Company to the Purchasers regarding the Company and its Subsidiaries, their respective businesses and the transactions
contemplated hereby, including the Disclosure Schedules to this Agreement, is true and correct and does not contain any untrue statement
of a material fact or omit to state any material fact necessary in order to make the statements made therein, in light of the circumstances
under which they were made, not misleading. The press releases disseminated by the Company during the 12 months preceding the date of
this Agreement taken as a whole do not contain any untrue statement of a material fact or omit to state a material fact required to be
stated therein or necessary in order to make the statements therein, in light of the circumstances under which they were made and when
made, not misleading. The Company acknowledges and agrees that no Purchaser makes or has made any representations or warranties with respect
to the transactions contemplated hereby other than those specifically set forth in Section 3.2 hereof.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 1pc; text-align: justify; text-indent: 6pc">(aa) <U>No Integrated Offering</U>.
Assuming the accuracy of the Purchasers&rsquo; representations and warranties set forth in Section 3.2, neither the Company, nor any of
its Affiliates, nor any Person acting on its or their behalf has, directly or indirectly, made any offers or sales of any security or
solicited any offers to buy any security, under circumstances that would cause this offering of the Shares to be integrated with prior
offerings by the Company for purposes of (i) the Securities Act which would require the registration of any such securities under the
Securities Act, or (ii) any applicable shareholder approval provisions of any Trading Market on which any of the securities of the Company
are listed or designated.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 1pc; text-align: justify; text-indent: 6pc">(bb) <U>Solvency</U>. &nbsp;Based
on the consolidated financial condition of the Company as of the Closing Date, after giving effect to the receipt by the Company of the
proceeds from the sale of the Shares hereunder: (i) the fair saleable value of the Company&rsquo;s assets exceeds the amount that will
be required to be paid on or in respect of the Company&rsquo;s existing debts and other liabilities (including known contingent liabilities)
as they mature, (ii) the Company&rsquo;s assets do not constitute unreasonably small capital to carry on its business as now conducted
and as proposed to be conducted including its capital needs taking into account the particular capital requirements of the business conducted
by the Company, consolidated and projected capital requirements and capital availability thereof, and (iii) the current cash flow of the
Company, together with the proceeds the Company would receive, were it to liquidate all of its assets, after taking into account all anticipated
uses of the cash, would be sufficient to pay all amounts on or in respect of its liabilities when such amounts are required to be paid.
The Company does not intend to incur debts beyond its ability to pay such debts as they mature (taking into account the timing and amounts
of cash to be payable on or in respect of its debt). The Company has no knowledge of any facts or circumstances which lead it to believe
that it will file for reorganization or liquidation under the bankruptcy or reorganization laws of any jurisdiction within one year from
the Closing Date. <U>Schedule 3.1(bb)</U> sets forth as of the date hereof all outstanding secured and unsecured Indebtedness of the Company
or any Subsidiary, or for which the Company or any Subsidiary has commitments. Neither the Company nor any Subsidiary is in default with
respect to any Indebtedness. For the purposes of this Agreement, &ldquo;<U>Indebtedness</U>&rdquo; means (x) any liabilities for borrowed
money or amounts owed in excess of $100,000 (other than trade accounts payable incurred in the ordinary course of business); (y) all guaranties,
endorsements and other contingent obligations in respect of indebtedness of others, whether or not the same are or should be reflected
in the Company&rsquo;s consolidated balance sheet (or the notes thereto), except guaranties by endorsement of negotiable instruments for
deposit or collection or similar transactions in the ordinary course of business; and (z) the present value of any lease payments in excess
of $100,000 due under leases required to be capitalized in accordance with GAAP.</P>


<!-- Field: Page; Sequence: 11 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%"><TR STYLE="font-size: 10pt"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->11<!-- Field: /Sequence -->&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%"><TR><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 1pc; text-align: justify; text-indent: 6pc">(cc) <U>Tax Status</U>. Except
as set forth on <U>Schedule 3.1(cc)</U> and for matters that would not, individually or in the aggregate, have or reasonably be expected
to result in a Material Adverse Effect, the Company and its Subsidiaries each (i) has made or filed all United States federal, state and
local income and all foreign income and franchise tax returns, reports and declarations required by any jurisdiction to which it is subject,
(ii) has paid all taxes and other governmental assessments and charges that are material in amount, shown or determined to be due on such
returns, reports and declarations and (iii) has set aside on its books provision reasonably adequate for the payment of all material taxes
for periods subsequent to the periods to which such returns, reports or declarations apply. There are no unpaid taxes in any material
amount claimed to be due by the taxing authority of any jurisdiction, and the officers of the Company or of any Subsidiary know of no
basis for any such claim.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 1pc; text-align: justify; text-indent: 6pc">(dd) <U>No General Solicitation</U>.
Neither the Company nor any Person acting on behalf of the Company has offered or sold any of the Shares by any form of general solicitation
or general advertising. Assuming the accuracy of the Purchasers&rsquo; representations and warranties under this Agreement, the Company
has offered the Shares for sale only to the Purchasers and certain other &ldquo;accredited investors&rdquo; within the meaning of Rule
501 under the Securities Act.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 1pc; text-align: justify; text-indent: 6pc">(ee) <U>Foreign Corrupt Practices</U>.
Neither the Company nor any Subsidiary nor, to the knowledge of the Company or any Subsidiary, any agent or other person acting on behalf
of the Company or any Subsidiary, has: (i) directly or indirectly, used any funds for unlawful contributions, gifts, entertainment or
other unlawful expenses related to foreign or domestic political activity, (ii) made any unlawful payment to foreign or domestic government
officials or employees or to any foreign or domestic political parties or campaigns from corporate funds, (iii) failed to disclose fully
any contribution made by the Company or any Subsidiary (or made by any person acting on its behalf of which the Company is aware) which
is in violation of law or (iv) violated in any material respect any provision of FCPA.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 1pc; text-align: justify; text-indent: 6pc">(ff) <U>Accountants</U>. The
Company&rsquo;s accounting firm is set forth on <U>Schedule 3.1(ff)</U> of the Disclosure Schedules. To the knowledge and belief of the
Company, such accounting firm: (i) is a registered public accounting firm as required by the Exchange Act and (ii) shall express its opinion
with respect to the financial statements to be included in the Company&rsquo;s Annual Report for the fiscal year ended December 31, 2022.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 1pc; text-align: justify; text-indent: 6pc">(gg) <U>No Disagreements with
Accountants and Lawyers</U>. There are no disagreements of any kind presently existing, or reasonably anticipated by the Company to arise,
between the Company and the accountants and lawyers formerly or presently employed by the Company and the Company is current with respect
to any fees owed to its accountants and lawyers which could affect the Company&rsquo;s ability to perform any of its obligations under
any of the Transaction Documents.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 1pc; text-align: justify; text-indent: 6pc">(hh) <U>Acknowledgment Regarding
Purchasers&rsquo; Purchase of Shares</U>. To the Company&rsquo;s knowledge, the Company acknowledges and agrees that each of the Purchasers
is acting solely in the capacity of an arm&rsquo;s-length purchaser with respect to the Transaction Documents and the transactions contemplated
thereby. The Company further acknowledges that no Purchaser is acting as a financial advisor or fiduciary of the Company (or in any similar
capacity) with respect to the Transaction Documents and the transactions contemplated thereby and any advice given by any Purchaser or
any of their respective representatives or agents in connection with the Transaction Documents and the transactions contemplated thereby
is merely incidental to the Purchasers&rsquo; purchase of the Shares. The Company further represents to each Purchaser that the Company&rsquo;s
decision to enter into this Agreement and the other Transaction Documents has been based solely on the independent evaluation of the transactions
contemplated hereby by the Company and its representatives.</P>


<!-- Field: Page; Sequence: 12 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%"><TR STYLE="font-size: 10pt"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->12<!-- Field: /Sequence -->&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%"><TR><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 1pc; text-align: justify; text-indent: 6pc">(ii) <U>Acknowledgment Regarding
Purchaser&rsquo;s Trading Activity</U>. Anything in this Agreement or elsewhere herein to the contrary notwithstanding (except for Sections
3.2(g) and 4.14 herein), it is understood and acknowledged by the Company that: (i) none of the Purchasers has been asked by the Company
to agree, nor has any Purchaser under this Agreement agreed, to desist from purchasing or selling, long and/or short, securities of the
Company, or &ldquo;derivative&rdquo; securities based on securities issued by the Company or to hold the Shares for any specified term,
(ii) past or future open market or other transactions by any Purchaser, specifically including, without limitation, Short Sales or &ldquo;derivative&rdquo;
transactions, before or after the closing of this or future private placement transactions, may negatively impact the market price of
the Company&rsquo;s publicly-traded securities, (iii) any Purchaser, and counter-parties in &ldquo;derivative&rdquo; transactions to which
any such Purchaser is a party, directly or indirectly, may presently have a &ldquo;short&rdquo; position in the Common Stock and (iv)
each Purchaser shall not be deemed to have any affiliation with or control over any arm&rsquo;s length counter-party in any &ldquo;derivative&rdquo;
transaction. The Company further understands and acknowledges that (y) one or more Purchasers may engage in hedging activities at various
times during the period that the Shares are outstanding, and (z) such hedging activities (if any) could reduce the value of the existing
stockholders&rsquo; equity interests in the Company at and after the time that the hedging activities are being conducted. The Company
acknowledges that such aforementioned hedging activities do not constitute a breach of any of the Transaction Documents.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 1pc; text-align: justify; text-indent: 6pc">(jj) <U>Regulation M Compliance</U>.
Within the past 12 months, the Company has not, and to its knowledge no one acting on its behalf has, (i) taken, directly or indirectly,
any action designed to cause or to result in the stabilization or manipulation of the price of any security of the Company to facilitate
the sale or resale of any of the Shares, (ii) sold, bid for, purchased, or paid any compensation for soliciting purchases of, any of the
Shares, or (iii) paid or agreed to pay to any Person any compensation for soliciting another to purchase any other securities of the Company,
other than, in the case of clauses (ii) and (iii), compensation paid to the Placement Agent in connection with the placement of the Shares.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 1pc; text-align: justify; text-indent: 6pc">(kk) <U>Office of Foreign
Assets Control</U>. Neither the Company nor any Subsidiary nor, to the Company&rsquo;s knowledge, any director, officer, agent, employee
or affiliate of the Company or any Subsidiary is currently subject to any U.S. sanctions administered by the Office of Foreign Assets
Control of the U.S. Treasury Department.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 1pc; text-align: justify; text-indent: 6pc">(ll) <U>U.S. Real Property
Holding Corporation</U>. The Company is not and has never been a U.S. real property holding corporation within the meaning of Section
897 of the Internal Revenue Code of 1986, as amended, and the Company shall so certify upon Purchaser&rsquo;s request.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 1pc; text-align: justify; text-indent: 6pc">(mm) <U>Bank Holding Company
Act</U>. Neither the Company nor any of its Subsidiaries or, to the knowledge of the Company, Affiliates is subject to the Bank Holding
Company Act of 1956, as amended (the &ldquo;<U>BHCA</U>&rdquo;), and to regulation by the Board of Governors of the Federal Reserve System
(the &ldquo;<U>Federal Reserve</U>&rdquo;). Neither the Company nor any of its Subsidiaries or, to the knowledge of the Company, Affiliates
owns or controls, directly or indirectly, five percent (5%) or more of the outstanding shares of any class of voting securities or twenty-five
percent (25%) or more of the total equity of a bank or any entity that is subject to the BHCA and to regulation by the Federal Reserve.
Neither the Company nor any of its Subsidiaries or, to the knowledge of the Company, Affiliates exercises a controlling influence over
the management or policies of a bank or any entity that is subject to the BHCA and to regulation by the Federal Reserve.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 1pc; text-align: justify; text-indent: 6pc">(nn) <U>Money Laundering</U>.
&nbsp;The operations of the Company and its Subsidiaries &nbsp;are and have been conducted at all times in compliance in all material
respects with applicable financial record-keeping and reporting requirements of the Currency and Foreign Transactions Reporting Act of
1970, as amended, applicable money laundering statutes and applicable rules and regulations thereunder (collectively, the &ldquo;<U>Money
Laundering Laws</U>&rdquo;), and no Action or Proceeding by or before any court or governmental agency, authority or body or any arbitrator
involving the Company or any Subsidiary with respect to the Money Laundering Laws is pending or, to the knowledge of the Company or any
Subsidiary, threatened.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 1pc; text-align: justify; text-indent: 6pc">(oo) <U>No Disqualification
Events</U>. With respect to the Shares to be offered and sold hereunder in reliance on Rule 506 under the Securities Act, none of the
Company, any of its predecessors, any affiliated issuer, any director, executive officer, other officer of the Company participating in
the offering hereunder, any beneficial owner of 20% or more of the Company&rsquo;s outstanding voting equity securities, calculated on
the basis of voting power, nor any promoter (as that term is defined in Rule 405 under the Securities Act) connected with the Company
in any capacity at the time of sale (each, an &ldquo;<U>Issuer Covered Person</U>&rdquo; and, together, &ldquo;<U>Issuer Covered Persons</U>&rdquo;)
is subject to any of the &ldquo;Bad Actor&rdquo; disqualifications described in Rule 506(d)(1)(i) to (viii) under the Securities Act (a
&ldquo;<U>Disqualification Event</U>&rdquo;), except for a Disqualification Event covered by Rule 506(d)(2) or (d)(3). The Company has
exercised reasonable care to determine whether any Issuer Covered Person is subject to a Disqualification Event. The Company has complied,
to the extent applicable, with its disclosure obligations under Rule 506(e), and has furnished to the Purchasers a copy of any disclosures
provided thereunder.</P>


<!-- Field: Page; Sequence: 13 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%"><TR STYLE="font-size: 10pt"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->13<!-- Field: /Sequence -->&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%"><TR><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 1pc; text-align: justify; text-indent: 6pc">(pp) <U>Other Covered Persons</U>.
Other than the Placement Agent, the Company is not aware of any person (other than any Issuer Covered Person) that has been or will be
paid (directly or indirectly) remuneration for solicitation of purchasers in connection with the sale of any Shares.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 1pc; text-align: justify; text-indent: 6pc">(qq) <U>Notice of Disqualification
Events</U>. The Company will notify the Purchasers in writing, prior to the Closing Date of (i) any Disqualification Event relating to
any Issuer Covered Person and (ii) any event that would, with the passage of time, become a Disqualification Event relating to any Issuer
Covered Person.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 1pc; text-align: justify; text-indent: 3pc">3.2 <U>Representations and
Warranties of the Purchasers</U>. Each Purchaser, for itself and for no other Purchaser, hereby represents and warrants as of the date
hereof and as of the Closing Date to the Company as follows (unless as of a specific date therein, in which case they shall be accurate
as of such date):</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 1pc; text-align: justify; text-indent: 6pc">(a) <U>Organization; Authority</U>.
Such Purchaser is either an individual or an entity duly incorporated or formed, validly existing and in good standing under the laws
of the jurisdiction of its incorporation or formation with full right, corporate, partnership, limited liability company or similar power
and authority to enter into and to consummate the transactions contemplated by the Transaction Documents and otherwise to carry out its
obligations hereunder and thereunder. The execution and delivery of the Transaction Documents and performance by such Purchaser of the
transactions contemplated by the Transaction Documents have been duly authorized by all necessary corporate, partnership, limited liability
company or similar action, as applicable, on the part of such Purchaser. Each Transaction Document to which it is a party has been duly
executed by such Purchaser, and when delivered by such Purchaser in accordance with the terms hereof and thereof, will constitute the
valid and legally binding obligation of such Purchaser, enforceable against it in accordance with its terms, except: (i) as limited by
general equitable principles and applicable bankruptcy, insolvency, reorganization, moratorium and other laws of general application affecting
enforcement of creditors&rsquo; rights generally, (ii) as limited by laws relating to the availability of specific performance, injunctive
relief or other equitable remedies and (iii) insofar as indemnification and contribution provisions may be limited by applicable law or
public policy.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 1pc; text-align: justify; text-indent: 6pc">(b) <U>Own Account</U>. Such
Purchaser understands that the Shares and Conversion Shares are &ldquo;restricted securities&rdquo; and have not been registered under
the Securities Act or any applicable state securities law and is acquiring the Shares and Conversion Shares as principal for its own account
and not with a view to or for distributing or reselling such Shares or Conversion Shares or any part thereof in violation of the Securities
Act or any applicable state securities law, has no present intention of distributing any of such Shares or Conversion Shares in violation
of the Securities Act or any applicable state securities law and has no direct or indirect arrangement or understandings with any other
persons to distribute or regarding the distribution of such Shares or Conversion Shares in violation of the Securities Act or any applicable
state securities law (this representation and warranty not limiting such Purchaser&rsquo;s right to sell the Common Stock Shares and/or
Conversion Shares pursuant to the Registration Statement or otherwise in compliance with applicable federal and state securities laws).
Such Purchaser is acquiring the Shares and Conversion Shares hereunder in the ordinary course of its business.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 1pc; text-align: justify; text-indent: 6pc">(c) <U>Purchaser Status</U>.
At the time such Purchaser was offered the Shares, it was, and as of the date hereof it is, either: (i) an &ldquo;accredited investor&rdquo;
as defined in Rule 501(a)(1), (a)(2), (a)(3), (a)(5), (a)(7), (a)(8) or (a)(9) under the Securities Act or (ii) a &ldquo;qualified institutional
buyer&rdquo; as defined in Rule 144A(a) under the Securities Act.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 1pc; text-align: justify; text-indent: 6pc">(d) <U>Experience of Such
Purchaser</U>. Such Purchaser, either alone or together with its representatives, has such knowledge, sophistication and experience in
business and financial matters so as to be capable of evaluating the merits and risks of the prospective investment in the Shares and
Conversion Shares, and has so evaluated the merits and risks of such investment. Such Purchaser is able to bear the economic risk of an
investment in the Shares and Conversion Shares and, at the present time, is able to afford a complete loss of such investment.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 1pc; text-align: justify; text-indent: 6pc">(e) <U>General Solicitation</U>.
Such Purchaser is not purchasing the Shares or the Conversion Shares as a result of any advertisement, article, notice or other communication
regarding the Shares or the Conversion Shares published in any newspaper, magazine or similar media or broadcast over television or radio
or presented at any seminar or, to such Purchaser&rsquo;s knowledge, any other general solicitation or general advertisement.</P>


<!-- Field: Page; Sequence: 14 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%"><TR STYLE="font-size: 10pt"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->14<!-- Field: /Sequence -->&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%"><TR><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 1pc; text-align: justify; text-indent: 6pc">(f) <U>Access to Information</U>.
Such Purchaser acknowledges that it has had the opportunity to review the Transaction Documents (including all exhibits and schedules
thereto) and the SEC Reports and has been afforded (i) the opportunity to ask such questions as it has deemed necessary of, and to receive
answers from, representatives of the Company concerning the terms and conditions of the offering of the Shares and Conversion Shares and
the merits and risks of investing in the Shares and Conversion Shares; (ii) access to information about the Company and its financial
condition, results of operations, business, properties, management and prospects sufficient to enable it to evaluate its investment; and
(iii) the opportunity to obtain such additional information that the Company possesses or can acquire without unreasonable effort or expense
that is necessary to make an informed investment decision with respect to the investment. Such Purchaser acknowledges and agrees that
neither the Placement Agent nor any Affiliate of the Placement Agent has provided such Purchaser with any information or advice with respect
to the Shares nor is such information or advice necessary or desired. Neither the Placement Agent nor any Affiliate has made or makes
any representation as to the Company or the quality of the Shares or the Conversion Shares and the Placement Agent and any Affiliate may
have acquired non-public information with respect to the Company which such Purchaser agrees need not be provided to it. In connection
with the issuance of the Shares to such Purchaser, neither the Placement Agent nor any of its Affiliates has acted as a financial advisor
or fiduciary to such Purchaser.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 1pc; text-align: justify; text-indent: 6pc">(g) <U>Certain Transactions
and Confidentiality</U>. Other than consummating the transactions contemplated hereunder, such Purchaser has not directly or indirectly,
nor has any Person acting on behalf of or pursuant to any understanding with such Purchaser, executed any purchases or sales, including
Short Sales, of the securities of the Company during the period commencing as of the time that such Purchaser first received a term sheet
(written or oral) from the Company or any other Person representing the Company setting forth the material terms of the transactions contemplated
hereunder and ending immediately prior to the execution hereof. Notwithstanding the foregoing, in the case of a Purchaser that is a multi-managed
investment vehicle whereby separate portfolio managers manage separate portions of such Purchaser&rsquo;s assets and the portfolio managers
have no direct knowledge of the investment decisions made by the portfolio managers managing other portions of such Purchaser&rsquo;s
assets, the representation set forth above shall only apply with respect to the portion of assets managed by the portfolio manager that
made the investment decision to purchase the Shares covered by this Agreement. Other than to other Persons party to this Agreement or
to such Purchaser&rsquo;s representatives, including, without limitation, its officers, directors, partners, legal and other advisors,
agents and Affiliates, such Purchaser has maintained the confidentiality of all disclosures made to it in connection with this transaction
(including the existence and terms of this transaction). Notwithstanding the foregoing, for avoidance of doubt, nothing contained herein
shall constitute a representation or warranty, or preclude any actions, with respect to the identification of the availability of, or
securing of, available shares to borrow in order to effect Short Sales or similar transactions in the future.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 1pc; text-align: justify; text-indent: 3pc">The Company acknowledges and
agrees that the representations contained in this Section 3.2 shall not modify, amend or affect such Purchaser&rsquo;s right to rely on
the Company&rsquo;s representations and warranties contained in this Agreement or any representations and warranties contained in any
other Transaction Document or any other document or instrument executed and/or delivered in connection with this Agreement or the consummation
of the transaction contemplated hereby.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 1pc; text-align: center"><FONT STYLE="text-transform: uppercase"><B>ARTICLE
IV.</B></FONT><B><BR>
OTHER AGREEMENTS OF THE PARTIES</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 1pc; text-align: justify; text-indent: 3pc">4.1 <U>Transfer Restrictions</U>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 1pc; text-align: justify; text-indent: 6pc">(a) The Shares and Conversion
Shares may only be disposed of in compliance with state and federal securities laws. In connection with any transfer of Shares or Conversion
Shares other than pursuant to an effective registration statement or Rule 144, to the Company or to an Affiliate of a Purchaser or in
connection with a pledge as contemplated in Section 4.1(b), the Company may require the transferor thereof to provide to the Company an
opinion of counsel selected by the transferor and reasonably acceptable to the Company, the form and substance of which opinion shall
be reasonably satisfactory to the Company, to the effect that such transfer does not require registration of such transferred Shares or
Conversion Shares under the Securities Act. As a condition of transfer, any such transferee shall agree in writing to be bound by the
terms of this Agreement and the Registration Rights Agreement and shall have the rights and obligations of a Purchaser under this Agreement
and the Registration Rights Agreement.</P>


<!-- Field: Page; Sequence: 15 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%"><TR STYLE="font-size: 10pt"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->15<!-- Field: /Sequence -->&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%"><TR><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 1pc; text-align: justify; text-indent: 6pc">(b) The Purchasers agree to
the imprinting, so long as is required by this Section 4.1, of a legend on any of the Shares and Conversion Shares in the following form:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 3pc 1pc; text-align: justify">THIS SECURITY HAS NOT BEEN REGISTERED WITH
THE SECURITIES AND EXCHANGE COMMISSION OR THE SECURITIES COMMISSION OF ANY STATE IN RELIANCE UPON AN EXEMPTION FROM REGISTRATION UNDER
THE SECURITIES ACT OF 1933, AS AMENDED (THE &ldquo;SECURITIES ACT&rdquo;), AND, ACCORDINGLY, MAY NOT BE OFFERED OR SOLD EXCEPT PURSUANT
TO AN EFFECTIVE REGISTRATION STATEMENT UNDER THE SECURITIES ACT OR PURSUANT TO AN AVAILABLE EXEMPTION FROM, OR IN A TRANSACTION NOT SUBJECT
TO, THE REGISTRATION REQUIREMENTS OF THE SECURITIES ACT AND IN ACCORDANCE WITH APPLICABLE STATE SECURITIES LAWS. THIS SECURITY MAY BE
PLEDGED IN CONNECTION WITH A BONA FIDE MARGIN ACCOUNT WITH A REGISTERED BROKER-DEALER OR OTHER LOAN WITH A FINANCIAL INSTITUTION THAT
IS AN &ldquo;ACCREDITED INVESTOR&rdquo; AS DEFINED IN RULE 501(a) UNDER THE SECURITIES ACT OR OTHER LOAN SECURED BY SUCH SECURITIES.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 1pc; text-align: justify; text-indent: 3pc">The Company acknowledges and
agrees that a Purchaser may from time to time pledge pursuant to a bona fide margin agreement with a registered broker-dealer or grant
a security interest in some or all of the Shares or Conversion Shares to a financial institution that is an &ldquo;accredited investor&rdquo;
as defined in Rule 501(a) under the Securities Act and who agrees to be bound by the provisions of this Agreement and the Registration
Rights Agreement and, if required under the terms of such arrangement, such Purchaser may transfer pledged or secured Shares or Conversion
Shares to the pledgees or secured parties. Such a pledge or transfer would not be subject to approval of the Company and no legal opinion
of legal counsel of the pledgee, secured party or pledgor shall be required in connection therewith. Further, no notice shall be required
of such pledge. At the appropriate Purchaser&rsquo;s expense, the Company will execute and deliver such reasonable documentation as a
pledgee or secured party of Shares or Conversion Shares may reasonably request in connection with a pledge or transfer of the Shares or
Conversion Shares, including, if the Common Stock Shares and and/or Conversion Shares are subject to registration pursuant to the Registration
Rights Agreement, the preparation and filing of any required prospectus supplement under Rule 424(b)(3) under the Securities Act or other
applicable provision of the Securities Act to appropriately amend the list of Selling Stockholders (as defined in the Registration Rights
Agreement) thereunder.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 1pc; text-align: justify; text-indent: 6pc">(c) Certificates evidencing
the Shares or Conversion Shares shall not contain any legend (including the legend set forth in Section 4.1(b) hereof), (i) while a registration
statement (including the Registration Statement) covering the resale of such security is effective under the Securities Act, (ii) following
any sale of such Shares or Conversion Shares pursuant to Rule 144, (iii) if such Shares are eligible for sale under Rule 144, and the
Company is then in compliance with the current public information required under Rule 144 or if the Conversion Shares may be sold without
the requirement for the Company to be in compliance with the current public information required under Rule 144 as to such Shares or Conversion
Shares and without volume or manner-of-sale restrictions, or (iv) if such legend is not required under applicable requirements of the
Securities Act (including judicial interpretations and pronouncements issued by the staff of the Commission), the Company shall instruct
its Transfer Agent to remove the legend from certificates evidencing the Shares or Conversion Shares. The Company shall, at its expense,
cause its counsel to issue a legal opinion to the Transfer Agent promptly after the Effective Date if required by the Transfer Agent to
effect the removal of the legend hereunder or if requested by a Purchaser and shall instruct its Transfer Agent to remove the legend without
requiring a medallion guarantee and provide such indemnity to its Transfer Agent as the Transfer Agent may require to waive any medallion
guarantee requirement. The Company agrees that following the Effective Date or at such time as such legend is no longer required under
this Section 4.1(c), it will, no later than the earlier of (i) two (2) Trading Days and (ii) the number of Trading Days comprising the
Standard Settlement Period (as defined below), in each case following the delivery by a Purchaser to the Company or the Transfer Agent
of a certificate representing Shares and Conversion Shares issued with a restrictive legend (such earlier date, the &ldquo;<U>Legend Removal
Date</U>&rdquo;), deliver or cause to be delivered to such Purchaser a certificate representing such shares that is free from all restrictive
and other legends. The Company may not make any notation on its records or give instructions to the Transfer Agent that enlarge the restrictions
on transfer set forth in this Section 4. The Company shall cause certificates for Shares or Conversion Shares subject to legend removal
hereunder to be transmitted by the Transfer Agent to the Purchaser by crediting the account of the Purchaser&rsquo;s prime broker with
the Depository Trust Company System as directed by such Purchaser. As used herein, &ldquo;<U>Standard Settlement Period</U>&rdquo; means
the standard settlement period, expressed in a number of Trading Days, on the Company&rsquo;s primary Trading Market with respect to the
Common Stock as in effect on the date of delivery of a stock certificate for removal of legends.</P>


<!-- Field: Page; Sequence: 16 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%"><TR STYLE="font-size: 10pt"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->16<!-- Field: /Sequence -->&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%"><TR><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 1pc; text-align: justify; text-indent: 6pc">(d) Each Purchaser, severally
and not jointly with the other Purchasers, agrees that such Purchaser may only sell any Shares or Conversion Shares pursuant to either
the registration requirements of the Securities Act, including any applicable prospectus delivery requirements, or an exemption therefrom,
and that if Shares or Conversion Shares are sold pursuant to a Registration Statement, they will be sold in compliance with the plan of
distribution set forth therein, and acknowledges that the removal of the restrictive legend from certificates representing Shares or Conversion
Shares as set forth in this Section 4.1 is predicated upon the Company&rsquo;s reliance upon this understanding.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 1pc; text-align: justify; text-indent: 6pc">(e) The Company shall hold
a special meeting of stockholders (which may also be the annual meeting of stockholders) at the earliest practical date, but in no event
later than 120 days following the Closing Date (150 days in the event of a review of the proxy statement by the Commission), for the purpose
of obtaining Stockholder Approval, with the recommendation of the Company&rsquo;s Board of Directors that such approval be approved, and
the Company shall solicit proxies from its stockholders in connection therewith in the same manner as all other management proposals in
such proxy statement and all management-appointed proxyholders shall vote their proxies in favor of such proposal. The Company shall use
best efforts to obtain Stockholder Approval. If the Company does not obtain Stockholder Approval at the first meeting, the Company shall
call a meeting every four months thereafter to seek Stockholder Approval until Stockholder Approval is obtained. Prior to any such stockholder
meeting, the Company shall timely file a proxy statement pursuant to Section 14(a) of the Exchange Act in compliance in all material respects
with the provisions of the Company&rsquo;s bylaws and all applicable law.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 1pc; text-align: justify; text-indent: 3pc">4.2 <U>Furnishing of Information;
Public Information</U>. Until the time that (i) no Purchaser owns Shares or (ii) 24 months after the date hereof, the Company covenants
to maintain the registration of the Common Stock under Section 12(b) or 12(g) of the Exchange Act and to timely file (or obtain extensions
in respect thereof and file within the applicable grace period) all reports required to be filed by the Company after the date hereof
pursuant to the Exchange Act even if the Company is not then subject to the reporting requirements of the Exchange Act.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 1pc; text-align: justify; text-indent: 3pc">4.3 <U>Integration</U>. The
Company shall not sell, offer for sale or solicit offers to buy or otherwise negotiate in respect of any security (as defined in Section
2 of the Securities Act) that would be integrated with the offer or sale of the Shares in a manner that would require the registration
under the Securities Act of the sale of the Shares or that would be integrated with the offer or sale of the Shares for purposes of the
rules and regulations of any Trading Market such that it would require shareholder approval prior to the closing of such other transaction
unless shareholder approval is obtained before the closing of such subsequent transaction.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 1pc; text-align: justify; text-indent: 3pc">4.4 <U>Securities Laws Disclosure;
Publicity</U>. The Company shall file a Current Report on Form 8-K disclosing the material terms of the transactions contemplated hereby,
including the Transaction Documents as exhibits thereto, with the Commission within the time required by the Exchange Act. From and after
the filing of such Form 8-K, the Company represents to the Purchasers that it shall have publicly disclosed all material, non-public information
delivered to any of the Purchasers by the Company or any of its Subsidiaries, or any of their respective officers, directors, employees
or agents in connection with the transactions contemplated by the Transaction Documents. The Company and each Purchaser shall consult
with each other in issuing any press releases with respect to the transactions contemplated hereby, and neither the Company nor any Purchaser
shall issue any such press release nor otherwise make any such public statement without the prior consent of the Company, with respect
to any press release of any Purchaser, or without the prior consent of each Purchaser, with respect to any press release of the Company,
which consent shall not unreasonably be withheld or delayed, except if such disclosure is required by law, in which case the disclosing
party shall promptly provide the other party with prior notice of such public statement or communication. Notwithstanding the foregoing,
the Company shall not publicly disclose the name of any Purchaser, or include the name of any Purchaser in any filing with the Commission
or any regulatory agency or Trading Market, without the prior written consent of such Purchaser, except: (a) as required by federal securities
law in connection with (i) any registration statement contemplated by the Registration Rights Agreement and (ii) the filing of final Transaction
Documents with the Commission and (b) to the extent such disclosure is required by law or Trading Market regulations, in which case the
Company shall provide the Purchasers with prior notice of such disclosure permitted under this clause (b).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 1pc; text-align: justify; text-indent: 3pc">4.5 <U>Shareholder Rights
Plan</U>. No claim will be made or enforced by the Company or, with the consent of the Company, any other Person, that any Purchaser is
an &ldquo;Acquiring Person&rdquo; under any control share acquisition, business combination, poison pill (including any distribution under
a rights agreement) or similar anti-takeover plan or arrangement in effect or hereafter adopted by the Company, or that any Purchaser
could be deemed to trigger the provisions of any such plan or arrangement, by virtue of receiving Shares under the Transaction Documents
or under any other agreement between the Company and the Purchasers.</P>


<!-- Field: Page; Sequence: 17 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%"><TR STYLE="font-size: 10pt"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->17<!-- Field: /Sequence -->&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%"><TR><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 1pc; text-align: justify; text-indent: 3pc">4.6 <U>Non-Public Information</U>.
Except with respect to the material terms and conditions of the transactions contemplated by the Transaction Documents, which shall be
disclosed pursuant to Section 4.4, the Company covenants and agrees that neither it, nor any other Person acting on its behalf will provide
any Purchaser or its agents or counsel with any information that constitutes, or the Company reasonably believes constitutes, material
non-public information, unless prior thereto such Purchaser shall have consented to the receipt of such information and agreed with the
Company to keep such information confidential. The Company understands and confirms that each Purchaser shall be relying on the foregoing
covenant in effecting transactions in securities of the Company. To the extent that the Company delivers any material, non-public information
to a Purchaser without such Purchaser&rsquo;s consent, the Company hereby covenants and agrees that such Purchaser shall not have any
duty of confidentiality to the Company, any of its Subsidiaries, or any of their respective officers, directors, agents, employees or
Affiliates, or a duty to the Company, and of its Subsidiaries or any of their respective officers, directors, agents, employees or Affiliates
not to trade on the basis of, such material, non-public information, provided that the Purchaser shall remain subject to applicable law.
To the extent that any notice provided pursuant to any Transaction Document constitutes, or contains, material, non-public information
regarding the Company or any Subsidiaries, the Company shall simultaneously file such notice with the Commission pursuant to a Current
Report on Form 8-K. The Company understands and confirms that each Purchaser shall be relying on the foregoing covenant in effecting transactions
in securities of the Company.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 1pc; text-align: justify; text-indent: 3pc">4.7 <U>Use of Proceeds</U>.
Except as set forth on <U>Schedule 4.7</U> attached hereto, the Company shall use the net proceeds from the sale of the Shares hereunder
for working capital purposes.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 1pc; text-align: justify; text-indent: 3pc">4.8 <U>Indemnification of
Purchasers</U>. Subject to the provisions of this Section 4.8, the Company will indemnify and hold each Purchaser and its directors, officers,
shareholders, members, partners, employees and agents (and any other Persons with a functionally equivalent role of a Person holding such
titles notwithstanding a lack of such title or any other title), each Person who controls such Purchaser (within the meaning of Section
15 of the Securities Act and Section 20 of the Exchange Act), and the directors, officers, shareholders, agents, members, partners or
employees (and any other Persons with a functionally equivalent role of a Person holding such titles notwithstanding a lack of such title
or any other title) of such controlling persons (each, a &ldquo;<U>Purchaser Party</U>&rdquo;) harmless from any and all losses, liabilities,
obligations, claims, contingencies, damages, costs and expenses, including all judgments, amounts paid in settlements, court costs and
reasonable attorneys&rsquo; fees and costs of investigation that any such Purchaser Party may suffer or incur as a result of or relating
to (a) any breach of any of the representations, warranties, covenants or agreements made by the Company in this Agreement or in the other
Transaction Documents or (b) any action instituted against the Purchaser Parties in any capacity, or any of them or their respective Affiliates,
by any stockholder of the Company who is not an Affiliate of such Purchaser Parties, with respect to any of the transactions contemplated
by the Transaction Documents (unless such action is based upon a breach of such Purchaser Party&rsquo;s representations, warranties or
covenants under the Transaction Documents or any agreements or understandings such Purchaser Parties may have with any such stockholder
or any violations by such Purchaser Parties of state or federal securities laws or any conduct by such Purchaser Parties which constitutes
fraud, gross negligence, willful misconduct or malfeasance). If any action shall be brought against any Purchaser Party in respect of
which indemnity may be sought pursuant to this Agreement, such Purchaser Party shall promptly notify the Company in writing, and the Company
shall have the right to assume the defense thereof with counsel of its own choosing reasonably acceptable to the Purchaser Party. Any
Purchaser Party shall have the right to employ separate counsel in any such action and participate in the defense thereof, but the fees
and expenses of such counsel shall be at the expense of such Purchaser Party except to the extent that (i) the employment thereof has
been specifically authorized by the Company in writing, (ii) the Company has failed after a reasonable period of time to assume such defense
and to employ counsel or (iii) in such action there is, in the reasonable opinion of counsel, a material conflict on any material issue
between the position of the Company and the position of such Purchaser Party, in which case the Company shall be responsible for the reasonable
fees and expenses of no more than one such separate counsel. The Company will not be liable to any Purchaser Party under this Agreement
(y) for any settlement by such Purchaser Party effected without the Company&rsquo;s prior written consent, which shall not be unreasonably
withheld or delayed; or (z) to the extent, but only to the extent that a loss, claim, damage or liability is attributable to such Purchaser
Party&rsquo;s breach of any of the representations, warranties, covenants or agreements made by such Purchaser Party in this Agreement
or in the other Transaction Documents. The indemnification required by this Section 4.8 shall be made by periodic payments of the amount
thereof during the course of the investigation or defense, as and when bills are received or are incurred. The indemnity agreements contained
herein shall be in addition to any cause of action or similar right of any Purchaser Party against the Company or others and any liabilities
the Company may be subject to pursuant to law.</P>


<!-- Field: Page; Sequence: 18 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%"><TR STYLE="font-size: 10pt"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->18<!-- Field: /Sequence -->&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%"><TR><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 1pc; text-align: justify; text-indent: 3pc">4.9 <U>Reservation of Common
Stock</U>. As of the date hereof, the Company has reserved and the Company shall continue to reserve and keep available at all times,
free of preemptive rights, a sufficient number of shares of Common Stock for the purpose of enabling the Company to issue Conversion Shares
upon conversion of the Preferred Stock.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 1pc; text-align: justify; text-indent: 3pc">4.10 <U>Listing of Common
Stock</U>. The Company hereby agrees to use best efforts to maintain the listing or quotation of the Common Stock on the Trading Market
on which it is currently listed, and concurrently with the Closing, the Company shall apply to list or quote all of the Common Stock Shares
and Conversion Shares on such Trading Market and promptly secure the listing or quotation of all of the Common Stock Shares and Conversion
Shares on such Trading Market. The Company further agrees, if the Company applies to have the Common Stock traded on any other Trading
Market, it will then include in such application all of the Common Stock Shares and Conversion Shares, and will take such other action
as is necessary to cause all of the Common Stock Shares and Conversion Shares to be listed or quoted on such other Trading Market as promptly
as possible. The Company will then take all action reasonably necessary to continue the listing or quotation and trading of its Common
Stock on a Trading Market and will comply in all respects with the Company&rsquo;s reporting, filing and other obligations under the bylaws
or rules of the Trading Market. The Company shall maintain the eligibility of the Common Stock for electronic transfer through the Depository
Trust Company or another established clearing corporation, including, without limitation, by timely payment of fees to the Depository
Trust Company or such other established clearing corporation in connection with such electronic transfer.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 1pc; text-align: justify; text-indent: 3pc">4.11 <U>Equal Treatment of
Purchasers</U>. No consideration (including any modification of any Transaction Document) shall be offered or paid to any Person to amend
or consent to a waiver or modification of any provision of this Agreement or any of the Transaction Documents unless the same consideration
is also offered to all of the parties to this Agreement or any of the Transaction Documents. For clarification purposes, this provision
constitutes a separate right granted to each Purchaser by the Company and negotiated separately by each Purchaser, and is intended for
the Company to treat the Purchasers as a class and shall not in any way be construed as the Purchasers acting in concert or as a group
with respect to the purchase, disposition or voting of Shares or Conversion Shares or otherwise.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 1pc; text-align: justify; text-indent: 3pc">4.12 <U>Certain Transactions
and Confidentiality</U>. Each Purchaser, severally and not jointly with the other Purchasers, covenants that neither it, nor any Affiliate
acting on its behalf or pursuant to any understanding with it will execute any purchases or sales, including Short Sales, of any of the
Company&rsquo;s securities during the period commencing with the execution of this Agreement and ending at such time that the transactions
contemplated by this Agreement are first publicly announced pursuant to the Form 8-K as described in Section 4.4. Each Purchaser, severally
and not jointly with the other Purchasers, covenants that until such time as the transactions contemplated by this Agreement are publicly
disclosed by the Company pursuant to the Form 8-K as described in Section 4.4, such Purchaser will maintain the confidentiality of the
existence and terms of this transaction and the information included in the Transaction Documents and the Disclosure Schedules. Notwithstanding
the foregoing, and notwithstanding anything contained in this Agreement to the contrary, the Company expressly acknowledges and agrees
that (i) no Purchaser makes any representation, warranty or covenant hereby that it will not engage in effecting transactions in any securities
of the Company after the time that the transactions contemplated by this Agreement are first publicly announced pursuant to the Form 8-K
as described in Section 4.4, (ii) no Purchaser shall be restricted or prohibited from effecting any transactions in any securities of
the Company in accordance with applicable securities laws from and after the time that the transactions contemplated by this Agreement
are first publicly announced pursuant to the Form 8-K as described in Section 4.4 and (iii) this Agreement shall impose no duty on any
Purchaser of confidentiality or to not trade in the securities of the Company to the Company or its Subsidiaries after the issuance of
the Form 8-K as described in Section 4.4. Notwithstanding the foregoing, in the case of a Purchaser that is a multi-managed investment
vehicle whereby separate portfolio managers manage separate portions of such Purchaser&rsquo;s assets and the portfolio managers have
no direct knowledge of the investment decisions made by the portfolio managers managing other portions of such Purchaser&rsquo;s assets,
the covenant set forth above shall only apply with respect to the portion of assets managed by the portfolio manager that made the investment
decision to purchase the Shares covered by this Agreement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 1pc; text-align: justify; text-indent: 3pc">4.13 <U>Form D; Blue Sky Filings</U>.
The Company shall timely file a Form D with respect to the Shares and Conversion Shares as required under Regulation D and provide a copy
thereof, promptly upon request of any Purchaser. The Company shall take such action as the Company shall reasonably determine is necessary
in order to obtain an exemption for, or to qualify the Shares for, sale to the Purchasers at the Closing under applicable securities or
&ldquo;Blue Sky&rdquo; laws of the states of the United States, and shall provide evidence of such actions promptly upon request of any
Purchaser.</P>


<!-- Field: Page; Sequence: 19 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%"><TR STYLE="font-size: 10pt"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->19<!-- Field: /Sequence -->&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%"><TR><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 1pc; text-align: justify; text-indent: 3pc">4.14 <U>Acknowledgment of
Dilution</U>. The Company acknowledges that the issuance of the Shares may result in dilution of the outstanding shares of Common Stock,
which dilution may be substantial. The Company further acknowledges that its obligations under the Transaction Documents, including, without
limitation, its obligation to issue the Shares and Conversion Shares pursuant to the Transaction Documents, are unconditional and absolute
and not subject to any right of set off, counterclaim, delay or reduction, regardless of the effect of any such dilution or any claim
the Company may have against any Purchaser and regardless of the dilutive effect that such issuance may have on the ownership of the other
stockholders of the Company.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 1pc; text-align: justify; text-indent: 3pc">4.15 <U>Subsequent Financing</U>.
From the date hereof until the date that is the twenty four (24) month anniversary of the Effective Date, the Company shall use its commercially
reasonable efforts to, prior to any issuance by the Company or any of its Subsidiaries of Common Stock or Common Stock Equivalents for
cash consideration, or a combination of units thereof (a &ldquo;<U>Subsequent Financing</U>&rdquo;), provide each Purchaser with (x) written
notice of the Subsequent Financing (including the contemplated terms and conditions of the Subsequent Financing, the amount of proceeds
intended to be raised thereunder and the Person or Persons through or with whom such Subsequent Financing is proposed to be effected)
and (y) the opportunity to consult reasonably with the Company with respect to the terms and conditions of such Subsequent Financing.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0.5pc; text-align: justify; text-indent: 3pc">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 1pc; text-align: center"><FONT STYLE="text-transform: uppercase"><B>ARTICLE
V.<BR>
MISCELLANEOUS</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 1pc; text-align: justify; text-indent: 3pc">5.1 <U>Termination</U>. This
Agreement may be terminated by any Purchaser, as to such Purchaser&rsquo;s obligations hereunder only and without any effect whatsoever
on the obligations between the Company and the other Purchasers, by written notice to the other parties, if the Closing has not been consummated
on or before October 31, 2022; provided, however, that such termination will not affect the right of any party to sue for any breach by
any other party (or parties).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 1pc; text-align: justify; text-indent: 3pc">5.2 <U>Fees and Expenses</U>.
Except as expressly set forth in the Transaction Documents to the contrary, each party shall pay the fees and expenses of its advisers,
counsel, accountants and other experts, if any, and all other expenses incurred by such party incident to the negotiation, preparation,
execution, delivery and performance of this Agreement. The Company shall pay all Transfer Agent fees (including, without limitation, any
fees required for same-day processing of any instruction letter delivered by the Company), stamp taxes and other taxes and duties levied
in connection with the delivery of any Shares and Conversion Shares to the Purchasers.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 1pc; text-align: justify; text-indent: 3pc">5.3 <U>Entire Agreement</U>.
The Transaction Documents, together with the exhibits and schedules thereto, contain the entire understanding of the parties with respect
to the subject matter hereof and thereof and supersede all prior agreements and understandings, oral or written, with respect to such
matters, which the parties acknowledge have been merged into such documents, exhibits and schedules.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 1pc; text-align: justify; text-indent: 3pc">5.4 <U>Notices</U>. Any and
all notices or other communications or deliveries required or permitted to be provided hereunder shall be in writing and shall be deemed
given and effective on the earliest of: (a) the date of transmission, if such notice or communication is delivered via email at the address
set forth on the signature pages attached hereto at or prior to 5:30 p.m. (New York City time) on a Trading Day, (b) the next Trading
Day after the date of transmission, if such notice or communication is delivered via email at the address set forth on the signature pages
attached hereto on a day that is not a Trading Day or later than 5:30 p.m. (New York City time) on any Trading Day, (c) the second (2<SUP>nd</SUP>)
Trading Day following the date of mailing, if sent by U.S. nationally recognized overnight courier service or (d) upon actual receipt
by the party to whom such notice is required to be given. The address for such notices and communications shall be as set forth on the
signature pages attached hereto. To the extent that any notice provided pursuant to any Transaction Document constitutes, or contains
material, non-public information regarding the Company or any of the Subsidiaries, the Company shall simultaneously file such notice with
the Commission pursuant to a Current Report on Form 8-K.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 1pc; text-align: justify; text-indent: 3pc">5.5 <U>Amendments; Waivers</U>.
No provision of this Agreement may be waived, modified, supplemented or amended except in a written instrument signed, in the case of
an amendment, by the Company and the Purchasers holding at least 51% in interest of the Shares then outstanding or, in the case of a waiver,
by the party against whom enforcement of any such waived provision is sought; provided, that if any amendment, modification or waiver
disproportionately and adversely impacts a Purchaser (or group of Purchasers), the consent of such disproportionately impacted Purchaser
(or group of Purchasers) shall also be required. No waiver of any default with respect to any provision, condition or requirement of this
Agreement shall be deemed to be a continuing waiver in the future or a waiver of any subsequent default or a waiver of any other provision,
condition or requirement hereof, nor shall any delay or omission of any party to exercise any right hereunder in any manner impair the
exercise of any such right.</P>


<!-- Field: Page; Sequence: 20 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%"><TR STYLE="font-size: 10pt"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->20<!-- Field: /Sequence -->&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%"><TR><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 1pc; text-align: justify; text-indent: 3pc">5.6 <U>Headings</U>. The headings
herein are for convenience only, do not constitute a part of this Agreement and shall not be deemed to limit or affect any of the provisions
hereof.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 1pc; text-align: justify; text-indent: 3pc">5.7 <U>Successors and Assigns</U>.
This Agreement shall be binding upon and inure to the benefit of the parties and their successors and permitted assigns. The Company may
not assign this Agreement or any rights or obligations hereunder without the prior written consent of each Purchaser (other than by merger).
Any Purchaser may assign any or all of its rights under this Agreement to any Person to whom such Purchaser assigns or transfers any Shares
or Conversion Shares, provided that such transferee agrees in writing to be bound, with respect to the transferred Shares or Conversion
Shares, by the provisions of the Transaction Documents that apply to the &ldquo;Purchasers.&rdquo;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 1pc; text-align: justify; text-indent: 3pc">5.8 <U>No Third-Party Beneficiaries</U>.
This Agreement is intended for the benefit of the parties hereto and their respective successors and permitted assigns and is not for
the benefit of, nor may any provision hereof be enforced by, any other Person, except as otherwise set forth in Section 4.8.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 1pc; text-align: justify; text-indent: 3pc">5.9 <U>Governing Law</U>.
All questions concerning the construction, validity, enforcement and interpretation of the Transaction Documents shall be governed by
and construed and enforced in accordance with the internal laws of the State of New York, without regard to the principles of conflicts
of law thereof. Each party agrees that all legal Proceedings concerning the interpretations, enforcement and defense of the transactions
contemplated by this Agreement and any other Transaction Documents (whether brought against a party hereto or its respective affiliates,
directors, officers, shareholders, partners, members, employees or agents) shall be commenced exclusively in the state and federal courts
sitting in the City of New York. Each party hereby irrevocably submits to the exclusive jurisdiction of the state and federal courts sitting
in the City of New York, Borough of Manhattan, for the adjudication of any dispute hereunder or in connection herewith or with any transaction
contemplated hereby or discussed herein (including with respect to the enforcement of any of the Transaction Documents), and hereby irrevocably
waives, and agrees not to assert in any Action or Proceeding, any claim that it is not personally subject to the jurisdiction of any such
court, or that such Action or Proceeding is improper or is an inconvenient venue for such Proceeding. Each party hereby irrevocably waives
personal service of process and consents to process being served in any such Action or Proceeding by mailing a copy thereof via registered
or certified mail or overnight delivery (with evidence of delivery) to such party at the address in effect for notices to it under this
Agreement and agrees that such service shall constitute good and sufficient service of process and notice thereof. Nothing contained herein
shall be deemed to limit in any way any right to serve process in any other manner permitted by law. If any party hereto shall commence
an Action or Proceeding to enforce any provisions of &nbsp;the Transaction Documents, then, in addition to the obligations of the Company
under Section 4.8, the prevailing party in such Action or Proceeding shall be reimbursed by the non-prevailing party for its reasonable
attorneys&rsquo; fees and other costs and expenses incurred with the investigation, preparation and prosecution of such Action or Proceeding.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 1pc; text-align: justify; text-indent: 3pc">5.10 <U>Survival</U>. The
representations and warranties contained herein shall survive the Closing and the delivery of the Shares.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 1pc; text-align: justify; text-indent: 3pc">5.11 <U>Execution</U>. This
Agreement may be executed in two or more counterparts, all of which when taken together shall be considered one and the same agreement
and shall become effective when counterparts have been signed by each party and delivered to each other party, it being understood that
the parties need not sign the same counterpart. In the event that any signature is delivered by facsimile transmission, by electronic
mail (including &ldquo;.pdf&rdquo; or any electronic signature complying with the U.S. federal ESIGN Act of 2000, e.g., docusign.com)
or other transmission method, such signature shall create a valid and binding obligation of the party executing (or on whose behalf such
signature is executed) with the same force and effect as if it were an original thereof.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 1pc; text-align: justify; text-indent: 3pc">5.12 <U>Severability</U>.
If any term, provision, covenant or restriction of this Agreement is held by a court of competent jurisdiction to be invalid, illegal,
void or unenforceable, the remainder of the terms, provisions, covenants and restrictions set forth herein shall remain in full force
and effect and shall in no way be affected, impaired or invalidated, and the parties hereto shall use their commercially reasonable efforts
to find and employ an alternative means to achieve the same or substantially the same result as that contemplated by such term, provision,
covenant or restriction. It is hereby stipulated and declared to be the intention of the parties that they would have executed the remaining
terms, provisions, covenants and restrictions without including any of such that may be hereafter declared invalid, illegal, void or unenforceable.</P>


<!-- Field: Page; Sequence: 21 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%"><TR STYLE="font-size: 10pt"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->21<!-- Field: /Sequence -->&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%"><TR><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 1pc; text-align: justify; text-indent: 3pc">5.13 <U>Rescission and Withdrawal
Right</U>. Notwithstanding anything to the contrary contained in (and without limiting any similar provisions of) any of the other Transaction
Documents, whenever any Purchaser exercises a right, election, demand or option under a Transaction Document and the Company does not
timely perform its related obligations within the periods therein provided, then such Purchaser may rescind or withdraw, in its sole discretion
from time to time upon written notice to the Company, any relevant notice, demand or election in whole or in part without prejudice to
its future actions and rights.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 1pc; text-align: justify; text-indent: 3pc">5.14 <U>Replacement of Shares</U>.
If any certificate or instrument evidencing any Shares or Conversion Shares is mutilated, lost, stolen or destroyed, the Company shall
issue or cause to be issued in exchange and substitution for and upon cancellation thereof (in the case of mutilation), or in lieu of
and substitution therefor, a new certificate or instrument, but only upon receipt of evidence reasonably satisfactory to the Company of
such loss, theft or destruction. The applicant for a new certificate or instrument under such circumstances shall also pay any reasonable
third-party costs (including customary indemnity) associated with the issuance of such replacement Shares or Conversion Shares.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 1pc; text-align: justify; text-indent: 3pc">5.15 <U>Remedies</U>. In addition
to being entitled to exercise all rights provided herein or granted by law, including recovery of damages, each of the Purchasers and
the Company will be entitled to specific performance under the Transaction Documents. The parties agree that monetary damages may not
be adequate compensation for any loss incurred by reason of any breach of obligations contained in the Transaction Documents and hereby
agree to waive and not to assert in any Action for specific performance of any such obligation the defense that a remedy at law would
be adequate.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 1pc; text-align: justify; text-indent: 3pc">5.16 <U>Payment Set Aside</U>.
To the extent that the Company makes a payment or payments to any Purchaser pursuant to any Transaction Document or a Purchaser enforces
or exercises its rights thereunder, and such payment or payments or the proceeds of such enforcement or exercise or any part thereof are
subsequently invalidated, declared to be fraudulent or preferential, set aside, recovered from, disgorged by or are required to be refunded,
repaid or otherwise restored to the Company, a trustee, receiver or any other Person under any law (including, without limitation, any
bankruptcy law, state or federal law, common law or equitable cause of action), then to the extent of any such restoration the obligation
or part thereof originally intended to be satisfied shall be revived and continued in full force and effect as if such payment had not
been made or such enforcement or setoff had not occurred.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 1pc; text-align: justify; text-indent: 3pc">5.17 <U>Independent Nature
of Purchasers&rsquo; Obligations and Rights</U>. The obligations of each Purchaser under any Transaction Document are several and not
joint with the obligations of any other Purchaser, and no Purchaser shall be responsible in any way for the performance or non-performance
of the obligations of any other Purchaser under any Transaction Document. Nothing contained herein or in any other Transaction Document,
and no action taken by any Purchaser pursuant hereof or thereto, shall be deemed to constitute the Purchasers as a partnership, an association,
a joint venture or any other kind of entity, or create a presumption that the Purchasers are in any way acting in concert or as a group
with respect to such obligations or the transactions contemplated by the Transaction Documents. Each Purchaser shall be entitled to independently
protect and enforce its rights, including, without limitation, the rights arising out of this Agreement or out of the other Transaction
Documents, and it shall not be necessary for any other Purchaser to be joined as an additional party in any proceeding for such purpose.
Each Purchaser has been represented by its own separate legal counsel in its review and negotiation of the Transaction Documents. The
Company has elected to provide all Purchasers with the same terms and Transaction Documents for the convenience of the Company and not
because it was required or requested to do so by any of the Purchasers.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 1pc; text-align: justify; text-indent: 3pc">5.18 <U>Saturdays, Sundays,
Holidays, etc</U>. If the last or appointed day for the taking of any action or the expiration of any right required or granted herein
shall not be a Business Day, then such action may be taken or such right may be exercised on the next succeeding Business Day.</P>


<!-- Field: Page; Sequence: 22 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%"><TR STYLE="font-size: 10pt"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->22<!-- Field: /Sequence -->&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%"><TR><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 1pc; text-align: justify; text-indent: 3pc">5.19 <U>Construction</U>.
The parties agree that each of them and/or their respective counsel have reviewed and had an opportunity to revise the Transaction Documents
and, therefore, the normal rule of construction to the effect that any ambiguities are to be resolved against the drafting party shall
not be employed in the interpretation of the Transaction Documents or any amendments thereto. In addition, each and every reference to
share prices and shares of Common Stock in any Transaction Document shall be subject to adjustment for reverse and forward stock splits,
stock dividends, stock combinations and other similar transactions of the Common Stock that occur after the date of this Agreement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 1pc; text-align: justify; text-indent: 3pc">5.20 <U>WAIVER OF JURY TRIAL</U>.
IN ANY ACTION, SUIT, OR PROCEEDING IN ANY JURISDICTION BROUGHT BY ANY PARTY AGAINST ANY OTHER PARTY, THE PARTIES EACH KNOWINGLY AND INTENTIONALLY,
TO THE GREATEST EXTENT PERMITTED BY APPLICABLE LAW, HEREBY ABSOLUTELY, UNCONDITIONALLY, IRREVOCABLY AND EXPRESSLY WAIVES FOREVER TRIAL
BY JURY.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 1pc; text-align: center"><I>(Signature Pages Follow)</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>


<!-- Field: Page; Sequence: 23 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%"><TR STYLE="font-size: 10pt"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->23<!-- Field: /Sequence -->&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%"><TR><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 1pc; text-align: justify; text-indent: 3pc">IN WITNESS WHEREOF, the parties
hereto have caused this Securities Purchase Agreement to be duly executed by their respective authorized signatories as of the date first
indicated above.</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="width: 100%; border-collapse: collapse">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 54%">
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">DUOS TECHNOLOGIES GROUP, INC.</P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><U>By:</U></P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><U>Name:</U>&nbsp;<U>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</U></P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><U>Title:</U>&nbsp;<U>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</U></P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P></TD>
    <TD STYLE="width: 46%">
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">Address for Notice:</P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">7660 Centurion Parkway</P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">Suite 100</P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">Jacksonville, Florida 32256</P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">Attn:</P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">Email:</P></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">With a copy to</P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">(which shall not constitute notice):</P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">Shutts &amp; Bowen LLP</P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">200 South Biscayne Boulevard</P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">Suite 4100</P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">Miami, Florida 33131</P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">Attn: J. Thomas Cookson</P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">Email: tcookson@shutts.com</P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P></TD>
    <TD STYLE="font: 12pt Times New Roman, Times, Serif">&nbsp;</TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 1pc">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 1pc; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 1pc; text-align: center">[REMAINDER OF PAGE INTENTIONALLY LEFT BLANK</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 1pc; text-align: center">SIGNATURE PAGE FOR PURCHASER FOLLOWS]</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 1pc; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 1pc; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 1pc; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 1pc; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>


<!-- Field: Page; Sequence: 24 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%"><TR STYLE="font-size: 10pt"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->24<!-- Field: /Sequence -->&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%"><TR><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 1pc; text-align: center">[PURCHASER SIGNATURE PAGES TO DUOS TECHNOLOGIES
GROUP, INC. SECURITIES PURCHASE AGREEMENT]</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 1pc; text-align: justify; text-indent: 3pc">IN WITNESS WHEREOF, the undersigned
have caused this Securities Purchase Agreement to be duly executed by their respective authorized signatories as of the date first indicated
above.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 1pc"><U>Name of Purchaser:</U> &nbsp;<U>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</U></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 1pc"><I>Signature of Authorized Signatory of Purchaser</I>:&nbsp;&nbsp;<U>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</U></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 1pc">&nbsp;Name of Authorized Signatory: <U>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</U></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 1pc">Title of Authorized Signatory: &#8239;<U>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</U></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 1pc">Email Address of Authorized Signatory: &#8239;<U>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</U></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 1pc">Facsimile Number of Authorized Signatory: <U>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</U></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 1pc">Address for Notice to Purchaser: <U>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</U></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 1pc">Address for Delivery of Securities to Purchaser (if not same as address
for notice):</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 1pc; text-indent: 36pc">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 1pc"><U>Subscription Amount: $</U></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 1pc">Number of Common Stock Shares: <U>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</U></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 1pc">Number of Preferred Shares: <U>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</U></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 1pc"><U>EIN Number: &#8239;</U></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="margin: 0; font: 10pt Times New Roman, Times, Serif">&nbsp;</P>

</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-10.2
<SEQUENCE>3
<FILENAME>duot_ex10z2.htm
<DESCRIPTION>FORM OF REGISTRATION RIGHTS AGREEMENT
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: right"><B>EXHIBIT 10.2</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><B>FORM OF</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 1pc; text-align: center"><FONT STYLE="text-transform: uppercase"><B>REGISTRATION
RIGHTS AGREEMENT</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 1pc; text-align: justify; text-indent: 3pc">This Registration Rights Agreement
(this &ldquo;<U>Agreement</U>&rdquo;) is made and entered into as of October__, 2022, between <B>Duos Technologies Group, Inc</B>., a
Florida corporation (the &ldquo;<U>Company</U>&rdquo;), and each of the several purchasers signatory hereto (each such purchaser, a &ldquo;<U>Purchaser</U>&rdquo;
and, collectively, the &ldquo;<U>Purchasers</U>&rdquo;).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 1pc; text-align: justify; text-indent: 3pc">This Agreement is made pursuant
to the Securities Purchase Agreement, dated as of the date hereof, between the Company and each Purchaser (the &ldquo;<U>Purchase Agreement</U>&rdquo;).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 1pc; text-align: justify; text-indent: 3pc">The Company and each Purchaser
hereby agrees as follows:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 1pc; text-align: justify; text-indent: 3pc">1. <U>Definitions</U>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 1pc; text-align: justify; text-indent: 3pc"><B>Capitalized terms used
and not otherwise defined herein that are defined in the Purchase Agreement shall have the meanings given such terms in the Purchase Agreement</B>.
As used in this Agreement, the following terms shall have the following meanings:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 1pc; text-align: justify; text-indent: 3pc">&ldquo;<U>Advice</U>&rdquo;
shall have the meaning set forth in Section 6(b).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 1pc; text-align: justify; text-indent: 3pc">&ldquo;<U>Effectiveness Date</U>&rdquo;
means, with respect to the Initial Registration Statement required to be filed hereunder, the 90<SUP>th</SUP> calendar day following the
date hereof (or, in the event of a &ldquo;full review&rdquo; by the Commission, the 120<SUP>th</SUP> calendar day following the date hereof)
and with respect to any additional Registration Statements which may be required pursuant to Section 2(c) or Section 3(c), the 45<SUP>th</SUP>
calendar day following the date on which an additional Registration Statement is required to be filed hereunder (or, in the event of a
&ldquo;full review&rdquo; by the Commission, the 75<SUP>th</SUP> calendar day following the date such additional Registration Statement
is required to be filed hereunder); <U>provided</U>, <U>however</U>, that in the event the Company is notified by the Commission that
one or more of the above Registration Statements will not be reviewed or is no longer subject to further review and comments, the Effectiveness
Dates as to such Registration Statement shall be the fifth Trading Day following the date on which the Company is so notified if such
date precedes the dates otherwise required above, subject to the Commission agreeing to the five Trading Day or shorter period, provided,
further, if such Effectiveness Date falls on a day that is not a Trading Day, then the Effectiveness Date shall be the next succeeding
Trading Day.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 1pc; text-align: justify; text-indent: 3pc">&ldquo;<U>Effectiveness Period</U>&rdquo;
shall have the meaning set forth in Section 2(a).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 1pc; text-align: justify; text-indent: 3pc">&ldquo;<U>Event</U>&rdquo;
shall have the meaning set forth in Section 2(d).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 1pc; text-align: justify; text-indent: 3pc">&ldquo;<U>Event Date</U>&rdquo;
shall have the meaning set forth in Section 2(d).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 1pc; text-align: justify; text-indent: 3pc">&ldquo;<U>Filing Date</U>&rdquo;
means, with respect to the Initial Registration Statement required hereunder, the 45<SUP>th</SUP> calendar day following the date hereof
and, with respect to any additional Registration Statements which may be required pursuant to Section 2(c) or Section 3(c), the earliest
practical date on which the Company is permitted by SEC Guidance to file such additional Registration Statement related to the Registrable
Securities.</P>


<!-- Field: Page; Sequence: 1 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%"><TR STYLE="font-size: 10pt"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->1<!-- Field: /Sequence -->&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%"><TR><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 1pc; text-align: justify; text-indent: 3pc">&ldquo;<U>Holder</U>&rdquo;
or &ldquo;<U>Holders</U>&rdquo; means the holder or holders, as the case may be, from time to time of Registrable Securities.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 1pc; text-align: justify; text-indent: 3pc">&ldquo;<U>Indemnified Party</U>&rdquo;
shall have the meaning set forth in Section 5(c).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 1pc; text-align: justify; text-indent: 3pc">&ldquo;<U>Indemnifying Party</U>&rdquo;
shall have the meaning set forth in Section 5(c).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 1pc; text-align: justify; text-indent: 3pc">&ldquo;<U>Initial Registration
Statement</U>&rdquo; means the initial Registration Statement filed pursuant to this Agreement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 1pc; text-align: justify; text-indent: 3pc">&ldquo;<U>Losses</U>&rdquo;
shall have the meaning set forth in Section 5(a).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 1pc; text-align: justify; text-indent: 3pc">&ldquo;<U>Plan of Distribution</U>&rdquo;
shall have the meaning set forth in Section 2(a).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 1pc; text-align: justify; text-indent: 3pc">&ldquo;<U>Prospectus</U>&rdquo;
means the prospectus included in a Registration Statement (including, without limitation, a prospectus that includes any information previously
omitted from a prospectus filed as part of an effective registration statement in reliance upon Rule 430A promulgated by the Commission
pursuant to the Securities Act), as amended or supplemented by any prospectus supplement, with respect to the terms of the offering of
any portion of the Registrable Securities covered by a Registration Statement, and all other amendments and supplements to the Prospectus,
including post-effective amendments, and all material incorporated by reference or deemed to be incorporated by reference in such Prospectus.</P>


<!-- Field: Page; Sequence: 2 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%"><TR STYLE="font-size: 10pt"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->2<!-- Field: /Sequence -->&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%"><TR><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 1pc; text-align: justify; text-indent: 3pc">&ldquo;<U>Registrable Securities</U>&rdquo;
means, as of any date of determination, (a) all Common Stock Shares, (b) all Conversion Shares then issued and issuable to the Purchasers
upon conversion of the Series D Preferred Stock (assuming on such date the Series D Preferred Stock is converted in full without regard
to any limitations on conversions of the Series D Preferred Stock); and (c) any securities issued or then issuable to the Purchasers upon
any stock split, dividend or other distribution, recapitalization or similar event with respect to the foregoing; <U>provided, however</U>,
that any such Registrable Securities shall cease to be Registrable Securities (and the Company shall not be required to maintain the effectiveness
of any, or file another, Registration Statement hereunder with respect thereto) for so long as (a) a Registration Statement with respect
to the sale of such Registrable Securities is declared effective by the Commission under the Securities Act and such Registrable Securities
have been disposed of by the Holder in accordance with such effective Registration Statement, (b) such Registrable Securities have been
previously sold in accordance with Rule 144, or (c) such securities become eligible for resale without volume or manner-of-sale restrictions
and without current public information pursuant to Rule 144 as set forth in a written opinion letter to such effect, addressed, delivered
and acceptable to the Transfer Agent and the affected Holders (solely in the case that such securities and any securities issuable upon
exercise, conversion or exchange of which, or as a dividend upon which, such securities were issued or are issuable, were at no time held
by any Affiliate of the Company, as reasonably determined by the Company, upon the advice of counsel to the Company).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 1pc; text-align: justify; text-indent: 3pc">&ldquo;<U>Registration Statement</U>&rdquo;
means any registration statement required to be filed hereunder pursuant to Section 2(a) and any additional registration statements contemplated
by Section 2(c) or Section 3(c), including (in each case) the Prospectus, amendments and supplements to any such registration statement
or Prospectus, including pre- and post-effective amendments, all exhibits thereto, and all material incorporated by reference or deemed
to be incorporated by reference in any such registration statement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 1pc; text-align: justify; text-indent: 3pc">&ldquo;<U>Rule 415</U>&rdquo;
means Rule 415 promulgated by the Commission pursuant to the Securities Act, as such Rule may be amended or interpreted from time to time,
or any similar rule or regulation hereafter adopted by the Commission having substantially the same purpose and effect as such Rule.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 1pc; text-align: justify; text-indent: 3pc">&ldquo;<U>Rule 424</U>&rdquo;
means Rule 424 promulgated by the Commission pursuant to the Securities Act, as such Rule may be amended or interpreted from time to time,
or any similar rule or regulation hereafter adopted by the Commission having substantially the same purpose and effect as such Rule.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 1pc; text-align: justify; text-indent: 3pc">&ldquo;<U>Selling Stockholder
Questionnaire</U>&rdquo; shall have the meaning set forth in Section 3(a).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 1pc; text-align: justify; text-indent: 3pc">&ldquo;<U>SEC Guidance</U>&rdquo;
means (i) any publicly-available written or oral guidance of the Commission staff, or any comments, requirements or requests of the Commission
staff and (ii) the Securities Act.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 1pc; text-align: justify; text-indent: 3pc">2. <U>Shelf Registration</U>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 1pc; text-align: justify; text-indent: 6pc">(a) On or prior to each Filing
Date, the Company shall prepare and file with the Commission a Registration Statement covering the resale of all of the Registrable Securities
that are not then registered on an effective Registration Statement for an offering to be made on a continuous basis pursuant to Rule
415. Each Registration Statement filed hereunder shall be on Form S-3 (except if the Company is not then eligible to register for resale
the Registrable Securities on Form S-3, in which case such registration shall be on another appropriate form in accordance herewith, subject
to the provisions of Section 2(e)) and shall contain (unless otherwise directed by at least 51% in interest of the Holders) substantially
the &ldquo;<U>Plan of Distribution</U>&rdquo; attached hereto as <U>Annex A</U> and substantially the &ldquo;<U>Selling Stockholder</U>&rdquo;
section attached hereto as <U>Annex B</U>; <U>provided</U>, <U>however</U>, that no Holder shall be required to be named as an &ldquo;underwriter&rdquo;
without such Holder&rsquo;s express prior written consent. Subject to the terms of this Agreement, the Company shall use its best efforts
to cause a Registration Statement filed under this Agreement (including, without limitation, under Section 3(c)) to be declared effective
under the Securities Act as promptly as possible after the filing thereof, but in any event no later than the applicable Effectiveness
Date, and shall use its best efforts to keep such Registration Statement continuously effective under the Securities Act until the date
that all Registrable Securities covered by such Registration Statement (i) have been sold, thereunder or pursuant to Rule 144, or (ii)
may be sold without volume or manner-of-sale restrictions pursuant to Rule 144 and without the requirement for the Company to be in compliance
with the current public information requirement under Rule 144, as determined by the counsel to the Company pursuant to a written opinion
letter to such effect, addressed and acceptable to the Transfer Agent and the affected Holders (the &ldquo;<U>Effectiveness Period</U>&rdquo;).
The Company shall request effectiveness of a Registration Statement as of 5:00 p.m. Eastern Time on a Trading Day. The Company shall notify
the Holders via facsimile or by e-mail of the effectiveness of a Registration Statement on the same Trading Day that the Company confirms
effectiveness with the Commission, which shall be the date requested for effectiveness of such Registration Statement. The Company shall,
by 9:30 a.m. Eastern Time on the Trading Day after the effective date of such Registration Statement, file a final Prospectus with the
Commission as required by Rule 424. Failure to so notify the Holder within one (1) Trading Day of such notification of effectiveness or
failure to file a final Prospectus as foresaid shall be deemed an Event under Section 2(d).</P>


<!-- Field: Page; Sequence: 3 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%"><TR STYLE="font-size: 10pt"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->3<!-- Field: /Sequence -->&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%"><TR><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 1pc; text-align: justify; text-indent: 6pc">(b) Notwithstanding the registration
obligations set forth in Section 2(a), if the staff of the Commission informs the Company that all of the Registrable Securities cannot,
as a result of the application of Rule 415, be registered for resale as a secondary offering on a single registration statement, the Company
shall promptly inform each of the Holders thereof and use its commercially reasonable efforts to file amendments to the Initial Registration
Statement as required by the staff of the Commission, covering the maximum number of Registrable Securities permitted to be registered
by the staff of the Commission, on Form S-3 or such other form available to register for resale the Registrable Securities as a secondary
offering, subject to the provisions of Section 2(e), with respect to filing on Form S-3 or other appropriate form, and subject to the
provisions of Section 2(d) with respect to the payment of liquidated damages; <U>provided</U>, <U>however</U>, that prior to filing such
amendment, the Company shall use diligent efforts to advocate with the staff of the Commission for the registration of all of the Registrable
Securities in accordance with the SEC Guidance, including without limitation, Compliance and Disclosure Interpretation 612.09.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 1pc; text-align: justify; text-indent: 6pc">(c) Notwithstanding any other
provision of this Agreement and subject to the payment of liquidated damages pursuant to Section 2(d), if the staff of the Commission
or any SEC Guidance sets forth a limitation on the number of Registrable Securities permitted to be registered on a particular Registration
Statement as a secondary offering (and notwithstanding that the Company used diligent efforts to advocate with the staff of the Commission
for the registration of all or a greater portion of Registrable Securities), unless otherwise directed in writing by a Holder as to its
Registrable Securities to register a lesser number, the number of Registrable Securities to be registered on such Registration Statement
will be reduced as follows:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 1pc; text-align: justify; text-indent: 9pc">a. First, the Company shall
reduce or eliminate any securities to be included other than Registrable Securities; and</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 1pc; text-align: justify; text-indent: 9pc">b. Second, the Company shall
reduce Registrable Securities represented by the Conversion Shares on a pro rata basis based on the total number of unregistered Conversion
Shares held by such Holders.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 1pc; text-align: justify; text-indent: 9pc">In the event of a cutback
hereunder, the Company shall give the Holder at least five (5) Trading Days prior written notice along with the calculations as to such
Holder&rsquo;s allotment. In the event the Company amends the Initial Registration Statement in accordance with the foregoing, the Company
will use its best efforts to file with the Commission, as promptly as allowed by the staff of the Commission or SEC Guidance provided
to the Company or to registrants of securities in general, one or more registration statements on Form S-3 or such other form available
to register for resale those Registrable Securities that were not registered for resale on the Initial Registration Statement, as amended.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 1pc; text-align: justify; text-indent: 6pc">(d) If: (i) the Initial Registration
Statement is not filed on or prior to its Filing Date (if the Company files the Initial Registration Statement without affording the Holders
the opportunity to review and comment on the same as required by Section 3(a) herein, the Company shall be deemed to have not satisfied
this clause (i)), or (ii) prior to the effective date of a Registration Statement, the Company fails to file a pre-effective amendment
and otherwise respond in writing to comments made by the staff of the Commission in respect of such Registration Statement within ten
(10) Trading Days after the receipt of comments by or notice from staff of the Commission that such amendment is required in order for
such Registration Statement to be declared effective or (iii) a Registration Statement registering for resale Registrable Securities is
not declared effective by the Commission by the Effectiveness Date of the Initial Registration Statement, or (iv) after the effective
date of a Registration Statement, such Registration Statement ceases for any reason to remain continuously effective as to the Registrable
Securities included in such Registration Statement, or the Holders are otherwise not permitted to utilize the Prospectus therein to resell
such Registrable Securities, for more than twenty (20) consecutive calendar days or more than an aggregate of thirty (30) Trading Days
(which need not be consecutive Trading Days) during any 12-month period (any such failure or breach being referred to as an &ldquo;<U>Event</U>&rdquo;,
and for purposes of clauses (i) and (ii), the date on which such Event occurs, and for purpose of clause (iii) the date on which such
ten (10) Trading Day period is exceeded, and for the purpose of clause (iv) the date on which such twenty (20) calendar day or thirty
(30) Trading Day period, as applicable, is exceeded being referred to as &ldquo;<U>Event Date</U>&rdquo;), then, in addition to any other
rights the Holders may have hereunder or under applicable law, on each such Event Date and on each monthly anniversary of each such Event
Date (if the applicable Event shall not have been cured by such date) until the applicable Event is cured, the Company shall pay to each
Holder an amount in cash, as partial liquidated damages and not as a penalty, equal to the product of 1.00% multiplied by the aggregate
Subscription Amount paid by such Holder pursuant to the Purchase Agreement. If the Company fails to pay any partial liquidated damages
pursuant to this Section in full within thirty (30) days after the date payable, the Company will pay interest thereon at a rate of 4.00%
per annum (or such lesser maximum amount that is permitted to be paid by applicable law) to the Holder, accruing daily from the date such
partial liquidated damages are due until such amounts, plus all such interest thereon, are paid in full. The partial liquidated damages
pursuant to the terms hereof shall apply on a daily pro rata basis for any portion of a month prior to the cure of an Event.</P>


<!-- Field: Page; Sequence: 4 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%"><TR STYLE="font-size: 10pt"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->4<!-- Field: /Sequence -->&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%"><TR><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 1pc; text-align: justify; text-indent: 6pc">(e) If Form S-3 is not available
for the registration of the resale of Registrable Securities hereunder, the Company shall (i) register the resale of the Registrable Securities
on another appropriate form and (ii) undertake to register the Registrable Securities on Form S-3 as soon as such form is available, provided
that the Company shall maintain the effectiveness of the Registration Statement then in effect until such time as a Registration Statement
on Form S-3 covering the Registrable Securities has been declared effective by the Commission.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 1pc; text-align: justify; text-indent: 6pc">(f) Notwithstanding anything
to the contrary contained herein, in no event shall the Company be permitted to name any Holder or affiliate of a Holder as any Underwriter
without the prior written consent of such Holder.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 1pc; text-align: justify; text-indent: 3pc">3. <U>Registration Procedures</U>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 1pc; text-align: justify; text-indent: 3pc">In connection with the Company&rsquo;s
registration obligations hereunder, the Company shall:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 1pc; text-align: justify; text-indent: 6pc">(a) Not less than five (5)
Trading Days prior to the filing of each Registration Statement and not less than one (1) Trading Day prior to the filing of any related
Prospectus or any amendment or supplement thereto, the Company shall (i) furnish to each Holder copies of all such documents proposed
to be filed, which documents will be subject to the review of such Holders, and (ii) cause its officers and directors, counsel and independent
registered public accountants to respond to such inquiries as shall be necessary, in the reasonable opinion of respective counsel to each
Holder, to conduct a reasonable investigation within the meaning of the Securities Act. The Company shall not file a Registration Statement
or any such Prospectus or any amendments or supplements thereto to which any Holder shall reasonably object in good faith, provided that,
the Company is notified of such objection in writing no later than three (3) Trading Days after the Holders have been so furnished copies
of a Registration Statement or one (1) Trading Day after the Holders have been so furnished copies of any related Prospectus or amendments
or supplements thereto. Each Holder agrees to furnish to the Company a completed questionnaire in the form attached to this Agreement
as <U>Annex C</U> (a &ldquo;<U>Selling Stockholder Questionnaire</U>&rdquo;) on a date that is not less than two (2) Trading Days prior
to the Filing Date or by the end of the fourth (4<SUP>th</SUP>) Trading Day following the date on which such Holder receives draft materials
in accordance with this Section.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 1pc; text-align: justify; text-indent: 6pc">(b) (i) Prepare and file with
the Commission such amendments, including post-effective amendments, to a Registration Statement and the Prospectus used in connection
therewith as may be necessary to keep a Registration Statement continuously effective as to the applicable Registrable Securities for
the Effectiveness Period and prepare and file with the Commission such additional Registration Statements in order to register for resale
under the Securities Act all of the Registrable Securities, (ii) cause the related Prospectus to be amended or supplemented by any required
Prospectus supplement (subject to the terms of this Agreement), and, as so supplemented or amended, to be filed pursuant to Rule 424,
(iii) respond as promptly as reasonably possible to any comments received from the Commission with respect to a Registration Statement
or any amendment thereto and provide as promptly as reasonably possible to the Holders true and complete copies of all correspondence
from and to the Commission relating to a Registration Statement (provided that, the Company shall excise any information contained therein
which would constitute material non-public information regarding the Company or any of its Subsidiaries), and (iv) comply in all material
respects with the applicable provisions of the Securities Act and the Exchange Act with respect to the disposition of all Registrable
Securities covered by a Registration Statement during the applicable period in accordance (subject to the terms of this Agreement) with
the intended methods of disposition by the Holders thereof set forth in such Registration Statement as so amended or in such Prospectus
as so supplemented.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 1pc; text-align: justify; text-indent: 6pc">(c) If during the Effectiveness
Period, the number of Registrable Securities at any time exceeds 100% of the number of shares of Common Stock then registered in a Registration
Statement, then the Company shall file as soon as reasonably practicable, but in any case prior to the applicable Filing Date (subject
to SEC Guidance), an additional Registration Statement covering the resale by the Holders of not less than the number of such Registrable
Securities.</P>


<!-- Field: Page; Sequence: 5 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%"><TR STYLE="font-size: 10pt"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->5<!-- Field: /Sequence -->&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%"><TR><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 1pc; text-align: justify; text-indent: 6pc">(d) Notify the Holders of
Registrable Securities to be sold (which notice shall, pursuant to clauses (iii) through (vi) hereof, be accompanied by an instruction
to suspend the use of the Prospectus until the requisite changes have been made) as promptly as reasonably possible (and, in the case
of (i)(A) below, not less than one (1) Trading Day prior to such filing) and (if requested by any such Person) confirm such notice in
writing no later than one (1) Trading Day following the day (i)(A) when a Prospectus or any Prospectus supplement or post-effective amendment
to a Registration Statement is proposed to be filed, (B) when the Commission notifies the Company whether there will be a &ldquo;review&rdquo;
of such Registration Statement and whenever the Commission comments in writing on such Registration Statement, and (C) with respect to
a Registration Statement or any post-effective amendment, when the same has become effective, (ii) of any request by the Commission or
any other federal or state governmental authority for amendments or supplements to a Registration Statement or Prospectus or for additional
information, (iii) of the issuance by the Commission or any other federal or state governmental authority of any stop order suspending
the effectiveness of a Registration Statement covering any or all of the Registrable Securities or the initiation of any Proceedings for
that purpose, (iv) of the receipt by the Company of any notification with respect to the suspension of the qualification or exemption
from qualification of any of the Registrable Securities for sale in any jurisdiction, or the initiation or threatening of any Proceeding
for such purpose, (v) of the occurrence of any event or passage of time that makes the financial statements included in a Registration
Statement ineligible for inclusion therein or any statement made in a Registration Statement or Prospectus or any document incorporated
or deemed to be incorporated therein by reference untrue in any material respect or that requires any revisions to a Registration Statement,
Prospectus or other documents so that, in the case of a Registration Statement or the Prospectus, as the case may be, it will not contain
any untrue statement of a material fact or omit to state any material fact required to be stated therein or necessary to make the statements
therein, in light of the circumstances under which they were made, not misleading, and (vi) of the occurrence or existence of any pending
corporate development with respect to the Company that the Company believes may be material and that, in the determination of the Company,
makes it not in the best interest of the Company to allow continued availability of a Registration Statement or Prospectus, <U>provided</U>,
<U>however</U>, in no event shall any such notice contain any information which would constitute material, non-public information regarding
the Company or any of its Subsidiaries.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 1pc; text-align: justify; text-indent: 6pc">(e) Use its best efforts to
avoid the issuance of, or, if issued, obtain the withdrawal of (i) any order stopping or suspending the effectiveness of a Registration
Statement, or (ii) any suspension of the qualification (or exemption from qualification) of any of the Registrable Securities for sale
in any jurisdiction, at the earliest practicable moment.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 1pc; text-align: justify; text-indent: 6pc">(f) Furnish to each Holder,
without charge, at least one conformed copy of each such Registration Statement and each amendment thereto, including financial statements
and schedules, all documents incorporated or deemed to be incorporated therein by reference to the extent requested by such Person, and
all exhibits to the extent requested by such Person (including those previously furnished or incorporated by reference) promptly after
the filing of such documents with the Commission; provided, that any such item which is available on the EDGAR system (or successor thereto)
need not be furnished in physical form.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 1pc; text-align: justify; text-indent: 6pc">(g) Subject to the terms of
this Agreement, the Company hereby consents to the use of such Prospectus and each amendment or supplement thereto by each of the selling
Holders in connection with the offering and sale of the Registrable Securities covered by such Prospectus and any amendment or supplement
thereto, except after the giving of any notice pursuant to Section 3(d).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 1pc; text-align: justify; text-indent: 6pc">(h) Prior to any resale of
Registrable Securities by a Holder, use its commercially reasonable efforts to register or qualify or cooperate with the selling Holders
in connection with the registration or qualification (or exemption from the registration or qualification) of such Registrable Securities
for the resale by the Holder under the securities or Blue Sky laws of such jurisdictions within the United States as any Holder reasonably
requests in writing, to keep each registration or qualification (or exemption therefrom) effective during the Effectiveness Period and
to do any and all other acts or things reasonably necessary to enable the disposition in such jurisdictions of the Registrable Securities
covered by each Registration Statement; provided, that, the Company shall not be required to qualify generally to do business in any jurisdiction
where it is not then so qualified, subject the Company to any material tax in any such jurisdiction where it is not then so subject or
file a general consent to service of process in any such jurisdiction.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 1pc; text-align: justify; text-indent: 6pc">(i) If requested by a Holder,
cooperate with such Holder to facilitate the timely preparation and delivery of certificates representing Registrable Securities to be
delivered to a transferee pursuant to a Registration Statement, which certificates shall be free, to the extent permitted by the Purchase
Agreement, of all restrictive legends, and to enable such Registrable Securities to be in such denominations and registered in such names
as any such Holder may request.</P>


<!-- Field: Page; Sequence: 6 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%"><TR STYLE="font-size: 10pt"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->6<!-- Field: /Sequence -->&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%"><TR><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 1pc; text-align: justify; text-indent: 6pc">(j) Upon the occurrence of
any event contemplated by Section 3(d), as promptly as reasonably possible under the circumstances taking into account the Company&rsquo;s
good faith assessment of any adverse consequences to the Company and its stockholders of the premature disclosure of such event, prepare
a supplement or amendment, including a post-effective amendment, to a Registration Statement or a supplement to the related Prospectus
or any document incorporated or deemed to be incorporated therein by reference, and file any other required document so that, as thereafter
delivered, neither a Registration Statement nor such Prospectus will contain an untrue statement of a material fact or omit to state a
material fact required to be stated therein or necessary to make the statements therein, in light of the circumstances under which they
were made, not misleading. If the Company notifies the Holders in accordance with clauses (iii) through (vi) of Section 3(d) above to
suspend the use of any Prospectus until the requisite changes to such Prospectus have been made, then the Holders shall suspend use of
such Prospectus. The Company will use its best efforts to ensure that the use of the Prospectus may be resumed as promptly as is practicable.
The Company shall be entitled to exercise its right under this Section 3(j) to suspend the availability of a Registration Statement and
Prospectus, subject to the payment of partial liquidated damages otherwise required pursuant to Section 2(d), for a period not to exceed
60 calendar days (which need not be consecutive days) in any 12-month period.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 1pc; text-align: justify; text-indent: 6pc">(k) Otherwise use commercially
reasonable efforts to comply with all applicable rules and regulations of the Commission under the Securities Act and the Exchange Act,
including, without limitation, Rule 172 under the Securities Act, file any final Prospectus, including any supplement or amendment thereof,
with the Commission pursuant to Rule 424 under the Securities Act, promptly inform the Holders in writing if, at any time during the Effectiveness
Period, the Company does not satisfy the conditions specified in Rule 172 and, as a result thereof, the Holders are required to deliver
a Prospectus in connection with any disposition of Registrable Securities and take such other actions as may be reasonably necessary to
facilitate the registration of the Registrable Securities hereunder.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 1pc; text-align: justify; text-indent: 6pc">(l) The Company shall use
its best efforts to acquire and maintain eligibility for use of Form S-3 (or any successor form thereto) for the registration of the resale
of Registrable Securities.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 1pc; text-align: justify; text-indent: 6pc">(m) The Company may require
each selling Holder to furnish to the Company a certified statement as to the number of shares of Common Stock beneficially owned by such
Holder and, if required by the Commission, the natural persons thereof that have voting and dispositive control over the shares. During
any periods that the Company is unable to meet its obligations hereunder with respect to the registration of the Registrable Securities
solely because any Holder fails to furnish such information within three Trading Days of the Company&rsquo;s request, any liquidated damages
that are accruing at such time as to such Holder only shall be tolled and any Event that may otherwise occur solely because of such delay
shall be suspended as to such Holder only, until such information is delivered to the Company.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 1pc; text-align: justify; text-indent: 3pc">4. <U>Registration Expenses</U>.
All fees and expenses incident to the performance of or compliance with, this Agreement by the Company shall be borne by the Company whether
or not any Registrable Securities are sold pursuant to a Registration Statement. The fees and expenses referred to in the foregoing sentence
shall include, without limitation, (i) all registration and filing fees (including, without limitation, fees and expenses of the Company&rsquo;s
counsel and independent registered public accountants) (A) with respect to filings made with the Commission, (B) with respect to filings
required to be made with any Trading Market on which the Common Stock is then listed for trading, and (C) in compliance with applicable
state securities or Blue Sky laws reasonably agreed to by the Company in writing (including, without limitation, fees and disbursements
of counsel for the Company in connection with Blue Sky qualifications or exemptions of the Registrable Securities), (ii) printing expenses
(including, without limitation, expenses of printing certificates for Registrable Securities), (iii) messenger, telephone and delivery
expenses, (iv) fees and disbursements of counsel for the Company, (v) Securities Act liability insurance, if the Company so desires such
insurance, and (vi) fees and expenses of all other Persons retained by the Company in connection with the consummation of the transactions
contemplated by this Agreement. In addition, the Company shall be responsible for all of its internal expenses incurred in connection
with the consummation of the transactions contemplated by this Agreement (including, without limitation, all salaries and expenses of
its officers and employees performing legal or accounting duties), the expense of any annual audit and the fees and expenses incurred
in connection with the listing of the Registrable Securities on any securities exchange as required hereunder. In no event shall the Company
be responsible for any broker or similar commissions of any Holder or, except to the extent provided for in the Transaction Documents,
any legal fees or other costs of the Holders.</P>


<!-- Field: Page; Sequence: 7 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%"><TR STYLE="font-size: 10pt"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->7<!-- Field: /Sequence -->&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%"><TR><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 1pc; text-align: justify; text-indent: 3pc">5. <U>Indemnification</U>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 1pc; text-align: justify; text-indent: 6pc">(a) <U>Indemnification by
the Company</U>. The Company shall, notwithstanding any termination of this Agreement, indemnify and hold harmless each Holder, the officers,
directors, members, partners, agents, brokers (including brokers who offer and sell Registrable Securities as principal as a result of
a pledge or any failure to perform under a margin call of Common Stock), investment advisors and employees (and any other Persons with
a functionally equivalent role of a Person holding such titles, notwithstanding a lack of such title or any other title) of each of them,
each Person who controls any such Holder (within the meaning of Section 15 of the Securities Act or Section 20 of the Exchange Act) and
the officers, directors, members, stockholders, partners, agents and employees (and any other Persons with a functionally equivalent role
of a Person holding such titles, notwithstanding a lack of such title or any other title) of each such controlling Person, to the fullest
extent permitted by applicable law, from and against any and all losses, claims, damages, liabilities, costs (including, without limitation,
reasonable attorneys&rsquo; fees) and expenses (collectively, &ldquo;<U>Losses</U>&rdquo;), as incurred, arising out of or relating to
(1) any untrue or alleged untrue statement of a material fact contained in a Registration Statement, any Prospectus or any form of prospectus
or in any amendment or supplement thereto or in any preliminary prospectus, or arising out of or relating to any omission or alleged omission
of a material fact required to be stated therein or necessary to make the statements therein (in the case of any Prospectus or supplement
thereto, in light of the circumstances under which they were made) not misleading or (2) any violation or alleged violation by the Company
of the Securities Act, the Exchange Act or any state securities law, or any rule or regulation thereunder, in connection with the performance
of its obligations under this Agreement, except to the extent, but only to the extent, that (i) such untrue statements or omissions are
based solely upon information regarding such Holder furnished in writing to the Company by such Holder expressly for use therein, or to
the extent that such information relates to such Holder or such Holder&rsquo;s proposed method of distribution of Registrable Securities
and was reviewed and expressly approved in writing by such Holder expressly for use in a Registration Statement, such Prospectus or in
any amendment or supplement thereto (it being understood that the Holder has approved Annex A hereto for this purpose) or (ii) in the
case of an occurrence of an event of the type specified in Section 3(d)(iii)-(vi), the use by such Holder of an outdated, defective or
otherwise unavailable Prospectus after the Company has notified such Holder in writing that the Prospectus is outdated, defective or otherwise
unavailable for use by such Holder and prior to the receipt by such Holder of the Advice contemplated in Section 6(d). The Company shall
notify the Holders promptly of the institution, threat or assertion of any Proceeding arising from or in connection with the transactions
contemplated by this Agreement of which the Company is aware. Such indemnity shall remain in full force and effect regardless of any investigation
made by or on behalf of such indemnified person and shall survive the transfer of any Registrable Securities by any of the Holders in
accordance with Section 6(e).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 1pc; text-align: justify; text-indent: 6pc">(b) <U>Indemnification by
Holders</U>. Each Holder shall, severally and not jointly, indemnify and hold harmless the Company, its directors, officers, agents and
employees, each Person who controls the Company (within the meaning of Section 15 of the Securities Act and Section 20 of the Exchange
Act), and the directors, officers, agents or employees of such controlling Persons, to the fullest extent permitted by applicable law,
from and against all Losses, as incurred, to the extent arising out of or based solely upon: any untrue or alleged untrue statement of
a material fact contained in any Registration Statement, any Prospectus, or in any amendment or supplement thereto or in any preliminary
prospectus, or arising out of or relating to any omission or alleged omission of a material fact required to be stated therein or necessary
to make the statements therein (in the case of any Prospectus or supplement thereto, in light of the circumstances under which they were
made) not misleading (i) to the extent, but only to the extent, that such untrue statement or omission is contained in any information
so furnished in writing by such Holder to the Company expressly for inclusion in such Registration Statement or such Prospectus or (ii)
to the extent, but only to the extent, that such information relates to such Holder&rsquo;s information provided in the Selling Stockholder
Questionnaire or the proposed method of distribution of Registrable Securities and was reviewed and expressly approved in writing by such
Holder expressly for use in a Registration Statement (it being understood that the Holder has approved Annex A hereto for this purpose),
such Prospectus or in any amendment or supplement thereto. In no event shall the liability of a selling Holder be greater in amount than
the dollar amount of the proceeds (net of all expenses paid by such Holder in connection with any claim relating to this Section 5 and
the amount of any damages such Holder has otherwise been required to pay by reason of such untrue statement or omission) received by such
Holder upon the sale of the Registrable Securities included in the Registration Statement giving rise to such indemnification obligation.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 1pc; text-align: justify; text-indent: 6pc">(c) <U>Conduct of Indemnification
Proceedings</U>. If any Proceeding shall be brought or asserted against any Person entitled to indemnity hereunder (an &ldquo;<U>Indemnified
Party</U>&rdquo;), such Indemnified Party shall promptly notify the Person from whom indemnity is sought (the &ldquo;<U>Indemnifying Party</U>&rdquo;)
in writing, and the Indemnifying Party shall have the right to assume the defense thereof, including the employment of counsel reasonably
satisfactory to the Indemnified Party and the payment of all fees and expenses incurred in connection with defense thereof; provided,
that, the failure of any Indemnified Party to give such notice shall not relieve the Indemnifying Party of its obligations or liabilities
pursuant to this Agreement, except (and only) to the extent that it shall be finally determined by a court of competent jurisdiction (which
determination is not subject to appeal or further review) that such failure shall have materially and adversely prejudiced the Indemnifying
Party.</P>


<!-- Field: Page; Sequence: 8 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%"><TR STYLE="font-size: 10pt"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->8<!-- Field: /Sequence -->&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%"><TR><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 1pc; text-align: justify; text-indent: 3pc">An Indemnified Party shall
have the right to employ separate counsel in any such Proceeding and to participate in the defense thereof, but the fees and expenses
of such counsel shall be at the expense of such Indemnified Party or Parties unless: (1) the Indemnifying Party has agreed in writing
to pay such fees and expenses, (2) the Indemnifying Party shall have failed promptly to assume the defense of such Proceeding and to employ
counsel reasonably satisfactory to such Indemnified Party in any such Proceeding or (3) the named parties to any such Proceeding (including
any impleaded parties) include both such Indemnified Party and the Indemnifying Party, and counsel to the Indemnified Party shall reasonably
believe that a material conflict of interest is likely to exist if the same counsel were to represent such Indemnified Party and the Indemnifying
Party (in which case, if such Indemnified Party notifies the Indemnifying Party in writing that it elects to employ separate counsel at
the expense of the Indemnifying Party, the Indemnifying Party shall not have the right to assume the defense thereof and the reasonable
fees and expenses of no more than one separate counsel shall be at the expense of the Indemnifying Party). The Indemnifying Party shall
not be liable for any settlement of any such Proceeding effected without its written consent, which consent shall not be unreasonably
withheld or delayed. No Indemnifying Party shall, without the prior written consent of the Indemnified Party, effect any settlement of
any pending Proceeding in respect of which any Indemnified Party is a party, unless such settlement includes an unconditional release
of such Indemnified Party from all liability on claims that are the subject matter of such Proceeding.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 1pc; text-align: justify; text-indent: 3pc">Subject to the terms of this
Agreement, all reasonable fees and expenses of the Indemnified Party (including reasonable fees and expenses to the extent incurred in
connection with investigating or preparing to defend such Proceeding in a manner not inconsistent with this Section) shall be paid to
the Indemnified Party, within thirty (30) Trading Days of written notice thereof to the Indemnifying Party; provided, that, the Indemnified
Party shall promptly reimburse the Indemnifying Party for that portion of such fees and expenses applicable to such actions for which
such Indemnified Party is finally determined by a court of competent jurisdiction (which determination is not subject to appeal or further
review) not to be entitled to indemnification hereunder.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 1pc; text-align: justify; text-indent: 6pc">(d) <U>Contribution</U>. If
the indemnification under Section 5(a) or 5(b) is unavailable to an Indemnified Party or insufficient to hold an Indemnified Party harmless
for any Losses, then each Indemnifying Party shall contribute to the amount paid or payable by such Indemnified Party, in such proportion
as is appropriate to reflect the relative fault of the Indemnifying Party and Indemnified Party in connection with the actions, statements
or omissions that resulted in such Losses as well as any other relevant equitable considerations. The relative fault of such Indemnifying
Party and Indemnified Party shall be determined by reference to, among other things, whether any action in question, including any untrue
or alleged untrue statement of a material fact or omission or alleged omission of a material fact, has been taken or made by, or relates
to information supplied by, such Indemnifying Party or Indemnified Party, and the parties&rsquo; relative intent, knowledge, access to
information and opportunity to correct or prevent such action, statement or omission. The amount paid or payable by a party as a result
of any Losses shall be deemed to include, subject to the limitations set forth in this Agreement, any reasonable attorneys&rsquo; or other
fees or expenses incurred by such party in connection with any Proceeding to the extent such party would have been indemnified for such
fees or expenses if the indemnification provided for in this Section was available to such party in accordance with its terms.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 1pc; text-align: justify; text-indent: 3pc">The parties hereto agree that
it would not be just and equitable if contribution pursuant to this Section 5(d) were determined by pro rata allocation or by any other
method of allocation that does not take into account the equitable considerations referred to in the immediately preceding paragraph.
In no event shall the contribution obligation of a Holder of Registrable Securities be greater in amount than the dollar amount of the
proceeds (net of all expenses paid by such Holder in connection with any claim relating to this Section 5 and the amount of any damages
such Holder has otherwise been required to pay by reason of such untrue or alleged untrue statement or omission or alleged omission) received
by it upon the sale of the Registrable Securities giving rise to such contribution obligation.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 1pc; text-align: justify; text-indent: 3pc">The indemnity and contribution
agreements contained in this Section are in addition to any liability that the Indemnifying Parties may have to the Indemnified Parties.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 1pc; text-align: justify; text-indent: 3pc">6. <U>Miscellaneous</U>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 1pc; text-align: justify; text-indent: 6pc">(a) <U>Remedies</U>. In the
event of a breach by the Company or by a Holder of any of their respective obligations under this Agreement, each Holder or the Company,
as the case may be, in addition to being entitled to exercise all rights granted by law and under this Agreement, including recovery of
damages, shall be entitled to specific performance of its rights under this Agreement. Each of the Company and each Holder agrees that
monetary damages would not provide adequate compensation for any losses incurred by reason of a breach by it of any of the provisions
of this Agreement and hereby further agrees that, in the event of any action for specific performance in respect of such breach, it shall
not assert or shall waive the defense that a remedy at law would be adequate.</P>


<!-- Field: Page; Sequence: 9 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%"><TR STYLE="font-size: 10pt"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->9<!-- Field: /Sequence -->&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%"><TR><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 1pc; text-align: justify; text-indent: 6pc">(b) <U>No Piggyback on Registrations;
Prohibition on Filing Other Registration Statements</U>. Neither the Company nor any of its security holders (other than the Holders in
such capacity pursuant hereto) may include securities of the Company in any Registration Statements other than the Registrable Securities.
The Company shall not file any other registration statements until all Registrable Securities are registered pursuant to a Registration
Statement that is declared effective by the Commission, provided that this Section 6(b) shall not prohibit the Company from filing amendments
to registration statements filed prior to the date of this Agreement or a Registration Statement on Form S-8 relating to any stock option
or similar plan.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 1pc; text-align: justify; text-indent: 6pc">(c) <U>Discontinued Disposition</U>.
By its acquisition of Registrable Securities, each Holder agrees that, upon receipt of a notice from the Company of the occurrence of
any event of the kind described in Section 3(d)(iii) through (vi), such Holder will forthwith discontinue disposition of such Registrable
Securities under a Registration Statement until it is advised in writing (the &ldquo;<U>Advice</U>&rdquo;) by the Company that the use
of the applicable Prospectus (as it may have been supplemented or amended) may be resumed. The Company will use its best efforts to ensure
that the use of the Prospectus may be resumed as promptly as is practicable. The Company agrees and acknowledges that any periods during
which the Holder is required to discontinue the disposition of the Registrable Securities hereunder shall be subject to the provisions
of Section 2(d).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 1pc; text-align: justify; text-indent: 6pc">(d) <U>Amendments and Waivers</U>.
The provisions of this Agreement, including the provisions of this sentence, may not be amended, modified or supplemented, and waivers
or consents to departures from the provisions hereof may not be given, unless the same shall be in writing and signed by the Company and
the Holders of 51% or more of the then outstanding Registrable Securities, provided that, if any amendment, modification or waiver disproportionately
and adversely impacts a Holder (or group of Holders), the consent of such disproportionately impacted Holder (or group of Holders) shall
be required. If a Registration Statement does not register all of the Registrable Securities pursuant to a waiver or amendment done in
compliance with the previous sentence, then the number of Registrable Securities to be registered for each Holder shall be reduced pro
rata among all Holders and each Holder shall have the right to designate which of its Registrable Securities shall be omitted from such
Registration Statement. Notwithstanding the foregoing, a waiver or consent to depart from the provisions hereof with respect to a matter
that relates exclusively to the rights of a Holder or some Holders and that does not directly or indirectly affect the rights of other
Holders may be given only by such Holder or Holders of all of the Registrable Securities to which such waiver or consent relates; <U>provided</U>,
<U>however</U>, that the provisions of this sentence may not be amended, modified, or supplemented except in accordance with the provisions
of the first sentence of this Section 6(d). No consideration shall be offered or paid to any Person to amend or consent to a waiver or
modification of any provision of this Agreement unless the same consideration also is offered to all of the parties to this Agreement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 1pc; text-align: justify; text-indent: 6pc">(e) <U>Notices</U>. Any and
all notices or other communications or deliveries required or permitted to be provided hereunder shall be delivered as set forth in the
Purchase Agreement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 1pc; text-align: justify; text-indent: 6pc">(f) <U>Successors and Assigns</U>.
This Agreement shall inure to the benefit of and be binding upon the successors and permitted assigns of each of the parties and shall
inure to the benefit of each Holder. The Company may not assign (except by merger) its rights or obligations hereunder without the prior
written consent of all of the Holders of the then outstanding Registrable Securities. Each Holder may assign their respective rights hereunder
in the manner and to the Persons as permitted under Section 5.7 of the Purchase Agreement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 1pc; text-align: justify; text-indent: 6pc">(g) <U>No Inconsistent Agreements</U>.
Neither the Company nor any of its Subsidiaries has entered, as of the date hereof, nor shall the Company or any of its Subsidiaries,
on or after the date of this Agreement, enter into any agreement with respect to its securities, that would have the effect of impairing
the rights granted to the Holders in this Agreement or otherwise conflicts with the provisions hereof. Except as set forth on <U>Schedule
6(f)</U>, neither the Company nor any of its Subsidiaries has previously entered into any agreement granting any registration rights with
respect to any of its securities to any Person that have not been satisfied in full.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 1pc; text-align: justify; text-indent: 6pc">(h) <U>Execution and Counterparts</U>.
This Agreement may be executed in two or more counterparts, all of which when taken together shall be considered one and the same agreement
and shall become effective when counterparts have been signed by each party and delivered to the other party, it being understood that
both parties need not sign the same counterpart. In the event that any signature is delivered by facsimile transmission, by electronic
mail (including &ldquo;.pdf&rdquo; or any electronic signature complying with the U.S. federal ESIGN Act of 2000, e.g. docusign.com) or
other transmission method, such signature shall create a valid and binding obligation of the party executing (or on whose behalf such
signature is executed) with the same force and effect as if it were an original thereof.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 1pc; text-align: justify; text-indent: 6pc">(i) <U>Governing Law</U>.
All questions concerning the construction, validity, enforcement and interpretation of this Agreement shall be determined in accordance
with the provisions of the Purchase Agreement.</P>


<!-- Field: Page; Sequence: 10 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%"><TR STYLE="font-size: 10pt"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->10<!-- Field: /Sequence -->&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%"><TR><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 1pc; text-align: justify; text-indent: 6pc">(j) <U>Cumulative Remedies</U>.
The remedies provided herein are cumulative and not exclusive of any other remedies provided by law.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 1pc; text-align: justify; text-indent: 6pc">(k) <U>Severability</U>. If
any term, provision, covenant or restriction of this Agreement is held by a court of competent jurisdiction to be invalid, illegal, void
or unenforceable, the remainder of the terms, provisions, covenants and restrictions set forth herein shall remain in full force and effect
and shall in no way be affected, impaired or invalidated, and the parties hereto shall use their commercially reasonable efforts to find
and employ an alternative means to achieve the same or substantially the same result as that contemplated by such term, provision, covenant
or restriction. It is hereby stipulated and declared to be the intention of the parties that they would have executed the remaining terms,
provisions, covenants and restrictions without including any of such that may be hereafter declared invalid, illegal, void or unenforceable.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 1pc; text-align: justify; text-indent: 6pc">(l) <U>Headings</U>. The headings
in this Agreement are for convenience only, do not constitute a part of this Agreement and shall not be deemed to limit or affect any
of the provisions hereof.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 1pc; text-align: justify; text-indent: 6pc">(m) <U>Independent Nature
of Holders&rsquo; Obligations and Rights</U>. The obligations of each Holder hereunder are several and not joint with the obligations
of any other Holder hereunder, and no Holder shall be responsible in any way for the performance of the obligations of any other Holder
hereunder. Nothing contained herein or in any other agreement or document delivered at any closing, and no action taken by any Holder
pursuant hereto or thereto, shall be deemed to constitute the Holders as a partnership, an association, a joint venture or any other kind
of group or entity, or create a presumption that the Holders are in any way acting in concert or as a group or entity with respect to
such obligations or the transactions contemplated by this Agreement or any other matters, and the Company acknowledges that the Holders
are not acting in concert or as a group, and the Company shall not assert any such claim, with respect to such obligations or transactions.
Each Holder shall be entitled to protect and enforce its rights, including without limitation the rights arising out of this Agreement,
and it shall not be necessary for any other Holder to be joined as an additional party in any proceeding for such purpose. The use of
a single agreement with respect to the obligations of the Company contained herein was solely in the control of the Company, not the action
or decision of any Holder, and was done solely for the convenience of the Company and not because it was required or requested to do so
by any Holder. It is expressly understood and agreed that each provision contained in this Agreement is between the Company and a Holder,
solely, and not between the Company and the Holders collectively and not between and among Holders.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center">********************</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><I>(Signature Pages Follow)</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>


<!-- Field: Page; Sequence: 11 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%"><TR STYLE="font-size: 10pt"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->11<!-- Field: /Sequence -->&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%"><TR><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 1pc; text-align: justify; text-indent: 3pc">IN WITNESS WHEREOF, the parties
have executed this Registration Rights Agreement as of the date first written above.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 18pc">DUOS TECHNOLOGIES GROUP, INC.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 18pc">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 18pc">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 18pc"><U>By:</U></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 18pc"><U>Name:</U></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 18pc"><U>Title:</U></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center">[SIGNATURE PAGES OF HOLDERS FOLLOW]</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>


<!-- Field: Page; Sequence: 12 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%"><TR STYLE="font-size: 10pt"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->12<!-- Field: /Sequence -->&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%"><TR><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 1pc">SIGNATURE PAGE OF HOLDERS TO REGISTRATION RIGHTS AGREEMENT OF DUOS
TECHNOLOGIES GROUP, INC.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><U>Name of Holder:</U></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Signature of Authorized Signatory of Holder: <U>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</U></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Name of Authorized Signatory: <U>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</U></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Title of Authorized Signatory: <U>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</U></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center">[SIGNATURE PAGES CONTINUE]</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>


<!-- Field: Page; Sequence: 13 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%"><TR STYLE="font-size: 10pt"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->13<!-- Field: /Sequence -->&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%"><TR><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: right"><B>Annex A</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 1pc; text-align: center"><U>Plan of Distribution</U></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 1pc; text-align: justify; text-indent: 3pc">Each Selling Stockholder (the
&ldquo;<U>Selling Stockholders</U>&rdquo;) of the securities and any of their pledgees, assignees and successors-in-interest may, from
time to time, sell, separately or together, any or all of their securities covered hereby on the principal Trading Market or any other
stock exchange, market or trading facility on which the securities are traded or in private transactions. These sales may be at fixed
or negotiated prices. To the extent the Selling Stockholders gift, pledge or otherwise transfer the securities offered hereby, such transferees
may offer and sell the securities from time to time under this prospectus, provided that, if required under the Securities Act, and the
rules and regulations promulgated thereunder, this prospectus has been amended under Rule 424(b)(3) or other applicable provision of the
Securities Act, to include the name of such transferee in the list of selling securityholders under this prospectus. A Selling Stockholder
may use any one or more of the following methods when selling securities:</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="width: 100%">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 48px">&nbsp;</TD>
    <TD STYLE="width: 24px; font: 12pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Symbol; font-size: 10pt">&#183;</FONT></TD>
    <TD STYLE="font: 12pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-size: 10pt">ordinary brokerage transactions and transactions in which the broker-dealer solicits purchasers;</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="width: 100%">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 48px">&nbsp;</TD>
    <TD STYLE="width: 24px; font: 12pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Symbol; font-size: 10pt">&#183;</FONT></TD>
    <TD STYLE="font: 12pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-size: 10pt">block trades in which the broker-dealer will attempt to sell the securities as agent but may position and resell a portion of the block as principal to facilitate the transaction;</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="width: 100%">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 48px">&nbsp;</TD>
    <TD STYLE="width: 24px; font: 12pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Symbol; font-size: 10pt">&#183;</FONT></TD>
    <TD STYLE="font: 12pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-size: 10pt">purchases by a broker-dealer as principal and resale by the broker-dealer for its account;</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="width: 100%">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 48px">&nbsp;</TD>
    <TD STYLE="width: 24px; font: 12pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Symbol; font-size: 10pt">&#183;</FONT></TD>
    <TD STYLE="font: 12pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-size: 10pt">an exchange distribution in accordance with the rules of the applicable exchange;</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="width: 100%">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 48px">&nbsp;</TD>
    <TD STYLE="width: 24px; font: 12pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Symbol; font-size: 10pt">&#183;</FONT></TD>
    <TD STYLE="font: 12pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-size: 10pt">privately negotiated transactions; through one or more underwritten offerings on a firm commitment or best efforts basis;</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="width: 100%">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 48px">&nbsp;</TD>
    <TD STYLE="width: 24px; font: 12pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Symbol; font-size: 10pt">&#183;</FONT></TD>
    <TD STYLE="font: 12pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-size: 10pt">settlement of short sales that are not in violation of Regulation SHO;</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="width: 100%">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 48px">&nbsp;</TD>
    <TD STYLE="width: 24px; font: 12pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Symbol; font-size: 10pt">&#183;</FONT></TD>
    <TD STYLE="font: 12pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-size: 10pt">in transactions through broker-dealers that agree with the Selling Stockholders to sell a specified number of such securities at a stipulated price per security;</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="width: 100%">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 48px">&nbsp;</TD>
    <TD STYLE="width: 24px; font: 12pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Symbol; font-size: 10pt">&#183;</FONT></TD>
    <TD STYLE="font: 12pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-size: 10pt">through the writing or settlement of options or other hedging transactions, whether through an options exchange or otherwise;</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="width: 100%">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 48px">&nbsp;</TD>
    <TD STYLE="width: 24px; font: 12pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Symbol; font-size: 10pt">&#183;</FONT></TD>
    <TD STYLE="font: 12pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-size: 10pt">through the distribution of securities by any Selling Stockholder to its partners, members or securityholders;</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="width: 100%">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 48px">&nbsp;</TD>
    <TD STYLE="width: 24px; font: 12pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Symbol; font-size: 10pt">&#183;</FONT></TD>
    <TD STYLE="font: 12pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-size: 10pt">a combination of any such methods of sale; or</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="width: 100%">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 48px">&nbsp;</TD>
    <TD STYLE="width: 24px; font: 12pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Symbol; font-size: 10pt">&#183;</FONT></TD>
    <TD STYLE="font: 12pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-size: 10pt">any other method permitted pursuant to applicable law.</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 1pc; text-align: justify; text-indent: 3pc">The Selling Stockholders may
also sell securities under Rule 144 or any other exemption from registration under the Securities Act of 1933, as amended (the &ldquo;<U>Securities
Act</U>&rdquo;), if available, rather than under this prospectus. The Selling Stockholders have the sole and absolute discretion not to
accept any purchase offer or make any sale of securities if they deem the purchase price to be unsatisfactory at any particular time.</P>


<!-- Field: Page; Sequence: 14 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%"><TR STYLE="font-size: 10pt"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->14<!-- Field: /Sequence -->&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%"><TR><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 1pc; text-align: justify; text-indent: 3pc">Broker-dealers engaged by
the Selling Stockholders may arrange for other brokers-dealers to participate in sales. Broker-dealers may receive commissions or discounts
from the Selling Stockholders (or, if any broker-dealer acts as agent for the purchaser of securities, from the purchaser) in amounts
to be negotiated, but, except as set forth in a supplement to this prospectus, in the case of an agency transaction not in excess of a
customary brokerage commission in compliance with FINRA Rule 2440; and in the case of a principal transaction a markup or markdown in
compliance with FINRA IM-2440.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 1pc; text-align: justify; text-indent: 3pc">In connection with the sale
of the securities or interests therein, the Selling Stockholders may enter into hedging transactions with broker-dealers or other financial
institutions, which may in turn engage in short sales of the securities in the course of hedging the positions they assume. The Selling
Stockholders may also sell securities short and deliver these securities to close out their short positions, or loan or pledge the securities
to broker-dealers that in turn may sell these securities. The Selling Stockholders may also enter into option or other transactions with
broker-dealers or other financial institutions or create one or more derivative securities which require the delivery to such broker-dealer
or other financial institution of securities offered by this prospectus, which securities such broker-dealer or other financial institution
may resell pursuant to this prospectus (as supplemented or amended to reflect such transaction).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 1pc; text-align: justify; text-indent: 3pc">The Selling Stockholders may
from time to time pledge or grant a security interest in some or all of their securities to their broker-dealers under the margin provisions
of customer agreements or to other parties to secure other obligations. If a Selling Stockholder defaults on a margin loan or other secured
obligation, the broker-dealer or secured party may, from time to time, offer and sell the securities pledged or secured thereby pursuant
to this prospectus. The Selling Stockholders and any other persons participating in the sale or distribution of the securities will be
subject to applicable provisions of the Securities Act and the Exchange Act, and the rules and regulations thereunder, including, without
limitation, Regulation M. These provisions may restrict certain activities of, and limit the timing of purchases and sales of any of the
securities by, the Selling Stockholders or any other person, which limitations may affect the marketability of the securities.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 1pc; text-align: justify; text-indent: 3pc">The Selling Stockholders also
may transfer the shares of our securities in other circumstances, in which case the transferees, pledgees or other successors-in-interest
will be the selling beneficial owners for purposes of this prospectus.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 1pc; text-align: justify; text-indent: 3pc">A Selling Stockholder that
is an entity may elect to make a pro rata in-kind distribution of securities to its members, partners or shareholders pursuant to the
registration statement of which this prospectus is part by delivering a prospectus. To the extent that such members, partners or shareholders
are not affiliates of ours, such members, partners or shareholders would thereby receive freely tradeable securities pursuant to the distribution
through a registration statement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 1pc; text-align: justify; text-indent: 3pc">The Selling Stockholders and
any broker-dealers or agents that are involved in selling the securities may be deemed to be &ldquo;underwriters&rdquo; within the meaning
of the Securities Act in connection with such sales. In such event, any commissions received by such broker-dealers or agents and any
profit on the resale of the securities purchased by them may be deemed to be underwriting commissions or discounts under the Securities
Act. Each Selling Stockholder has informed the Company that it does not have any written or oral agreement or understanding, directly
or indirectly, with any person to distribute the securities.</P>


<!-- Field: Page; Sequence: 15 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%"><TR STYLE="font-size: 10pt"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->15<!-- Field: /Sequence -->&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%"><TR><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 1pc; text-align: justify; text-indent: 3pc">The Company is required to
pay certain fees and expenses incurred by the Company incident to the registration of the securities. The Company has agreed to indemnify
the Selling Stockholders against certain losses, claims, damages and liabilities, including liabilities under the Securities Act.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 1pc; text-align: justify; text-indent: 3pc">We agreed to keep this prospectus
effective until the earlier of the date on which (i) the securities may be resold by the Selling Stockholders without registration and
without regard to any volume or manner-of-sale limitations by reason of Rule 144, without the requirement for the Company to be in compliance
with the current public information under Rule 144 under the Securities Act or any other rule of similar effect or (ii) all of the securities
have been sold pursuant to this prospectus or Rule 144 under the Securities Act or any other rule of similar effect. The resale securities
will be sold only through registered or licensed brokers or dealers if required under applicable state securities laws. In addition, in
certain states, the resale securities covered hereby may not be sold unless they have been registered or qualified for sale in the applicable
state or an exemption from the registration or qualification requirement is available and is complied with.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 1pc; text-align: justify; text-indent: 3pc">Under applicable rules and
regulations under the Exchange Act, any person engaged in the distribution of the resale securities may not simultaneously engage in market
making activities with respect to the common stock for the applicable restricted period, as defined in Regulation M, prior to the commencement
of the distribution. In addition, the Selling Stockholders will be subject to applicable provisions of the Exchange Act and the rules
and regulations thereunder, including Regulation M, which may limit the timing of purchases and sales of the common stock by the Selling
Stockholders or any other person. We will make copies of this prospectus available to the Selling Stockholders and have informed them
of the need to deliver a copy of this prospectus to each purchaser at or prior to the time of the sale (including by compliance with Rule
172 under the Securities Act).</P>


<!-- Field: Page; Sequence: 16 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%"><TR STYLE="font-size: 10pt"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->16<!-- Field: /Sequence -->&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%"><TR><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 1pc; text-align: right"><B>Annex <FONT STYLE="text-transform: uppercase">b</FONT></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 1pc; text-align: center"><FONT STYLE="text-transform: uppercase"><B>SELLING
STOCKHOLDERS</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 1pc; text-align: justify; text-indent: 3pc">The common stock being offered
by the selling stockholders are those [previously issued] [issuable to] the selling stockholders pursuant to the Purchase Agreement and/or
upon conversion of the preferred stock. For additional information regarding the issuances of those shares, see &ldquo;Private Placement&rdquo;
above. We are registering the shares of common stock in order to permit the selling stockholders to offer the shares for resale from time
to time. Except for the ownership of the shares of preferred stock and common stock and as otherwise set forth in this prospectus, the
selling stockholders have not had any material relationship with us within the past three years.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 1pc; text-align: justify; text-indent: 3pc">The table below lists the
selling stockholders and other information regarding the beneficial ownership of the shares of common stock by each of the selling stockholders.
The second column lists the number of shares of common stock beneficially owned by each selling stockholder, based on its ownership of
the shares of preferred stock, common stock and warrants, as of ________________, 2022, assuming conversion of the preferred stock and
exercise of the warrants held by the selling stockholders on that date, without regard to any limitations on conversions or exercises.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 1pc; text-align: justify; text-indent: 3pc">The third column lists the
shares of common stock being offered by this prospectus by the selling stockholders.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 1pc; text-align: justify; text-indent: 3pc">In accordance with the terms
of a registration rights agreement with the selling stockholders, this prospectus generally covers the resale of the maximum number of
shares of common stock issued pursuant to the Purchase Agreement or issuable upon conversion of the preferred stock, determined as if
the outstanding shares of preferred stock were converted in full as of the trading day immediately preceding the date this registration
statement was initially filed with the SEC as of the trading day immediately preceding the applicable date of determination and subject
to adjustment as provided in the registration rights agreement, without regard to any limitations on the conversion of the preferred stock.
The fourth column assumes the sale of all of the shares offered by the selling stockholders pursuant to this prospectus.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 1pc; text-align: justify; text-indent: 3pc">Under the terms of the Certificate
of Designation, a selling stockholder may not convert the preferred stock to the extent such conversion would cause such selling stockholder,
together with its affiliates and attribution parties, to beneficially own a number of shares of common stock which would exceed [4.99%]
[19.99%] of our then outstanding common stock following such conversion, excluding for purposes of such determination shares of common
stock issuable upon conversion of the preferred stock which has not been converted. The number of shares in the second column does not
reflect this limitation. The selling stockholders may sell all, some or none of their shares in this offering. See &ldquo;Plan of Distribution.&rdquo;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="width: 100%">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 29%; font: 12pt Times New Roman, Times, Serif"><FONT STYLE="font-size: 10pt"><U>Name of Selling Stockholder</U></FONT></TD>
    <TD STYLE="width: 23%; font: 12pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-size: 10pt"><U>Number of shares of Common Stock Owned Prior to Offering</U></FONT></TD>
    <TD STYLE="width: 25%">
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><U>Maximum Number of shares of Common Stock to be Sold
    Pursuant to this</U></P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><U>Prospectus</U></P></TD>
    <TD STYLE="width: 23%; font: 12pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-size: 10pt"><U>Number of shares of Common Stock Owned After Offering</U></FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="font: 12pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 12pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 12pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 12pt Times New Roman, Times, Serif">&nbsp;</TD></TR>
  </TABLE>
<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0; text-align: right">&nbsp;</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0; text-align: right">&nbsp;</P>


<!-- Field: Page; Sequence: 17 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%"><TR STYLE="font-size: 10pt"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->17<!-- Field: /Sequence -->&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%"><TR><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: right"><B>Annex C</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 1pc; text-align: center"><FONT STYLE="text-transform: uppercase"><B>DUOS
TECHNOLOGIES GROUP, INC.</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 1pc; text-align: center"><B>Selling Stockholder Notice and Questionnaire</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 1pc; text-align: justify; text-indent: 3pc">The undersigned beneficial
owner of common stock (the &ldquo;<U>Registrable Securities</U>&rdquo;) of Duos Technologies Group, Inc., a Florida corporation (the &ldquo;<U>Company</U>&rdquo;),
understands that the Company has filed or intends to file with the Securities and Exchange Commission (the &ldquo;<U>Commission</U>&rdquo;)
a registration statement (the &ldquo;<U>Registration Statement</U>&rdquo;) for the registration and resale under Rule 415 of the Securities
Act of 1933, as amended (the &ldquo;<U>Securities Act</U>&rdquo;), of the Registrable Securities, in accordance with the terms of the
Registration Rights Agreement (the &ldquo;<U>Registration Rights Agreement</U>&rdquo;) to which this document is annexed. A copy of the
Registration Rights Agreement is available from the Company upon request at the address set forth below. All capitalized terms not otherwise
defined herein shall have the meanings ascribed thereto in the Registration Rights Agreement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 1pc; text-align: justify; text-indent: 3pc">Certain legal consequences
arise from being named as a selling stockholder in the Registration Statement and the related prospectus. Accordingly, holders and beneficial
owners of Registrable Securities are advised to consult their own securities law counsel regarding the consequences of being named or
not being named as a selling stockholder in the Registration Statement and the related prospectus.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 1pc; text-align: center"><FONT STYLE="text-transform: uppercase"><B>NOTICE</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 1pc; text-align: justify; text-indent: 3pc">The undersigned beneficial
owner (the &ldquo;<U>Selling Stockholder</U>&rdquo;) of Registrable Securities hereby elects to include the Registrable Securities owned
by it in the Registration Statement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 1pc; text-align: justify; text-indent: 3pc">The undersigned hereby provides
the following information to the Company and represents and warrants that such information is accurate:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>


<!-- Field: Page; Sequence: 18 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%"><TR STYLE="font-size: 10pt"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->18<!-- Field: /Sequence -->&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%"><TR><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="text-transform: uppercase"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 1pc; text-align: center"><FONT STYLE="text-transform: uppercase"><B>QUESTIONNAIRE</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 1pc; text-align: justify; text-indent: 3pc">1. <B>Name.</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 1pc; text-align: justify; text-indent: 6pc">(a) Full Legal Name of Selling
Stockholder:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 1pc; text-align: justify; text-indent: 6pc">(b) Full Legal Name of Registered
Holder (if not the same as (a) above) through which Registrable Securities are held:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 1pc; text-align: justify; text-indent: 6pc">(c) Full Legal Name of Natural
Control Person (which means a natural person who directly or indirectly alone or with others has power to vote or dispose of the securities
covered by this Questionnaire):</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 1pc; text-align: justify; text-indent: 3pc">2. <B>Address for Notices
to Selling Stockholder:</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">Telephone:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">Fax:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">Email:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">Contact</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">Person:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 1pc; text-align: justify; text-indent: 3pc">3. <B>Broker-Dealer Status:</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 1pc; text-align: justify; text-indent: 6pc">(a) Are you a broker-dealer?</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 1pc 9pc">Yes [_] No [_]</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 1pc; text-align: justify; text-indent: 6pc">(b) If &ldquo;yes&rdquo; to
Section 3(a), did you receive your Registrable Securities as compensation for investment banking services to the Company?</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 1pc 9pc">Yes [_] No [_]</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 1pc">Note: If &ldquo;no&rdquo; to Section 3(b), the Commission&rsquo;s
staff has indicated that you should be identified as an underwriter in the Registration Statement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 1pc; text-align: justify; text-indent: 6pc">(c) Are you an affiliate of
a broker-dealer?</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 1pc 9pc">Yes [_] No [_]</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 1pc; text-align: justify; text-indent: 6pc">&nbsp;</P>


<!-- Field: Page; Sequence: 19 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%"><TR STYLE="font-size: 10pt"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->19<!-- Field: /Sequence -->&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%"><TR><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 1pc; text-align: justify; text-indent: 6pc">(d) If you are an affiliate
of a broker-dealer, do you certify that you purchased the Registrable Securities in the ordinary course of business, and at the time of
the purchase of the Registrable Securities to be resold, you had no agreements or understandings, directly or indirectly, with any person
to distribute the Registrable Securities?</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 1pc 9pc">Yes [_] No [_]</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 1pc">Note: If &ldquo;no&rdquo; to Section 3(d), the Commission&rsquo;s
staff has indicated that you should be identified as an underwriter in the Registration Statement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 1pc; text-align: justify; text-indent: 3pc">4. <B>Beneficial Ownership
of Securities of the Company Owned by the Selling Stockholder.</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 1pc"><I>Except as set forth below in this Item 4, the undersigned is not
the beneficial or registered owner of any securities of the Company other than the securities issuable pursuant to the Purchase Agreement.</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 5pc; text-align: justify; text-indent: 6pc">(a) Type and Amount of other
securities beneficially owned by the Selling Stockholder:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 1pc; text-align: justify; text-indent: 3pc">5. <B>Relationships with the
Company:</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 1pc"><I>Except as set forth below, neither the undersigned nor any of
its affiliates, officers, directors or principal equity holders (owners of 5% of more of the equity securities of the undersigned) has
held any position or office or has had any other material relationship with the Company (or its predecessors or affiliates) during the
past three years.</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 1pc">State any exceptions here:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 1pc; text-align: justify; text-indent: 3pc">The undersigned agrees to
promptly notify the Company of any material inaccuracies or changes in the information provided herein that may occur subsequent to the
date hereof at any time while the Registration Statement remains effective; provided, that the undersigned shall not be required to notify
the Company of any changes to the number of securities held or owned by the undersigned or its affiliates.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 1pc; text-align: justify; text-indent: 3pc">By signing below, the undersigned
consents to the disclosure of the information contained herein in its answers to Items 1 through 5 and the inclusion of such information
in the Registration Statement and the related prospectus and any amendments or supplements thereto. The undersigned understands that such
information will be relied upon by the Company in connection with the preparation or amendment of the Registration Statement and the related
prospectus and any amendments or supplements thereto.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 1pc; text-align: justify; text-indent: 3pc">IN WITNESS WHEREOF the undersigned,
by authority duly given, has caused this Notice and Questionnaire to be executed and delivered either in person or by its duly authorized
agent.</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="width: 100%; border-collapse: collapse">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 50%; font: 12pt Times New Roman, Times, Serif"><FONT STYLE="font-size: 10pt">Date:</FONT></TD>
    <TD STYLE="width: 50%; font: 12pt Times New Roman, Times, Serif"><FONT STYLE="font-size: 10pt">Beneficial Owner:</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="font: 12pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 12pt Times New Roman, Times, Serif">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="font: 12pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 12pt Times New Roman, Times, Serif"><FONT STYLE="font-size: 10pt">By: _________________________________</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="font: 12pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 12pt Times New Roman, Times, Serif"><FONT STYLE="font-size: 10pt">Name: _______________________________</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="font: 12pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 12pt Times New Roman, Times, Serif"><FONT STYLE="font-size: 10pt">Title:&nbsp;________________________________</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 1pc"><B>PLEASE FAX A COPY (OR EMAIL A .PDF COPY) OF THE COMPLETED AND
EXECUTED NOTICE AND QUESTIONNAIRE TO:</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.SCH
<SEQUENCE>4
<FILENAME>duot-20221029.xsd
<DESCRIPTION>XBRL SCHEMA FILE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="US-ASCII" ?>
    <!-- Field: Doc-Info; Name: Generator; Value: GoFiler Complete; Version: 5.16a -->
    <!-- Field: Doc-Info; Name: VendorURI; Value: https://www.novaworks.com -->
    <!-- Field: Doc-Info; Name: Status; Value: 0x00000000 -->
    <!-- Field: Doc-Info; Name: Misc; Value: +qsps7xRiXgOn8uMY3pMOaqNObP9z5V9GYkhsWt9bVl6PyQhy4CpTSzGZv3mgUEI -->
<schema xmlns="http://www.w3.org/2001/XMLSchema" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" xmlns:xbrldi="http://xbrl.org/2006/xbrldi" xmlns:dei="http://xbrl.sec.gov/dei/2022" xmlns:us-gaap="http://fasb.org/srt-sup/2022q3" xmlns:srt="http://fasb.org/srt/2022" xmlns:srt-types="http://fasb.org/srt-types/2022" xmlns:DUOT="http://duostech.com/20221029" elementFormDefault="qualified" targetNamespace="http://duostech.com/20221029">
    <annotation>
      <appinfo>
	<link:roleType roleURI="http://duostech.com/role/Cover" id="Cover">
	  <link:definition>00000001 - Document - Cover</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:linkbaseRef xlink:type="simple" xlink:href="duot-20221029_pre.xml" xlink:role="http://www.xbrl.org/2003/role/presentationLinkbaseRef" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:title="Presentation Links" />
	<link:linkbaseRef xlink:type="simple" xlink:href="duot-20221029_lab.xml" xlink:role="http://www.xbrl.org/2003/role/labelLinkbaseRef" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:title="Label Links" />
      </appinfo>
    </annotation>
    <import namespace="http://www.xbrl.org/2003/instance" schemaLocation="http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd" />
    <import namespace="http://www.xbrl.org/2003/linkbase" schemaLocation="http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd" />
    <import namespace="http://xbrl.sec.gov/dei/2022" schemaLocation="https://xbrl.sec.gov/dei/2022/dei-2022.xsd" />
    <import namespace="http://fasb.org/us-gaap/2022" schemaLocation="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd" />
    <import namespace="http://fasb.org/us-gaap-sup/2022q3" schemaLocation="https://xbrl.fasb.org/us-gaap/2022q3/us-gaap-sup-2022q3.xsd" />
    <import namespace="http://fasb.org/srt-sup/2022q3" schemaLocation="https://xbrl.fasb.org/srt/2022q3/srt-sup-2022q3.xsd" />
    <import namespace="http://fasb.org/us-types/2022" schemaLocation="https://xbrl.fasb.org/us-gaap/2022/elts/us-types-2022.xsd" />
    <import namespace="http://www.xbrl.org/dtr/type/2020-01-21" schemaLocation="https://www.xbrl.org/dtr/type/2020-01-21/types.xsd" />
    <import namespace="http://xbrl.sec.gov/country/2022" schemaLocation="https://xbrl.sec.gov/country/2022/country-2022.xsd" />
    <import namespace="http://fasb.org/srt/2022" schemaLocation="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd" />
    <import namespace="http://fasb.org/srt-types/2022" schemaLocation="https://xbrl.fasb.org/srt/2022/elts/srt-types-2022.xsd" />
</schema>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.LAB
<SEQUENCE>5
<FILENAME>duot-20221029_lab.xml
<DESCRIPTION>XBRL LABEL FILE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="US-ASCII" standalone="no"?>
    <!-- Field: Doc-Info; Name: Generator; Value: GoFiler Complete; Version: 5.16a -->
    <!-- Field: Doc-Info; Name: VendorURI; Value: https://www.novaworks.com -->
    <!-- Field: Doc-Info; Name: Status; Value: 0x00000000 -->
<link:linkbase xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xbrli="http://www.xbrl.org/2003/instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedLabel" roleURI="http://www.xbrl.org/2009/role/negatedLabel" />
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodEndLabel" roleURI="http://www.xbrl.org/2009/role/negatedPeriodEndLabel" />
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodStartLabel" roleURI="http://www.xbrl.org/2009/role/negatedPeriodStartLabel" />
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTotalLabel" roleURI="http://www.xbrl.org/2009/role/negatedTotalLabel" />
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedNetLabel" roleURI="http://www.xbrl.org/2009/role/negatedNetLabel" />
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTerseLabel" roleURI="http://www.xbrl.org/2009/role/negatedTerseLabel" />
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/net-2009-12-16.xsd#netLabel" roleURI="http://www.xbrl.org/2009/role/netLabel" />
    <link:labelLink xlink:type="extended" xlink:role="http://www.xbrl.org/2003/role/link">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_CoverAbstract" xlink:label="dei_CoverAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_CoverAbstract" xlink:to="dei_CoverAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_CoverAbstract_lbl" xml:lang="en-US">Cover [Abstract]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentType" xlink:label="dei_DocumentType" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentType" xlink:to="dei_DocumentType_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentType_lbl" xml:lang="en-US">Document Type</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_AmendmentFlag" xlink:label="dei_AmendmentFlag" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_AmendmentFlag" xlink:to="dei_AmendmentFlag_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_AmendmentFlag_lbl" xml:lang="en-US">Amendment Flag</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_AmendmentDescription" xlink:label="dei_AmendmentDescription" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_AmendmentDescription" xlink:to="dei_AmendmentDescription_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_AmendmentDescription_lbl" xml:lang="en-US">Amendment Description</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentRegistrationStatement" xlink:label="dei_DocumentRegistrationStatement" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentRegistrationStatement" xlink:to="dei_DocumentRegistrationStatement_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentRegistrationStatement_lbl" xml:lang="en-US">Document Registration Statement</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentAnnualReport" xlink:label="dei_DocumentAnnualReport" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentAnnualReport" xlink:to="dei_DocumentAnnualReport_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentAnnualReport_lbl" xml:lang="en-US">Document Annual Report</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentQuarterlyReport" xlink:label="dei_DocumentQuarterlyReport" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentQuarterlyReport" xlink:to="dei_DocumentQuarterlyReport_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentQuarterlyReport_lbl" xml:lang="en-US">Document Quarterly Report</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentTransitionReport" xlink:label="dei_DocumentTransitionReport" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentTransitionReport" xlink:to="dei_DocumentTransitionReport_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentTransitionReport_lbl" xml:lang="en-US">Document Transition Report</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentShellCompanyReport" xlink:label="dei_DocumentShellCompanyReport" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentShellCompanyReport" xlink:to="dei_DocumentShellCompanyReport_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentShellCompanyReport_lbl" xml:lang="en-US">Document Shell Company Report</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentShellCompanyEventDate" xlink:label="dei_DocumentShellCompanyEventDate" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentShellCompanyEventDate" xlink:to="dei_DocumentShellCompanyEventDate_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentShellCompanyEventDate_lbl" xml:lang="en-US">Document Shell Company Event Date</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentPeriodStartDate" xlink:label="dei_DocumentPeriodStartDate" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentPeriodStartDate" xlink:to="dei_DocumentPeriodStartDate_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentPeriodStartDate_lbl" xml:lang="en-US">Document Period Start Date</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentPeriodEndDate" xlink:label="dei_DocumentPeriodEndDate" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentPeriodEndDate" xlink:to="dei_DocumentPeriodEndDate_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentPeriodEndDate_lbl" xml:lang="en-US">Document Period End Date</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentFiscalPeriodFocus" xlink:label="dei_DocumentFiscalPeriodFocus" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentFiscalPeriodFocus" xlink:to="dei_DocumentFiscalPeriodFocus_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentFiscalPeriodFocus_lbl" xml:lang="en-US">Document Fiscal Period Focus</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentFiscalYearFocus" xlink:label="dei_DocumentFiscalYearFocus" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentFiscalYearFocus" xlink:to="dei_DocumentFiscalYearFocus_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentFiscalYearFocus_lbl" xml:lang="en-US">Document Fiscal Year Focus</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_CurrentFiscalYearEndDate" xlink:label="dei_CurrentFiscalYearEndDate" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_CurrentFiscalYearEndDate" xlink:to="dei_CurrentFiscalYearEndDate_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_CurrentFiscalYearEndDate_lbl" xml:lang="en-US">Current Fiscal Year End Date</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityFileNumber" xlink:label="dei_EntityFileNumber" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityFileNumber" xlink:to="dei_EntityFileNumber_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityFileNumber_lbl" xml:lang="en-US">Entity File Number</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityRegistrantName" xlink:label="dei_EntityRegistrantName" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityRegistrantName" xlink:to="dei_EntityRegistrantName_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityRegistrantName_lbl" xml:lang="en-US">Entity Registrant Name</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityCentralIndexKey" xlink:label="dei_EntityCentralIndexKey" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityCentralIndexKey" xlink:to="dei_EntityCentralIndexKey_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityCentralIndexKey_lbl" xml:lang="en-US">Entity Central Index Key</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityPrimarySicNumber" xlink:label="dei_EntityPrimarySicNumber" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityPrimarySicNumber" xlink:to="dei_EntityPrimarySicNumber_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityPrimarySicNumber_lbl" xml:lang="en-US">Entity Primary SIC Number</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityTaxIdentificationNumber" xlink:label="dei_EntityTaxIdentificationNumber" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityTaxIdentificationNumber" xlink:to="dei_EntityTaxIdentificationNumber_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityTaxIdentificationNumber_lbl" xml:lang="en-US">Entity Tax Identification Number</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityIncorporationStateCountryCode" xlink:label="dei_EntityIncorporationStateCountryCode" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityIncorporationStateCountryCode" xlink:to="dei_EntityIncorporationStateCountryCode_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityIncorporationStateCountryCode_lbl" xml:lang="en-US">Entity Incorporation, State or Country Code</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressAddressLine1" xlink:label="dei_EntityAddressAddressLine1" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressAddressLine1" xlink:to="dei_EntityAddressAddressLine1_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressAddressLine1_lbl" xml:lang="en-US">Entity Address, Address Line One</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressAddressLine2" xlink:label="dei_EntityAddressAddressLine2" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressAddressLine2" xlink:to="dei_EntityAddressAddressLine2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressAddressLine2_lbl" xml:lang="en-US">Entity Address, Address Line Two</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressAddressLine3" xlink:label="dei_EntityAddressAddressLine3" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressAddressLine3" xlink:to="dei_EntityAddressAddressLine3_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressAddressLine3_lbl" xml:lang="en-US">Entity Address, Address Line Three</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressCityOrTown" xlink:label="dei_EntityAddressCityOrTown" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressCityOrTown" xlink:to="dei_EntityAddressCityOrTown_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressCityOrTown_lbl" xml:lang="en-US">Entity Address, City or Town</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressStateOrProvince" xlink:label="dei_EntityAddressStateOrProvince" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressStateOrProvince" xlink:to="dei_EntityAddressStateOrProvince_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressStateOrProvince_lbl" xml:lang="en-US">Entity Address, State or Province</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressCountry" xlink:label="dei_EntityAddressCountry" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressCountry" xlink:to="dei_EntityAddressCountry_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressCountry_lbl" xml:lang="en-US">Entity Address, Country</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressPostalZipCode" xlink:label="dei_EntityAddressPostalZipCode" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressPostalZipCode" xlink:to="dei_EntityAddressPostalZipCode_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressPostalZipCode_lbl" xml:lang="en-US">Entity Address, Postal Zip Code</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_CountryRegion" xlink:label="dei_CountryRegion" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_CountryRegion" xlink:to="dei_CountryRegion_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_CountryRegion_lbl" xml:lang="en-US">Country Region</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_CityAreaCode" xlink:label="dei_CityAreaCode" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_CityAreaCode" xlink:to="dei_CityAreaCode_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_CityAreaCode_lbl" xml:lang="en-US">City Area Code</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_LocalPhoneNumber" xlink:label="dei_LocalPhoneNumber" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_LocalPhoneNumber" xlink:to="dei_LocalPhoneNumber_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_LocalPhoneNumber_lbl" xml:lang="en-US">Local Phone Number</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_Extension" xlink:label="dei_Extension" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_Extension" xlink:to="dei_Extension_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_Extension_lbl" xml:lang="en-US">Extension</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_WrittenCommunications" xlink:label="dei_WrittenCommunications" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_WrittenCommunications" xlink:to="dei_WrittenCommunications_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_WrittenCommunications_lbl" xml:lang="en-US">Written Communications</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_SolicitingMaterial" xlink:label="dei_SolicitingMaterial" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_SolicitingMaterial" xlink:to="dei_SolicitingMaterial_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_SolicitingMaterial_lbl" xml:lang="en-US">Soliciting Material</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_PreCommencementTenderOffer" xlink:label="dei_PreCommencementTenderOffer" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_PreCommencementTenderOffer" xlink:to="dei_PreCommencementTenderOffer_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_PreCommencementTenderOffer_lbl" xml:lang="en-US">Pre-commencement Tender Offer</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_PreCommencementIssuerTenderOffer" xlink:label="dei_PreCommencementIssuerTenderOffer" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_PreCommencementIssuerTenderOffer" xlink:to="dei_PreCommencementIssuerTenderOffer_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_PreCommencementIssuerTenderOffer_lbl" xml:lang="en-US">Pre-commencement Issuer Tender Offer</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_Security12bTitle" xlink:label="dei_Security12bTitle" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_Security12bTitle" xlink:to="dei_Security12bTitle_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_Security12bTitle_lbl" xml:lang="en-US">Title of 12(b) Security</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_NoTradingSymbolFlag" xlink:label="dei_NoTradingSymbolFlag" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_NoTradingSymbolFlag" xlink:to="dei_NoTradingSymbolFlag_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_NoTradingSymbolFlag_lbl" xml:lang="en-US">No Trading Symbol Flag</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_TradingSymbol" xlink:label="dei_TradingSymbol" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_TradingSymbol" xlink:to="dei_TradingSymbol_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_TradingSymbol_lbl" xml:lang="en-US">Trading Symbol</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_SecurityExchangeName" xlink:label="dei_SecurityExchangeName" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_SecurityExchangeName" xlink:to="dei_SecurityExchangeName_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_SecurityExchangeName_lbl" xml:lang="en-US">Security Exchange Name</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_Security12gTitle" xlink:label="dei_Security12gTitle" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_Security12gTitle" xlink:to="dei_Security12gTitle_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_Security12gTitle_lbl" xml:lang="en-US">Title of 12(g) Security</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_SecurityReportingObligation" xlink:label="dei_SecurityReportingObligation" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_SecurityReportingObligation" xlink:to="dei_SecurityReportingObligation_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_SecurityReportingObligation_lbl" xml:lang="en-US">Security Reporting Obligation</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_AnnualInformationForm" xlink:label="dei_AnnualInformationForm" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_AnnualInformationForm" xlink:to="dei_AnnualInformationForm_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_AnnualInformationForm_lbl" xml:lang="en-US">Annual Information Form</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_AuditedAnnualFinancialStatements" xlink:label="dei_AuditedAnnualFinancialStatements" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_AuditedAnnualFinancialStatements" xlink:to="dei_AuditedAnnualFinancialStatements_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_AuditedAnnualFinancialStatements_lbl" xml:lang="en-US">Audited Annual Financial Statements</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityWellKnownSeasonedIssuer" xlink:label="dei_EntityWellKnownSeasonedIssuer" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityWellKnownSeasonedIssuer" xlink:to="dei_EntityWellKnownSeasonedIssuer_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityWellKnownSeasonedIssuer_lbl" xml:lang="en-US">Entity Well-known Seasoned Issuer</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityVoluntaryFilers" xlink:label="dei_EntityVoluntaryFilers" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityVoluntaryFilers" xlink:to="dei_EntityVoluntaryFilers_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityVoluntaryFilers_lbl" xml:lang="en-US">Entity Voluntary Filers</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityCurrentReportingStatus" xlink:label="dei_EntityCurrentReportingStatus" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityCurrentReportingStatus" xlink:to="dei_EntityCurrentReportingStatus_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityCurrentReportingStatus_lbl" xml:lang="en-US">Entity Current Reporting Status</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityInteractiveDataCurrent" xlink:label="dei_EntityInteractiveDataCurrent" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityInteractiveDataCurrent" xlink:to="dei_EntityInteractiveDataCurrent_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityInteractiveDataCurrent_lbl" xml:lang="en-US">Entity Interactive Data Current</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityFilerCategory" xlink:label="dei_EntityFilerCategory" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityFilerCategory" xlink:to="dei_EntityFilerCategory_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityFilerCategory_lbl" xml:lang="en-US">Entity Filer Category</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntitySmallBusiness" xlink:label="dei_EntitySmallBusiness" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntitySmallBusiness" xlink:to="dei_EntitySmallBusiness_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntitySmallBusiness_lbl" xml:lang="en-US">Entity Small Business</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityEmergingGrowthCompany" xlink:label="dei_EntityEmergingGrowthCompany" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityEmergingGrowthCompany" xlink:to="dei_EntityEmergingGrowthCompany_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityEmergingGrowthCompany_lbl" xml:lang="en-US">Entity Emerging Growth Company</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityExTransitionPeriod" xlink:label="dei_EntityExTransitionPeriod" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityExTransitionPeriod" xlink:to="dei_EntityExTransitionPeriod_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityExTransitionPeriod_lbl" xml:lang="en-US">Elected Not To Use the Extended Transition Period</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentAccountingStandard" xlink:label="dei_DocumentAccountingStandard" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentAccountingStandard" xlink:to="dei_DocumentAccountingStandard_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentAccountingStandard_lbl" xml:lang="en-US">Document Accounting Standard</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_OtherReportingStandardItemNumber" xlink:label="dei_OtherReportingStandardItemNumber" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_OtherReportingStandardItemNumber" xlink:to="dei_OtherReportingStandardItemNumber_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_OtherReportingStandardItemNumber_lbl" xml:lang="en-US">Other Reporting Standard Item Number</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityShellCompany" xlink:label="dei_EntityShellCompany" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityShellCompany" xlink:to="dei_EntityShellCompany_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityShellCompany_lbl" xml:lang="en-US">Entity Shell Company</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityPublicFloat" xlink:label="dei_EntityPublicFloat" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityPublicFloat" xlink:to="dei_EntityPublicFloat_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityPublicFloat_lbl" xml:lang="en-US">Entity Public Float</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityBankruptcyProceedingsReportingCurrent" xlink:label="dei_EntityBankruptcyProceedingsReportingCurrent" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityBankruptcyProceedingsReportingCurrent" xlink:to="dei_EntityBankruptcyProceedingsReportingCurrent_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityBankruptcyProceedingsReportingCurrent_lbl" xml:lang="en-US">Entity Bankruptcy Proceedings, Reporting Current</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityCommonStockSharesOutstanding" xlink:label="dei_EntityCommonStockSharesOutstanding" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityCommonStockSharesOutstanding" xlink:to="dei_EntityCommonStockSharesOutstanding_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityCommonStockSharesOutstanding_lbl" xml:lang="en-US">Entity Common Stock, Shares Outstanding</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentsIncorporatedByReferenceTextBlock" xlink:label="dei_DocumentsIncorporatedByReferenceTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentsIncorporatedByReferenceTextBlock" xlink:to="dei_DocumentsIncorporatedByReferenceTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentsIncorporatedByReferenceTextBlock_lbl" xml:lang="en-US">Documents Incorporated by Reference [Text Block]</link:label>
    </link:labelLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.PRE
<SEQUENCE>6
<FILENAME>duot-20221029_pre.xml
<DESCRIPTION>XBRL PRESENTATION FILE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="US-ASCII" standalone="no"?>
    <!-- Field: Doc-Info; Name: Generator; Value: GoFiler Complete; Version: 5.16a -->
    <!-- Field: Doc-Info; Name: VendorURI; Value: https://www.novaworks.com -->
    <!-- Field: Doc-Info; Name: Status; Value: 0x00000000 -->
<link:linkbase xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xbrli="http://www.xbrl.org/2003/instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
    <link:roleRef roleURI="http://duostech.com/role/Cover" xlink:href="duot-20221029.xsd#Cover" xlink:type="simple" />
    <link:presentationLink xlink:type="extended" xlink:role="http://duostech.com/role/Cover" xlink:title="00000001 - Document - Cover">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_CoverAbstract" xlink:label="loc_deiCoverAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentType" xlink:label="loc_deiDocumentType" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentType" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_AmendmentFlag" xlink:label="loc_deiAmendmentFlag" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiAmendmentFlag" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_AmendmentDescription" xlink:label="loc_deiAmendmentDescription" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiAmendmentDescription" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentRegistrationStatement" xlink:label="loc_deiDocumentRegistrationStatement" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentRegistrationStatement" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentAnnualReport" xlink:label="loc_deiDocumentAnnualReport" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentAnnualReport" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentQuarterlyReport" xlink:label="loc_deiDocumentQuarterlyReport" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentQuarterlyReport" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentTransitionReport" xlink:label="loc_deiDocumentTransitionReport" />
      <link:presentationArc order="60" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentTransitionReport" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentShellCompanyReport" xlink:label="loc_deiDocumentShellCompanyReport" />
      <link:presentationArc order="70" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentShellCompanyReport" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentShellCompanyEventDate" xlink:label="loc_deiDocumentShellCompanyEventDate" />
      <link:presentationArc order="80" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentShellCompanyEventDate" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentPeriodStartDate" xlink:label="loc_deiDocumentPeriodStartDate" />
      <link:presentationArc order="90" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentPeriodStartDate" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentPeriodEndDate" xlink:label="loc_deiDocumentPeriodEndDate" />
      <link:presentationArc order="100" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentPeriodEndDate" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentFiscalPeriodFocus" xlink:label="loc_deiDocumentFiscalPeriodFocus" />
      <link:presentationArc order="110" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentFiscalPeriodFocus" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentFiscalYearFocus" xlink:label="loc_deiDocumentFiscalYearFocus" />
      <link:presentationArc order="120" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentFiscalYearFocus" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_CurrentFiscalYearEndDate" xlink:label="loc_deiCurrentFiscalYearEndDate" />
      <link:presentationArc order="130" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiCurrentFiscalYearEndDate" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityFileNumber" xlink:label="loc_deiEntityFileNumber" />
      <link:presentationArc order="140" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityFileNumber" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityRegistrantName" xlink:label="loc_deiEntityRegistrantName" />
      <link:presentationArc order="150" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityRegistrantName" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityCentralIndexKey" xlink:label="loc_deiEntityCentralIndexKey" />
      <link:presentationArc order="160" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityCentralIndexKey" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityPrimarySicNumber" xlink:label="loc_deiEntityPrimarySicNumber" />
      <link:presentationArc order="170" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityPrimarySicNumber" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityTaxIdentificationNumber" xlink:label="loc_deiEntityTaxIdentificationNumber" />
      <link:presentationArc order="180" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityTaxIdentificationNumber" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityIncorporationStateCountryCode" xlink:label="loc_deiEntityIncorporationStateCountryCode" />
      <link:presentationArc order="190" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityIncorporationStateCountryCode" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressAddressLine1" xlink:label="loc_deiEntityAddressAddressLine1" />
      <link:presentationArc order="200" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityAddressAddressLine1" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressAddressLine2" xlink:label="loc_deiEntityAddressAddressLine2" />
      <link:presentationArc order="210" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityAddressAddressLine2" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressAddressLine3" xlink:label="loc_deiEntityAddressAddressLine3" />
      <link:presentationArc order="220" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityAddressAddressLine3" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressCityOrTown" xlink:label="loc_deiEntityAddressCityOrTown" />
      <link:presentationArc order="230" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityAddressCityOrTown" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressStateOrProvince" xlink:label="loc_deiEntityAddressStateOrProvince" />
      <link:presentationArc order="240" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityAddressStateOrProvince" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressCountry" xlink:label="loc_deiEntityAddressCountry" />
      <link:presentationArc order="250" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityAddressCountry" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressPostalZipCode" xlink:label="loc_deiEntityAddressPostalZipCode" />
      <link:presentationArc order="260" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityAddressPostalZipCode" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_CountryRegion" xlink:label="loc_deiCountryRegion" />
      <link:presentationArc order="270" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiCountryRegion" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_CityAreaCode" xlink:label="loc_deiCityAreaCode" />
      <link:presentationArc order="280" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiCityAreaCode" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_LocalPhoneNumber" xlink:label="loc_deiLocalPhoneNumber" />
      <link:presentationArc order="290" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiLocalPhoneNumber" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_Extension" xlink:label="loc_deiExtension" />
      <link:presentationArc order="300" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiExtension" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_WrittenCommunications" xlink:label="loc_deiWrittenCommunications" />
      <link:presentationArc order="310" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiWrittenCommunications" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_SolicitingMaterial" xlink:label="loc_deiSolicitingMaterial" />
      <link:presentationArc order="320" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiSolicitingMaterial" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_PreCommencementTenderOffer" xlink:label="loc_deiPreCommencementTenderOffer" />
      <link:presentationArc order="330" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiPreCommencementTenderOffer" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_PreCommencementIssuerTenderOffer" xlink:label="loc_deiPreCommencementIssuerTenderOffer" />
      <link:presentationArc order="340" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiPreCommencementIssuerTenderOffer" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_Security12bTitle" xlink:label="loc_deiSecurity12bTitle" />
      <link:presentationArc order="350" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiSecurity12bTitle" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_NoTradingSymbolFlag" xlink:label="loc_deiNoTradingSymbolFlag" />
      <link:presentationArc order="360" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiNoTradingSymbolFlag" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_TradingSymbol" xlink:label="loc_deiTradingSymbol" />
      <link:presentationArc order="370" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiTradingSymbol" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_SecurityExchangeName" xlink:label="loc_deiSecurityExchangeName" />
      <link:presentationArc order="380" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiSecurityExchangeName" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_Security12gTitle" xlink:label="loc_deiSecurity12gTitle" />
      <link:presentationArc order="390" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiSecurity12gTitle" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_SecurityReportingObligation" xlink:label="loc_deiSecurityReportingObligation" />
      <link:presentationArc order="400" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiSecurityReportingObligation" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_AnnualInformationForm" xlink:label="loc_deiAnnualInformationForm" />
      <link:presentationArc order="410" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiAnnualInformationForm" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_AuditedAnnualFinancialStatements" xlink:label="loc_deiAuditedAnnualFinancialStatements" />
      <link:presentationArc order="420" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiAuditedAnnualFinancialStatements" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityWellKnownSeasonedIssuer" xlink:label="loc_deiEntityWellKnownSeasonedIssuer" />
      <link:presentationArc order="430" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityWellKnownSeasonedIssuer" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityVoluntaryFilers" xlink:label="loc_deiEntityVoluntaryFilers" />
      <link:presentationArc order="440" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityVoluntaryFilers" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityCurrentReportingStatus" xlink:label="loc_deiEntityCurrentReportingStatus" />
      <link:presentationArc order="450" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityCurrentReportingStatus" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityInteractiveDataCurrent" xlink:label="loc_deiEntityInteractiveDataCurrent" />
      <link:presentationArc order="460" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityInteractiveDataCurrent" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityFilerCategory" xlink:label="loc_deiEntityFilerCategory" />
      <link:presentationArc order="470" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityFilerCategory" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntitySmallBusiness" xlink:label="loc_deiEntitySmallBusiness" />
      <link:presentationArc order="480" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntitySmallBusiness" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityEmergingGrowthCompany" xlink:label="loc_deiEntityEmergingGrowthCompany" />
      <link:presentationArc order="490" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityEmergingGrowthCompany" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityExTransitionPeriod" xlink:label="loc_deiEntityExTransitionPeriod" />
      <link:presentationArc order="500" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityExTransitionPeriod" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentAccountingStandard" xlink:label="loc_deiDocumentAccountingStandard" />
      <link:presentationArc order="510" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentAccountingStandard" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_OtherReportingStandardItemNumber" xlink:label="loc_deiOtherReportingStandardItemNumber" />
      <link:presentationArc order="520" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiOtherReportingStandardItemNumber" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityShellCompany" xlink:label="loc_deiEntityShellCompany" />
      <link:presentationArc order="530" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityShellCompany" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityPublicFloat" xlink:label="loc_deiEntityPublicFloat" />
      <link:presentationArc order="540" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityPublicFloat" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityBankruptcyProceedingsReportingCurrent" xlink:label="loc_deiEntityBankruptcyProceedingsReportingCurrent" />
      <link:presentationArc order="550" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityBankruptcyProceedingsReportingCurrent" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityCommonStockSharesOutstanding" xlink:label="loc_deiEntityCommonStockSharesOutstanding" />
      <link:presentationArc order="560" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityCommonStockSharesOutstanding" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentsIncorporatedByReferenceTextBlock" xlink:label="loc_deiDocumentsIncorporatedByReferenceTextBlock" />
      <link:presentationArc order="570" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentsIncorporatedByReferenceTextBlock" xlink:type="arc" />
    </link:presentationLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>7
<FILENAME>R1.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2.2</span><table class="report" border="0" cellspacing="2" id="idm140223345109120">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Cover<br></strong></div></th>
<th class="th"><div>Oct. 29, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_CoverAbstract', window );"><strong>Cover [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentType', window );">Document Type</a></td>
<td class="text">8-K<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_AmendmentFlag', window );">Amendment Flag</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentPeriodEndDate', window );">Document Period End Date</a></td>
<td class="text">Oct. 29,  2022<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityFileNumber', window );">Entity File Number</a></td>
<td class="text">001-39227<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityRegistrantName', window );">Entity Registrant Name</a></td>
<td class="text">Duos Technologies Group, Inc.<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityCentralIndexKey', window );">Entity Central Index Key</a></td>
<td class="text">0001396536<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityTaxIdentificationNumber', window );">Entity Tax Identification Number</a></td>
<td class="text">65-0493217<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityIncorporationStateCountryCode', window );">Entity Incorporation, State or Country Code</a></td>
<td class="text">FL<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressAddressLine1', window );">Entity Address, Address Line One</a></td>
<td class="text">7660 Centurion Parkway<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressAddressLine2', window );">Entity Address, Address Line Two</a></td>
<td class="text">Suite 100<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressCityOrTown', window );">Entity Address, City or Town</a></td>
<td class="text">Jacksonville<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressStateOrProvince', window );">Entity Address, State or Province</a></td>
<td class="text">FL<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressPostalZipCode', window );">Entity Address, Postal Zip Code</a></td>
<td class="text">32256<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_CityAreaCode', window );">City Area Code</a></td>
<td class="text">(904)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_LocalPhoneNumber', window );">Local Phone Number</a></td>
<td class="text">296-2807<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_WrittenCommunications', window );">Written Communications</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_SolicitingMaterial', window );">Soliciting Material</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_PreCommencementTenderOffer', window );">Pre-commencement Tender Offer</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_PreCommencementIssuerTenderOffer', window );">Pre-commencement Issuer Tender Offer</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_Security12bTitle', window );">Title of 12(b) Security</a></td>
<td class="text">Common Stock (par value $0.001 per share)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_TradingSymbol', window );">Trading Symbol</a></td>
<td class="text">DUOT<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_SecurityExchangeName', window );">Security Exchange Name</a></td>
<td class="text">NASDAQ<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityEmergingGrowthCompany', window );">Entity Emerging Growth Company</a></td>
<td class="text">false<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_AmendmentFlag">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_AmendmentFlag</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CityAreaCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Area code of city</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CityAreaCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CoverAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Cover page.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CoverAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentPeriodEndDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period.  The format of the date is YYYY-MM-DD.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentPeriodEndDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:dateItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentType">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentType</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:submissionTypeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressAddressLine1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Address Line 1 such as Attn, Building Name, Street Name</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressAddressLine1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressAddressLine2">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Address Line 2 such as Street or Suite number</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressAddressLine2</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressCityOrTown">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Name of the City or Town</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressCityOrTown</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressPostalZipCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Code for the postal or zip code</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressPostalZipCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressStateOrProvince">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Name of the state or province.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressStateOrProvince</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:stateOrProvinceItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCentralIndexKey">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityCentralIndexKey</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:centralIndexKeyItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityEmergingGrowthCompany">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicate if registrant meets the emerging growth company criteria.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityEmergingGrowthCompany</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityFileNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityFileNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:fileNumberItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityIncorporationStateCountryCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Two-character EDGAR code representing the state or country of incorporation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityIncorporationStateCountryCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarStateCountryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityRegistrantName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityRegistrantName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityTaxIdentificationNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityTaxIdentificationNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:employerIdItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_LocalPhoneNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Local phone number for entity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_LocalPhoneNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_PreCommencementIssuerTenderOffer">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 13e<br> -Subsection 4c<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_PreCommencementIssuerTenderOffer</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_PreCommencementTenderOffer">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 14d<br> -Subsection 2b<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_PreCommencementTenderOffer</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_Security12bTitle">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Title of a 12(b) registered security.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_Security12bTitle</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:securityTitleItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_SecurityExchangeName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Name of the Exchange on which a security is registered.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection d1-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_SecurityExchangeName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarExchangeCodeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_SolicitingMaterial">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Section 14a<br> -Number 240<br> -Subsection 12<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_SolicitingMaterial</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_TradingSymbol">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Trading symbol of an instrument as listed on an exchange.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_TradingSymbol</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:tradingSymbolItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_WrittenCommunications">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Securities Act<br> -Number 230<br> -Section 425<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_WrittenCommunications</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>8
<FILENAME>duot_8k_htm.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version="1.0" encoding="utf-8"?>
<xbrl
  xmlns="http://www.xbrl.org/2003/instance"
  xmlns:dei="http://xbrl.sec.gov/dei/2022"
  xmlns:iso4217="http://www.xbrl.org/2003/iso4217"
  xmlns:link="http://www.xbrl.org/2003/linkbase"
  xmlns:xlink="http://www.w3.org/1999/xlink">
    <link:schemaRef xlink:href="duot-20221029.xsd" xlink:type="simple"/>
    <context id="From2022-10-29to2022-10-29">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001396536</identifier>
        </entity>
        <period>
            <startDate>2022-10-29</startDate>
            <endDate>2022-10-29</endDate>
        </period>
    </context>
    <unit id="USD">
        <measure>iso4217:USD</measure>
    </unit>
    <unit id="Shares">
        <measure>shares</measure>
    </unit>
    <unit id="USDPShares">
        <divide>
            <unitNumerator>
                <measure>iso4217:USD</measure>
            </unitNumerator>
            <unitDenominator>
                <measure>shares</measure>
            </unitDenominator>
        </divide>
    </unit>
    <dei:EntityCentralIndexKey contextRef="From2022-10-29to2022-10-29">0001396536</dei:EntityCentralIndexKey>
    <dei:AmendmentFlag contextRef="From2022-10-29to2022-10-29">false</dei:AmendmentFlag>
    <dei:DocumentType contextRef="From2022-10-29to2022-10-29">8-K</dei:DocumentType>
    <dei:DocumentPeriodEndDate contextRef="From2022-10-29to2022-10-29">2022-10-29</dei:DocumentPeriodEndDate>
    <dei:EntityRegistrantName contextRef="From2022-10-29to2022-10-29">Duos Technologies Group, Inc.</dei:EntityRegistrantName>
    <dei:EntityIncorporationStateCountryCode contextRef="From2022-10-29to2022-10-29">FL</dei:EntityIncorporationStateCountryCode>
    <dei:EntityFileNumber contextRef="From2022-10-29to2022-10-29">001-39227</dei:EntityFileNumber>
    <dei:EntityTaxIdentificationNumber contextRef="From2022-10-29to2022-10-29">65-0493217</dei:EntityTaxIdentificationNumber>
    <dei:EntityAddressAddressLine1 contextRef="From2022-10-29to2022-10-29">7660 Centurion Parkway</dei:EntityAddressAddressLine1>
    <dei:EntityAddressAddressLine2 contextRef="From2022-10-29to2022-10-29">Suite 100</dei:EntityAddressAddressLine2>
    <dei:EntityAddressCityOrTown contextRef="From2022-10-29to2022-10-29">Jacksonville</dei:EntityAddressCityOrTown>
    <dei:EntityAddressStateOrProvince contextRef="From2022-10-29to2022-10-29">FL</dei:EntityAddressStateOrProvince>
    <dei:EntityAddressPostalZipCode contextRef="From2022-10-29to2022-10-29">32256</dei:EntityAddressPostalZipCode>
    <dei:CityAreaCode contextRef="From2022-10-29to2022-10-29">(904)</dei:CityAreaCode>
    <dei:LocalPhoneNumber contextRef="From2022-10-29to2022-10-29">296-2807</dei:LocalPhoneNumber>
    <dei:WrittenCommunications contextRef="From2022-10-29to2022-10-29">false</dei:WrittenCommunications>
    <dei:SolicitingMaterial contextRef="From2022-10-29to2022-10-29">false</dei:SolicitingMaterial>
    <dei:PreCommencementTenderOffer contextRef="From2022-10-29to2022-10-29">false</dei:PreCommencementTenderOffer>
    <dei:PreCommencementIssuerTenderOffer contextRef="From2022-10-29to2022-10-29">false</dei:PreCommencementIssuerTenderOffer>
    <dei:Security12bTitle contextRef="From2022-10-29to2022-10-29">Common Stock (par value $0.001 per share)</dei:Security12bTitle>
    <dei:TradingSymbol contextRef="From2022-10-29to2022-10-29">DUOT</dei:TradingSymbol>
    <dei:SecurityExchangeName contextRef="From2022-10-29to2022-10-29">NASDAQ</dei:SecurityExchangeName>
    <dei:EntityEmergingGrowthCompany contextRef="From2022-10-29to2022-10-29">false</dei:EntityEmergingGrowthCompany>
</xbrl>
</XML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EXCEL
<SEQUENCE>9
<FILENAME>Financial_Report.xlsx
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 Financial_Report.xlsx
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M?!^2!F.,6_0T7X\48JVFL:W&VC$,>8!8\PRA9CC?AT6:&C/5BZPYC0IO0=5
MY3_;U UH]@TT')$%7C&9MC:CY$X*/-S^[PVPPL2.X>V+OP%02P,$%     @
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M YR0KBHSJ^%7 7%V-%%KK@<M"U+N0"O<AWW>A=$C8<^AO22T?TZH3^E_PUM
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M='@//GL?)=-[*CG_5U/\!%!+ P04    " #&HV)5EXJ[',     3 @  "P
M %]R96QS+RYR96QSG9*Y;L,P#$!_Q=">, ?0(8@S9?$6!/D!5J(/V!(%BD6=
MOZ_:I7&0"QEY/3P2W!YI0.TXI+:+J1C]$%)I6M6X 4BV)8]ISI%"KM0L'C6'
MTD!$VV-#L%HL/D N&6:WO606IW.D5XA<UYVE/=LO3T%O@*\Z3'%":4A+,P[P
MS=)_,O?S##5%Y4HCE5L:>-/E_G;@2=&A(E@6FD7)TZ(=I7\=Q_:0T^FO8R*T
M>EOH^7%H5 J.W&,EC'%BM/XU@LD/['X 4$L#!!0    ( ,:C8E6JQ"(6,P$
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M'EKG5LJ]AU>RY1AQ_)[E#U!+ P04    " #&HV)5)!Z;HJT   #X 0  &@
M 'AL+U]R96QS+W=O<FMB;V]K+GAM;"YR96QSM9$]#H,P#(6O$N4 -5"I0P5,
M75@K+A %\R,2$L6N"K<OA0&0.G1ALIXM?^_)3I]H%'=NH+;S)$9K!LIDR^SO
M *1;M(HNSN,P3VH7K.)9A@:\TKUJ$)(HND'8,V2>[IFBG#S^0W1UW6E\./VR
M./ /,+Q=Z*E%9"E*%1KD3,)HMC;!4N++3):BJ#(9BBJ6<%H@XLD@;6E6?;!/
M3K3G>1<W]T6NS>,)KM\,<'AT_@%02P,$%     @ QJ-B5660>9(9 0  SP,
M !,   !;0V]N=&5N=%]4>7!E<UTN>&ULK9--3L,P$(6O$F5;)2XL6*"F&V +
M77 !8T\:J_Z39UK2VS-.VDJ@$A6%3:QXWKS/GI>LWH\1L.B=]=B4'5%\% )5
M!TYB'2)XKK0A.4G\FK8B2K636Q#WR^6#4,$3>*HH>Y3KU3.T<F^I>.EY&TWP
M39G 8ED\C<+,:DH9HS5*$M?%P>L?E.I$J+EST&!G(BY84(JKA%SY'7#J>SM
M2D9#L9&)7J5CE>BM0#I:P'K:XLH90]L:!3JHO>.6&F,"J;$#(&?KT70Q32:>
M,(S/N]G\P68*R,I-"A$YL01_QYTCR=U59"-(9*:O>"&R]>S[04Y;@[Z1S>/]
M#&DWY(%B6.;/^'O&%_\;SO$1PNZ_/[&\UDX:?^:+X3]>?P%02P$"% ,4
M" #&HV)5!T%-8H$   "Q    $               @ $     9&]C4')O<',O
M87!P+GAM;%!+ 0(4 Q0    ( ,:C8E7Q@% I[0   "L"   1
M  "  :\   !D;V-0<F]P<R]C;W)E+GAM;%!+ 0(4 Q0    ( ,:C8E697)PC
M$ 8  )PG   3              "  <L!  !X;"]T:&5M92]T:&5M93$N>&UL
M4$L! A0#%     @ QJ-B5<" P%%J!   ,!$  !@              ("!# @
M 'AL+W=O<FMS:&5E=',O<VAE970Q+GAM;%!+ 0(4 Q0    ( ,:C8E6?H!OP
ML0(  .(,   -              "  :P,  !X;"]S='EL97,N>&UL4$L! A0#
M%     @ QJ-B59>*NQS     $P(   L              ( !B \  %]R96QS
M+RYR96QS4$L! A0#%     @ QJ-B5:K$(A8S 0  (@(   \
M ( !<1   'AL+W=O<FMB;V]K+GAM;%!+ 0(4 Q0    ( ,:C8E4D'INBK0
M /@!   :              "  =$1  !X;"]?<F5L<R]W;W)K8F]O:RYX;6PN
M<F5L<U!+ 0(4 Q0    ( ,:C8E5ED'F2&0$  ,\#   3              "
M ;82  !;0V]N=&5N=%]4>7!E<UTN>&UL4$L%!@     )  D /@(    4
!  $!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>10
<FILENAME>Show.js
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
// Edgar(tm) Renderer was created by staff of the U.S. Securities and Exchange Commission.  Data and content created by government employees within the scope of their employment are not subject to domestic copyright protection. 17 U.S.C. 105.
var Show={};Show.LastAR=null,Show.showAR=function(a,r,w){if(Show.LastAR)Show.hideAR();var e=a;while(e&&e.nodeName!='TABLE')e=e.nextSibling;if(!e||e.nodeName!='TABLE'){var ref=((window)?w.document:document).getElementById(r);if(ref){e=ref.cloneNode(!0);
e.removeAttribute('id');a.parentNode.appendChild(e)}}
if(e)e.style.display='block';Show.LastAR=e};Show.hideAR=function(){Show.LastAR.style.display='none'};Show.toggleNext=function(a){var e=a;while(e.nodeName!='DIV')e=e.nextSibling;if(!e.style){}else if(!e.style.display){}else{var d,p_;if(e.style.display=='none'){d='block';p='-'}else{d='none';p='+'}
e.style.display=d;if(a.textContent){a.textContent=p+a.textContent.substring(1)}else{a.innerText=p+a.innerText.substring(1)}}}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>11
<FILENAME>report.css
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
/* Updated 2009-11-04 */
/* v2.2.0.24 */

/* DefRef Styles */
..report table.authRefData{
	background-color: #def;
	border: 2px solid #2F4497;
	font-size: 1em;
	position: absolute;
}

..report table.authRefData a {
	display: block;
	font-weight: bold;
}

..report table.authRefData p {
	margin-top: 0px;
}

..report table.authRefData .hide {
	background-color: #2F4497;
	padding: 1px 3px 0px 0px;
	text-align: right;
}

..report table.authRefData .hide a:hover {
	background-color: #2F4497;
}

..report table.authRefData .body {
	height: 150px;
	overflow: auto;
	width: 400px;
}

..report table.authRefData table{
	font-size: 1em;
}

/* Report Styles */
..pl a, .pl a:visited {
	color: black;
	text-decoration: none;
}

/* table */
..report {
	background-color: white;
	border: 2px solid #acf;
	clear: both;
	color: black;
	font: normal 8pt Helvetica, Arial, san-serif;
	margin-bottom: 2em;
}

..report hr {
	border: 1px solid #acf;
}

/* Top labels */
..report th {
	background-color: #acf;
	color: black;
	font-weight: bold;
	text-align: center;
}

..report th.void	{
	background-color: transparent;
	color: #000000;
	font: bold 10pt Helvetica, Arial, san-serif;
	text-align: left;
}

..report .pl {
	text-align: left;
	vertical-align: top;
	white-space: normal;
	width: 200px;
	white-space: normal; /* word-wrap: break-word; */
}

..report td.pl a.a {
	cursor: pointer;
	display: block;
	width: 200px;
	overflow: hidden;
}

..report td.pl div.a {
	width: 200px;
}

..report td.pl a:hover {
	background-color: #ffc;
}

/* Header rows... */
..report tr.rh {
	background-color: #acf;
	color: black;
	font-weight: bold;
}

/* Calendars... */
..report .rc {
	background-color: #f0f0f0;
}

/* Even rows... */
..report .re, .report .reu {
	background-color: #def;
}

..report .reu td {
	border-bottom: 1px solid black;
}

/* Odd rows... */
..report .ro, .report .rou {
	background-color: white;
}

..report .rou td {
	border-bottom: 1px solid black;
}

..report .rou table td, .report .reu table td {
	border-bottom: 0px solid black;
}

/* styles for footnote marker */
..report .fn {
	white-space: nowrap;
}

/* styles for numeric types */
..report .num, .report .nump {
	text-align: right;
	white-space: nowrap;
}

..report .nump {
	padding-left: 2em;
}

..report .nump {
	padding: 0px 0.4em 0px 2em;
}

/* styles for text types */
..report .text {
	text-align: left;
	white-space: normal;
}

..report .text .big {
	margin-bottom: 1em;
	width: 17em;
}

..report .text .more {
	display: none;
}

..report .text .note {
	font-style: italic;
	font-weight: bold;
}

..report .text .small {
	width: 10em;
}

..report sup {
	font-style: italic;
}

..report .outerFootnotes {
	font-size: 1em;
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>12
<FILENAME>FilingSummary.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version='1.0' encoding='utf-8'?>
<FilingSummary>
  <Version>3.22.2.2</Version>
  <ProcessingTime/>
  <ReportFormat>html</ReportFormat>
  <ContextCount>1</ContextCount>
  <ElementCount>23</ElementCount>
  <EntityCount>1</EntityCount>
  <FootnotesReported>false</FootnotesReported>
  <SegmentCount>0</SegmentCount>
  <ScenarioCount>0</ScenarioCount>
  <TuplesReported>false</TuplesReported>
  <UnitCount>3</UnitCount>
  <MyReports>
    <Report instance="duot_8k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R1.htm</HtmlFileName>
      <LongName>00000001 - Document - Cover</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://duostech.com/role/Cover</Role>
      <ShortName>Cover</ShortName>
      <MenuCategory>Cover</MenuCategory>
      <Position>1</Position>
    </Report>
    <Report>
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <LongName>All Reports</LongName>
      <ReportType>Book</ReportType>
      <ShortName>All Reports</ShortName>
    </Report>
  </MyReports>
  <InputFiles>
    <File doctype="8-K" original="duot_8k.htm">duot_8k.htm</File>
    <File>duot-20221029.xsd</File>
    <File>duot-20221029_lab.xml</File>
    <File>duot-20221029_pre.xml</File>
    <File>duot_ex10z1.htm</File>
    <File>duot_ex10z2.htm</File>
  </InputFiles>
  <SupplementalFiles/>
  <BaseTaxonomies>
    <BaseTaxonomy items="23">http://xbrl.sec.gov/dei/2022</BaseTaxonomy>
  </BaseTaxonomies>
  <HasPresentationLinkbase>true</HasPresentationLinkbase>
  <HasCalculationLinkbase>false</HasCalculationLinkbase>
</FilingSummary>
</XML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>JSON
<SEQUENCE>14
<FILENAME>MetaLinks.json
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
{
 "instance": {
  "duot_8k.htm": {
   "axisCustom": 0,
   "axisStandard": 0,
   "contextCount": 1,
   "dts": {
    "inline": {
     "local": [
      "duot_8k.htm"
     ]
    },
    "labelLink": {
     "local": [
      "duot-20221029_lab.xml"
     ]
    },
    "presentationLink": {
     "local": [
      "duot-20221029_pre.xml"
     ]
    },
    "schema": {
     "local": [
      "duot-20221029.xsd"
     ],
     "remote": [
      "http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xl-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xlink-2003-12-31.xsd",
      "http://www.xbrl.org/2005/xbrldt-2005.xsd",
      "http://www.xbrl.org/2006/ref-2006-02-27.xsd",
      "http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd",
      "http://www.xbrl.org/lrr/role/net-2009-12-16.xsd",
      "https://www.xbrl.org/2020/extensible-enumerations-2.0.xsd",
      "https://www.xbrl.org/dtr/type/2020-01-21/types.xsd",
      "https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd",
      "https://xbrl.fasb.org/srt/2022/elts/srt-roles-2022.xsd",
      "https://xbrl.fasb.org/srt/2022/elts/srt-types-2022.xsd",
      "https://xbrl.fasb.org/srt/2022q3/srt-sup-2022q3.xsd",
      "https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd",
      "https://xbrl.fasb.org/us-gaap/2022/elts/us-roles-2022.xsd",
      "https://xbrl.fasb.org/us-gaap/2022/elts/us-types-2022.xsd",
      "https://xbrl.fasb.org/us-gaap/2022q3/us-gaap-sup-2022q3.xsd",
      "https://xbrl.sec.gov/country/2022/country-2022.xsd",
      "https://xbrl.sec.gov/dei/2022/dei-2022.xsd"
     ]
    }
   },
   "elementCount": 59,
   "entityCount": 1,
   "hidden": {
    "http://xbrl.sec.gov/dei/2022": 2,
    "total": 2
   },
   "keyCustom": 0,
   "keyStandard": 23,
   "memberCustom": 0,
   "memberStandard": 0,
   "nsprefix": "DUOT",
   "nsuri": "http://duostech.com/20221029",
   "report": {
    "R1": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "b",
       "p",
       "body",
       "html"
      ],
      "baseRef": "duot_8k.htm",
      "contextRef": "From2022-10-29to2022-10-29",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "dei:DocumentType",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "document",
     "isDefault": "true",
     "longName": "00000001 - Document - Cover",
     "role": "http://duostech.com/role/Cover",
     "shortName": "Cover",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "b",
       "p",
       "body",
       "html"
      ],
      "baseRef": "duot_8k.htm",
      "contextRef": "From2022-10-29to2022-10-29",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "dei:DocumentType",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    }
   },
   "segmentCount": 0,
   "tag": {
    "dei_AmendmentDescription": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Description of changes contained within amended document.",
        "label": "Amendment Description"
       }
      }
     },
     "localname": "AmendmentDescription",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://duostech.com/role/Cover"
     ],
     "xbrltype": "stringItemType"
    },
    "dei_AmendmentFlag": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.",
        "label": "Amendment Flag"
       }
      }
     },
     "localname": "AmendmentFlag",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://duostech.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_AnnualInformationForm": {
     "auth_ref": [
      "r14"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag with value true on a form if it is an annual report containing an annual information form.",
        "label": "Annual Information Form"
       }
      }
     },
     "localname": "AnnualInformationForm",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://duostech.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_AuditedAnnualFinancialStatements": {
     "auth_ref": [
      "r14"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag with value true on a form if it is an annual report containing audited financial statements.",
        "label": "Audited Annual Financial Statements"
       }
      }
     },
     "localname": "AuditedAnnualFinancialStatements",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://duostech.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_CityAreaCode": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Area code of city",
        "label": "City Area Code"
       }
      }
     },
     "localname": "CityAreaCode",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://duostech.com/role/Cover"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_CountryRegion": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Region code of country",
        "label": "Country Region"
       }
      }
     },
     "localname": "CountryRegion",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://duostech.com/role/Cover"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_CoverAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Cover page.",
        "label": "Cover [Abstract]"
       }
      }
     },
     "localname": "CoverAbstract",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "xbrltype": "stringItemType"
    },
    "dei_CurrentFiscalYearEndDate": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "End date of current fiscal year in the format --MM-DD.",
        "label": "Current Fiscal Year End Date"
       }
      }
     },
     "localname": "CurrentFiscalYearEndDate",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://duostech.com/role/Cover"
     ],
     "xbrltype": "gMonthDayItemType"
    },
    "dei_DocumentAccountingStandard": {
     "auth_ref": [
      "r13"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The basis of accounting the registrant has used to prepare the financial statements included in this filing This can either be 'U.S. GAAP', 'International Financial Reporting Standards', or 'Other'.",
        "label": "Document Accounting Standard"
       }
      }
     },
     "localname": "DocumentAccountingStandard",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://duostech.com/role/Cover"
     ],
     "xbrltype": "accountingStandardItemType"
    },
    "dei_DocumentAnnualReport": {
     "auth_ref": [
      "r11",
      "r13",
      "r14"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true only for a form used as an annual report.",
        "label": "Document Annual Report"
       }
      }
     },
     "localname": "DocumentAnnualReport",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://duostech.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_DocumentFiscalPeriodFocus": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Fiscal period values are FY, Q1, Q2, and Q3.  1st, 2nd and 3rd quarter 10-Q or 10-QT statements have value Q1, Q2, and Q3 respectively, with 10-K, 10-KT or other fiscal year statements having FY.",
        "label": "Document Fiscal Period Focus"
       }
      }
     },
     "localname": "DocumentFiscalPeriodFocus",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://duostech.com/role/Cover"
     ],
     "xbrltype": "fiscalPeriodItemType"
    },
    "dei_DocumentFiscalYearFocus": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "This is focus fiscal year of the document report in YYYY format. For a 2006 annual report, which may also provide financial information from prior periods, fiscal 2006 should be given as the fiscal year focus. Example: 2006.",
        "label": "Document Fiscal Year Focus"
       }
      }
     },
     "localname": "DocumentFiscalYearFocus",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://duostech.com/role/Cover"
     ],
     "xbrltype": "gYearItemType"
    },
    "dei_DocumentPeriodEndDate": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period.  The format of the date is YYYY-MM-DD.",
        "label": "Document Period End Date"
       }
      }
     },
     "localname": "DocumentPeriodEndDate",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://duostech.com/role/Cover"
     ],
     "xbrltype": "dateItemType"
    },
    "dei_DocumentPeriodStartDate": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The start date of the period covered in the document, in YYYY-MM-DD format.",
        "label": "Document Period Start Date"
       }
      }
     },
     "localname": "DocumentPeriodStartDate",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://duostech.com/role/Cover"
     ],
     "xbrltype": "dateItemType"
    },
    "dei_DocumentQuarterlyReport": {
     "auth_ref": [
      "r12"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true only for a form used as an quarterly report.",
        "label": "Document Quarterly Report"
       }
      }
     },
     "localname": "DocumentQuarterlyReport",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://duostech.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_DocumentRegistrationStatement": {
     "auth_ref": [
      "r0"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true only for a form used as a registration statement.",
        "label": "Document Registration Statement"
       }
      }
     },
     "localname": "DocumentRegistrationStatement",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://duostech.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_DocumentShellCompanyEventDate": {
     "auth_ref": [
      "r13"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Date of event requiring a shell company report.",
        "label": "Document Shell Company Event Date"
       }
      }
     },
     "localname": "DocumentShellCompanyEventDate",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://duostech.com/role/Cover"
     ],
     "xbrltype": "dateItemType"
    },
    "dei_DocumentShellCompanyReport": {
     "auth_ref": [
      "r13"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true for a Shell Company Report pursuant to section 13 or 15(d) of the Exchange Act.",
        "label": "Document Shell Company Report"
       }
      }
     },
     "localname": "DocumentShellCompanyReport",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://duostech.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_DocumentTransitionReport": {
     "auth_ref": [
      "r15"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true only for a form used as a transition report.",
        "label": "Document Transition Report"
       }
      }
     },
     "localname": "DocumentTransitionReport",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://duostech.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_DocumentType": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.",
        "label": "Document Type"
       }
      }
     },
     "localname": "DocumentType",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://duostech.com/role/Cover"
     ],
     "xbrltype": "submissionTypeItemType"
    },
    "dei_DocumentsIncorporatedByReferenceTextBlock": {
     "auth_ref": [
      "r3"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Documents incorporated by reference.",
        "label": "Documents Incorporated by Reference [Text Block]"
       }
      }
     },
     "localname": "DocumentsIncorporatedByReferenceTextBlock",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://duostech.com/role/Cover"
     ],
     "xbrltype": "textBlockItemType"
    },
    "dei_EntityAddressAddressLine1": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Address Line 1 such as Attn, Building Name, Street Name",
        "label": "Entity Address, Address Line One"
       }
      }
     },
     "localname": "EntityAddressAddressLine1",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://duostech.com/role/Cover"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressAddressLine2": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Address Line 2 such as Street or Suite number",
        "label": "Entity Address, Address Line Two"
       }
      }
     },
     "localname": "EntityAddressAddressLine2",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://duostech.com/role/Cover"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressAddressLine3": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Address Line 3 such as an Office Park",
        "label": "Entity Address, Address Line Three"
       }
      }
     },
     "localname": "EntityAddressAddressLine3",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://duostech.com/role/Cover"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressCityOrTown": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Name of the City or Town",
        "label": "Entity Address, City or Town"
       }
      }
     },
     "localname": "EntityAddressCityOrTown",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://duostech.com/role/Cover"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressCountry": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "ISO 3166-1 alpha-2 country code.",
        "label": "Entity Address, Country"
       }
      }
     },
     "localname": "EntityAddressCountry",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://duostech.com/role/Cover"
     ],
     "xbrltype": "countryCodeItemType"
    },
    "dei_EntityAddressPostalZipCode": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Code for the postal or zip code",
        "label": "Entity Address, Postal Zip Code"
       }
      }
     },
     "localname": "EntityAddressPostalZipCode",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://duostech.com/role/Cover"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressStateOrProvince": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Name of the state or province.",
        "label": "Entity Address, State or Province"
       }
      }
     },
     "localname": "EntityAddressStateOrProvince",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://duostech.com/role/Cover"
     ],
     "xbrltype": "stateOrProvinceItemType"
    },
    "dei_EntityBankruptcyProceedingsReportingCurrent": {
     "auth_ref": [
      "r6"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "For registrants involved in bankruptcy proceedings during the preceding five years, the value Yes indicates that the registrant has filed all documents and reports required to be filed by Section 12, 13 or 15(d) of the Securities Exchange Act of 1934 subsequent to the distribution of securities under a plan confirmed by a court; the value No indicates the registrant has not.  Registrants not involved in bankruptcy proceedings during the preceding five years should not report this element.",
        "label": "Entity Bankruptcy Proceedings, Reporting Current"
       }
      }
     },
     "localname": "EntityBankruptcyProceedingsReportingCurrent",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://duostech.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_EntityCentralIndexKey": {
     "auth_ref": [
      "r2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.",
        "label": "Entity Central Index Key"
       }
      }
     },
     "localname": "EntityCentralIndexKey",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://duostech.com/role/Cover"
     ],
     "xbrltype": "centralIndexKeyItemType"
    },
    "dei_EntityCommonStockSharesOutstanding": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report. Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument.",
        "label": "Entity Common Stock, Shares Outstanding"
       }
      }
     },
     "localname": "EntityCommonStockSharesOutstanding",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://duostech.com/role/Cover"
     ],
     "xbrltype": "sharesItemType"
    },
    "dei_EntityCurrentReportingStatus": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate 'Yes' or 'No' whether registrants (1) have filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that registrants were required to file such reports), and (2) have been subject to such filing requirements for the past 90 days. This information should be based on the registrant's current or most recent filing containing the related disclosure.",
        "label": "Entity Current Reporting Status"
       }
      }
     },
     "localname": "EntityCurrentReportingStatus",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://duostech.com/role/Cover"
     ],
     "xbrltype": "yesNoItemType"
    },
    "dei_EntityEmergingGrowthCompany": {
     "auth_ref": [
      "r2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate if registrant meets the emerging growth company criteria.",
        "label": "Entity Emerging Growth Company"
       }
      }
     },
     "localname": "EntityEmergingGrowthCompany",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://duostech.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_EntityExTransitionPeriod": {
     "auth_ref": [
      "r19"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate if an emerging growth company has elected not to use the extended transition period for complying with any new or revised financial accounting standards.",
        "label": "Elected Not To Use the Extended Transition Period"
       }
      }
     },
     "localname": "EntityExTransitionPeriod",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://duostech.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_EntityFileNumber": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.",
        "label": "Entity File Number"
       }
      }
     },
     "localname": "EntityFileNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://duostech.com/role/Cover"
     ],
     "xbrltype": "fileNumberItemType"
    },
    "dei_EntityFilerCategory": {
     "auth_ref": [
      "r2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate whether the registrant is one of the following: Large Accelerated Filer, Accelerated Filer, Non-accelerated Filer. Definitions of these categories are stated in Rule 12b-2 of the Exchange Act. This information should be based on the registrant's current or most recent filing containing the related disclosure.",
        "label": "Entity Filer Category"
       }
      }
     },
     "localname": "EntityFilerCategory",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://duostech.com/role/Cover"
     ],
     "xbrltype": "filerCategoryItemType"
    },
    "dei_EntityIncorporationStateCountryCode": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Two-character EDGAR code representing the state or country of incorporation.",
        "label": "Entity Incorporation, State or Country Code"
       }
      }
     },
     "localname": "EntityIncorporationStateCountryCode",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://duostech.com/role/Cover"
     ],
     "xbrltype": "edgarStateCountryItemType"
    },
    "dei_EntityInteractiveDataCurrent": {
     "auth_ref": [
      "r16"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T during the preceding 12 months (or for such shorter period that the registrant was required to submit such files).",
        "label": "Entity Interactive Data Current"
       }
      }
     },
     "localname": "EntityInteractiveDataCurrent",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://duostech.com/role/Cover"
     ],
     "xbrltype": "yesNoItemType"
    },
    "dei_EntityPrimarySicNumber": {
     "auth_ref": [
      "r14"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Primary Standard Industrial Classification (SIC) Number for the Entity.",
        "label": "Entity Primary SIC Number"
       }
      }
     },
     "localname": "EntityPrimarySicNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://duostech.com/role/Cover"
     ],
     "xbrltype": "sicNumberItemType"
    },
    "dei_EntityPublicFloat": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The aggregate market value of the voting and non-voting common equity held by non-affiliates computed by reference to the price at which the common equity was last sold, or the average bid and asked price of such common equity, as of the last business day of the registrant's most recently completed second fiscal quarter.",
        "label": "Entity Public Float"
       }
      }
     },
     "localname": "EntityPublicFloat",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://duostech.com/role/Cover"
     ],
     "xbrltype": "monetaryItemType"
    },
    "dei_EntityRegistrantName": {
     "auth_ref": [
      "r2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.",
        "label": "Entity Registrant Name"
       }
      }
     },
     "localname": "EntityRegistrantName",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://duostech.com/role/Cover"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityShellCompany": {
     "auth_ref": [
      "r2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the registrant is a shell company as defined in Rule 12b-2 of the Exchange Act.",
        "label": "Entity Shell Company"
       }
      }
     },
     "localname": "EntityShellCompany",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://duostech.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_EntitySmallBusiness": {
     "auth_ref": [
      "r2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicates that the company is a Smaller Reporting Company (SRC).",
        "label": "Entity Small Business"
       }
      }
     },
     "localname": "EntitySmallBusiness",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://duostech.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_EntityTaxIdentificationNumber": {
     "auth_ref": [
      "r2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.",
        "label": "Entity Tax Identification Number"
       }
      }
     },
     "localname": "EntityTaxIdentificationNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://duostech.com/role/Cover"
     ],
     "xbrltype": "employerIdItemType"
    },
    "dei_EntityVoluntaryFilers": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate 'Yes' or 'No' if the registrant is not required to file reports pursuant to Section 13 or Section 15(d) of the Act.",
        "label": "Entity Voluntary Filers"
       }
      }
     },
     "localname": "EntityVoluntaryFilers",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://duostech.com/role/Cover"
     ],
     "xbrltype": "yesNoItemType"
    },
    "dei_EntityWellKnownSeasonedIssuer": {
     "auth_ref": [
      "r17"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate 'Yes' or 'No' if the registrant is a well-known seasoned issuer, as defined in Rule 405 of the Securities Act. Is used on Form Type: 10-K, 10-Q, 8-K, 20-F, 6-K, 10-K/A, 10-Q/A, 20-F/A, 6-K/A, N-CSR, N-Q, N-1A.",
        "label": "Entity Well-known Seasoned Issuer"
       }
      }
     },
     "localname": "EntityWellKnownSeasonedIssuer",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://duostech.com/role/Cover"
     ],
     "xbrltype": "yesNoItemType"
    },
    "dei_Extension": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Extension number for local phone number.",
        "label": "Extension"
       }
      }
     },
     "localname": "Extension",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://duostech.com/role/Cover"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_LocalPhoneNumber": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Local phone number for entity.",
        "label": "Local Phone Number"
       }
      }
     },
     "localname": "LocalPhoneNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://duostech.com/role/Cover"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_NoTradingSymbolFlag": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true only for a security having no trading symbol.",
        "label": "No Trading Symbol Flag"
       }
      }
     },
     "localname": "NoTradingSymbolFlag",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://duostech.com/role/Cover"
     ],
     "xbrltype": "trueItemType"
    },
    "dei_OtherReportingStandardItemNumber": {
     "auth_ref": [
      "r13"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "\"Item 17\" or \"Item 18\" specified when the basis of accounting is neither US GAAP nor IFRS.",
        "label": "Other Reporting Standard Item Number"
       }
      }
     },
     "localname": "OtherReportingStandardItemNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://duostech.com/role/Cover"
     ],
     "xbrltype": "otherReportingStandardItemNumberItemType"
    },
    "dei_PreCommencementIssuerTenderOffer": {
     "auth_ref": [
      "r7"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act.",
        "label": "Pre-commencement Issuer Tender Offer"
       }
      }
     },
     "localname": "PreCommencementIssuerTenderOffer",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://duostech.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_PreCommencementTenderOffer": {
     "auth_ref": [
      "r8"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act.",
        "label": "Pre-commencement Tender Offer"
       }
      }
     },
     "localname": "PreCommencementTenderOffer",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://duostech.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_Security12bTitle": {
     "auth_ref": [
      "r1"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Title of a 12(b) registered security.",
        "label": "Title of 12(b) Security"
       }
      }
     },
     "localname": "Security12bTitle",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://duostech.com/role/Cover"
     ],
     "xbrltype": "securityTitleItemType"
    },
    "dei_Security12gTitle": {
     "auth_ref": [
      "r5"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Title of a 12(g) registered security.",
        "label": "Title of 12(g) Security"
       }
      }
     },
     "localname": "Security12gTitle",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://duostech.com/role/Cover"
     ],
     "xbrltype": "securityTitleItemType"
    },
    "dei_SecurityExchangeName": {
     "auth_ref": [
      "r4"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Name of the Exchange on which a security is registered.",
        "label": "Security Exchange Name"
       }
      }
     },
     "localname": "SecurityExchangeName",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://duostech.com/role/Cover"
     ],
     "xbrltype": "edgarExchangeCodeItemType"
    },
    "dei_SecurityReportingObligation": {
     "auth_ref": [
      "r9"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "15(d), indicating whether the security has a reporting obligation under that section of the Exchange Act.",
        "label": "Security Reporting Obligation"
       }
      }
     },
     "localname": "SecurityReportingObligation",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://duostech.com/role/Cover"
     ],
     "xbrltype": "securityReportingObligationItemType"
    },
    "dei_SolicitingMaterial": {
     "auth_ref": [
      "r10"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act.",
        "label": "Soliciting Material"
       }
      }
     },
     "localname": "SolicitingMaterial",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://duostech.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_TradingSymbol": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Trading symbol of an instrument as listed on an exchange.",
        "label": "Trading Symbol"
       }
      }
     },
     "localname": "TradingSymbol",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://duostech.com/role/Cover"
     ],
     "xbrltype": "tradingSymbolItemType"
    },
    "dei_WrittenCommunications": {
     "auth_ref": [
      "r18"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act.",
        "label": "Written Communications"
       }
      }
     },
     "localname": "WrittenCommunications",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://duostech.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    }
   },
   "unitCount": 3
  }
 },
 "std_ref": {
  "r0": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12"
  },
  "r1": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "b"
  },
  "r10": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "14a",
   "Subsection": "12"
  },
  "r11": {
   "Name": "Form 10-K",
   "Number": "249",
   "Publisher": "SEC",
   "Section": "310"
  },
  "r12": {
   "Name": "Form 10-Q",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "308",
   "Subsection": "a"
  },
  "r13": {
   "Name": "Form 20-F",
   "Number": "249",
   "Publisher": "SEC",
   "Section": "220",
   "Subsection": "f"
  },
  "r14": {
   "Name": "Form 40-F",
   "Number": "249",
   "Publisher": "SEC",
   "Section": "240",
   "Subsection": "f"
  },
  "r15": {
   "Name": "Forms 10-K, 10-Q, 20-F",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "13",
   "Subsection": "a-1"
  },
  "r16": {
   "Name": "Regulation S-T",
   "Number": "232",
   "Publisher": "SEC",
   "Section": "405"
  },
  "r17": {
   "Name": "Securities Act",
   "Number": "230",
   "Publisher": "SEC",
   "Section": "405"
  },
  "r18": {
   "Name": "Securities Act",
   "Number": "230",
   "Publisher": "SEC",
   "Section": "425"
  },
  "r19": {
   "Name": "Securities Act",
   "Number": "7A",
   "Publisher": "SEC",
   "Section": "B",
   "Subsection": "2"
  },
  "r2": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "b-2"
  },
  "r3": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "b-23"
  },
  "r4": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "d1-1"
  },
  "r5": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "g"
  },
  "r6": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12, 13, 15d"
  },
  "r7": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "13e",
   "Subsection": "4c"
  },
  "r8": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "14d",
   "Subsection": "2b"
  },
  "r9": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "15",
   "Subsection": "d"
  }
 },
 "version": "2.1"
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>ZIP
<SEQUENCE>15
<FILENAME>0001553350-22-000849-xbrl.zip
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 0001553350-22-000849-xbrl.zip
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M@[9XIM0+$3,Q,G&<SFE,=K^0/=@N0^>6"<!F&PI-%! 5=F< %I48%6HDY%[
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MY^ @1$KI&(([3B2$1'1$\1*@3"S$;Q\>K+-]E]@5%/V&%1RP,@A(>NWIL(B
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M+KI'OF[M!O=^VN(;]\N]@]5N^1]02P,$%     @ QJ-B57G3$^Z3%0  ='$
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MH#@+?I/]CQ/7"1",B.-2#1L!T5#F!3V2$U</1OG <_G?UW;6PXBS@B]8#JQ
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MA4$!OTDI^9 F'*(1$+$>X@ 23XT079#V6Z&032H02P)!\:9 A)TQ?T;#,@"
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MH[3YPAJ(J^UU'T%A7%H:W(*8R4?IHL/#DM%X,(0B FDXZ FMD F/E@2\2X.
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MVH=W.I]S@'>;+5D6[0)NGUZW'T;)6; ?%&R 4<BD6&1GY64%HI\CWF2/T"4
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MBS_ SU1:'!Y,&RK;!%MM(?KA'>F&_W!24!8I<Q(I+SS9GUE6X_+1Q4-<1.1
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M,NR1S)BM7?U/%JT=JF#7",2;90=>#/UX<O+&RA]% )KB61Z"&Y#S=:/CEHL
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MXD,7FZ;-,L3?$BG9S52^%P87C^/Z&0W]LN9*P&?&KQ1XL'Q] A*4."?E2,G
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M"Z'9OT92?KY>@'FU$+VB"LN(-:YJF+)K50Y?[B=GI+;N-GJ#5"?C.1ZADR4
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MX[@417$9T'6LTKO5E9'9TAJL'CL*Q[SNZTY\Z/,UAG6)NJX&,WJ^EB0EP8/
M_%Y6<^*)1=T']X%PBDA!:/^:R_3A>E DM/1V0X$(UQLLPA39O6'%B?D< ZB:
M:7OH(P&N2975(RWY"TKRW9 3F\ 7GLJE56MV>U?()2<91@5,*SPI#ED%EI0\
M59H5C'18/$:%5B(D9+%A]C,[A2Z?9KLA?]"T[DG*%]P"(G"DFK9)Y!$!F0"[
MF?Y&!3GB(APPKQPDN#Y4-K=9?/DXPY6S%O5.A;>?/WUSLILS.I\S*$ORH"UP
M>YB7ZM/?,\0ID-JS31>%QKF6^WPT%I]@FT/)2+XMO3Z,2Y3]A&$W7.4>A=L+
MM)RP%W&7BU"KZV-DMJ-]Y?P*.'H4'*?@VZJJZ>I)06626?(:Z1)^P1$'PTE=
M(V,78X8]:1!,%OR6G&N4/)$]*Z=,4//P.,\>W'_P8#<[YO)2=0583U.[G#U=
M9B/17+XL;C9PWDRI5U739L';HBV]J\C3K@Q0&OK((SO$>*<3F51@571ECG&7
M_D:+9\8XPB+JYX+[*24B6:R;?K#8&WQL"T)Y2X[@#8LW<DV/=,/4*+1<R8,#
M:3S;94L*DZA3M&&-VTQ(-(RR]1EE^UU=B1!2(4!WTYEBA_;WAGJ;_@9'PQJ7
M;+$F.5%.ND3FZ#; 13H9B*2_W!V@D98+1SXP+5;%U%D,L N7^OE[6!T78]P.
MOY$2(>DBN"GD4P#4(*^[SPWT,,J6M(A@B$,@B1\,(7.2";N^YFND'QVPWX L
M&/9,[N_I+!Q^RC%F,L3,\<O,D#8+H\)EK?>Z'U03[/005&85_FO62P0-.)(V
M^QN[3/L%1 IOE"DQAWI^QN'&7IF-[<V)]-JZL3"'!NY7/PEQ2HQN1G0O<W%D
M)M[HF<HYAL1Y$Y<^E9X%EY[#3 9R'AIE&IB56 <7&_/4!BG8:!+)EY*U*-6B
M!;RK/_G!%W_RP)_\X(L_^<_O3T9E]FZ7J[LM%:]T(F8D7ZTG]::_XO!X+"LH
M):PKF<]8<)8BX3CSG.SW'F6J"^@>F&H1 ID#0?#PB+(^\; _.CI^)(TA&R=Y
M604QK:4QS.4V5 0=UY8A([4>&">\BN[=X'56V2ZIEJ-F:X:73,HUQ&\P02H"
MM;J>35T1ZI)QV)64WH#%:1A4\!6')+% Y  '9HR?QOF(X,O(C #RS^5I^_<<
MJXSY75@PQ]C*F.F*7KC(<T57NN,S0A>S.K97!9-K2AYBLZ("%HQK<P4P[*48
MW\YYB" U#,C#K S8_3@MV7DA9$YCXX?E,M_,,Y9$=+DSS 5WH@ 3-+SN![$2
MG@G/0A*VAJ3!-49%J 1 5L'LB4(N(X<&IIZ$(58^V11=;.Y1#'UFUL4QH843
MQ"#T-<JP>^H_J>KQQ0_F6SWHK *1P1RJ>UK.>1PWNC&FCY"(R[=IE^IG*4@M
M^08R;I\\JGQK^WN17L*&M7 JS/#<&++RFNA]" SKE+"F#;F*Z"&O7&>B7-L)
MVZA:>J?]DE:NXN2,H2*-: 82+5C7J UD"\XADWQC3Z[@)5*Q69X2O1;&W]NJ
M66/."TE^ ZT7FBVGP6FB$>YH#XG)752?%CGQD0/.?#L40[(M08]G.&P :E0K
M&Z'RC@_7UZK_=<W\O$RLVT5NC*Q@5=&?,R)%<WU/C;U%=BK.M17\7; $F,$?
MSS4[?O!0X_FLL+Y$JNDA6+'(4#=A2^[SM'Y_^<664,,._4PS88I8[^_]TWO^
M20*[[(N1;'WA80P)#I#%J"Y'TZ=R1L!BGL:H=&"IDF!88-QWTX8URGI.IT W
MA<>AP>15*U.2F$$I6E<C0*8/\HND2A&1K_0.T4L6GF![!_$D<8)CL DNAHK"
MXKFSLYAVC$.UY%]>HK.=^S;G&!5&G8@.6U[I,BUQK5>T?JB1FLT"\&U%'U#D
MH7B!-%AVR^<T41Y?5J.P<*EPHX#Q7.,'"-O*O7."34JN7=@-ZA8&'>'X:9).
M;,Q*]E?G9Y#I^.X=G:C7%)PE_SJ'*"CM X&'0K,[6O#@MOC3%O<205,]:[F2
MCPNMF<9/&)QH.(INB6$$5 R&DP<?>WMT?@3GH%:*U]FRJM4++@K?8":DOATJ
MEW*S<@^HK8N6:J!LD$<!+E.JRK.3=5PL:!VI4V>EJ3"SO_<3G&8F3';9R<.D
M<4<'):0;):H/K/+S2,,J:%?2IDV=3D=<S[58\#???NV)G(2*\ P^@\P<3QNN
M/7?\[3=_LRQ(0_H:5HFP\@OS3'+MGZ%=AI&+<E<E)Y9<P_D)LO#YV?>$3[<?
M)G%+!]B?.]4)\/E1!FFCK]D.^2HRCH'J<3#WV0&^XM&T3WYZ>A*4Q-2+T_.B
MZ1ERS ,_4G#4%,MXSI D6'@J[9>=$W$TV$OAMZ+'HNI@O^^\@;RYJ3NC2F_)
M&YNCFQ1.!#I1LH/'_W'H%%QI/X!ELVHJ]R[<+HS#O6YZ!]JN-/[;WT"+FWO8
M_OZ>^\"#Q!?Z!GVDHGE2#JB2/^)72JX8H5P$\7Z )1U?Q6@1;H$??(H=*WP%
MJ/?JY"^DZ-6"_6W,\L#FI');DU)"NH 20?Y>,[";JL%<-OAG J._+,C6\LF9
M["U#28Z2.60GW(HDY!>)N(-DOM+@^JRB@M-;V.0*29.DJJJ'BDG40#)G3=J?
MI9=%A/.]=V6YT@01SSB;2CUZ2K?XE/NOEW%0Q^?,O<\R;'_O^-NO[T<7B.\+
MX_D7;@HI_DS\!$)"OIU_OS?%P+?5.:25VM_S2S4H$2Z%#1OR&K*B_\;5!1;6
M4W'+L.:[YDKL(1CR$B<GM_ [3%Z8.9VH:"<5IG%BB*>JKYO%=4PN,%2>4H&H
M>.=QR7$BH&?!=G>TD2'.IFG#(O1EO:O\S*8QX7DL!>9XY/;W3J\],]\_$Y,2
M).@JIHTX1M%%Z'<*Y6#(J4$V1<1[/+[_MU'X650/RDE)(V)7\"G*RF_:+@_\
M0 B<0.]E&^O67#$!+RNG9;/A(S_&J\7)@8@:8/'+(M<E*;OA\7>X5 X=<F)Q
MP=8>W/^/^*:*+0%[-\HE*->8]?I-BP5F*7*9 ^X' T+]U;EJ;K K>A-AG8P&
M/2P'A=*##%FY:2$>W7\\NA"':KO9H@9.B1.?F8MC%R[YC6LHHX%]@+X4RWF*
M*4FT/- .L\*S>6MSDZ1F&&<SYK>]&4@5"I]&!H],O33SI)CAT)I6OS:+]GU4
MIUUWZ\'L\.#XD#P>379P36;[*$/G00&WDNMV?+(R.EBA,#31C6)P%/D%RZ-O
M>_6 ]"'\U\-ARB!6P&.%8F9K3TP+J2"I>'"7 H7O)><YTAS&>CE,6N0[DVI5
M*0OC>UN:&/K#SGS.?/2HKP$@Q0^[//3DB)YP)@&;I:K$JF_ZMCNAR9IIY)W:
MOVMP^.&7X/ @./SP2W#XSQ\<7G$%<Z8T38CAD#@VX0^,*4[9X7)3M,X7*W!;
MFTLZ*I*DAK6+S#:N!@$<;W1*'J2-5JR7MUS78BM81ZIS,J^\#!EQ85H'\BZ]
ME[_^*AJ<EIK>KLA9Z:S$L>A#B@0GUE=L*P93$M>*\V6:?&TE5L&V1NXLPJ"3
MSMUP+"!]MS@<+9FK]*;/0,N-W[CHND(T:YB^W!$*WN'[9A^A4FF__T>OW$-<
M.>0]HD#.(*5D?^^?/J=D@$20!+\@3)K3)H;[LUS,72X?QF_H%)G'!"QEH& F
MA:6+DNOW]VZMD1:YN/&I.=B%#5A'!^MZ(5P>Y)%P=<<H;[\W5%D"7RV8&5T=
MG!--R*&*6)Y@&5\__/MNJ*)8_!G*@^^R$[4]10">#T+HXC$J:I-%R<:@>F9F
M:X8V:(K#3)@'EFB]7T/'9@;=G$D!ZDN$M3CKP>NB2,+@<E."'$0QGD*V3_F2
MB:!C_@2S9.8^ZR+7*J?(3YEKV6G''+#12@ V[YR,$J%N<19ZB"(4OQ,5>5DN
M96-\)$FD3YFDPK2>7&:-?!<X)T:A].9I40<Z($E(,19%,LW >@5QL3T:3$\*
MK)I,W<D 3J$6[4<.SSNH:+]HQ3I). VX;.^\;(BE'*R;,N$67:"C-QI0;GMW
M&-W@1"*E>A[GOFJA9G=OXW#(4.&2AH.)8UV?F%]D*5)/I2@$:#,1&ZF19+U2
M[-#]9X+_M#ATW!A=7UX2YFA2B8_'E_09#!_SLF#EITP"I07DJS[5*3R#U"DU
M^QAW5G1N>1 'K.F*Y ^@5N$>KJ?5:C%TUGE2%I2GG9!MY1$]2XZN"/2%5>NE
M/RN.M,7E1QK&Y4)Y09%W@\:G05O..FQ,:B33ZDHK"TTF"T;%W[)W,BY0P'^$
M,ZL7A3E-.*Y?UC6Y&]'5ROD^BB#S<X3^TYG6%N3@.D[(''=U1QCC9>UU!&%1
M]2EBAHQ-2K^;SIL)Y_PMT#(Y;8A<[SLJLL$$:Z]OZDR2:5@_.*>,[@A_*/BD
M 5((IN%I4V,>/DZ"P0^)$P.1/&U%?B#OES+N&JUZU?-Y-GE5KAKKL(J)>&@-
M/1ZEZ)L@$,ZRU.DA9FV'>-K>[TY/2K%0M0B=<IH]PQ<2=I8=]=EU!8LB-<LQ
M*]'1<#/^$A4ECL'0D9>O-&WBT^I]0PDI4F:0^A=.A12_N=-<Y,H!I90L1&6E
M[0;=%K_7K1VVG7,ZP\<OE/2/[2QK<P4E[QN[&XF\T=$I2[&VE=0VXZQ.'I;@
M=BQ!<$"8_J'#':Y%>K3""!L/]X! H1&3LM&E"<',TL-MG42(7NL"X18;HB+]
M/O^J(:,E'I"MB(-O!V6+SCTO;FOTHE3M#Q.LDG@?^?$3 ^\.DSKN!YS/(#!
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M!!B!6.J;8-=W$B4>4@VA7!ZWU0>NMELH(R@Z)+R\N<.+=SYPGG,@V$1,Y7;
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MTQ?Z(_87-O7;IS^9AS]SX]VJ&JBYLM.8/- -_U>TX$ GAVN_QIC&K)0N9JZ
M@BK/!J@]:9MWH"/,RF+!ZO8E&M+0#T^OIYR.* ,[S+I#S7:Q& :CAE*3^N/#
M*P8NZ-W OPWK. Y;Y-R1QD4B!VIC5(+]#JKC_EY*=\RS:NXO'=\?IY1RS-<C
MH0=^0EQ<IX^OA*BX:5TUVZVVF7IVZ35Q6\E[P@HKT5IG-#6M_YJK]<=EFGV>
MO]:I3Q#JU(VX1EVM$WB(?Z-&D6(+N5-YT".NFH%_:5J?\^<F,/2JD%F&V_8H
M>\Z4J^B 5/39X&WJ"LTN?QJL#G:"T7A 8T ;<^B[DH!Y:"Q2FI!X?VP^F!:=
M<X%W=1RY(&ZQOR<CCU=C,V9J9\;N-Z:=<+FE7$W)Y8S/9!*T:3SCE5O=%/I<
M75[I)!&S6P*3<1LX?7B"<H5EKJ1<GX!<%X)#89>?[ T%:*PQ8+^"\=,9-"01
MCQX\ LWQX.%V.+.D&QCX>U!G*?&2G@C>06C+DU,4GUP@?S>Q_7&VR+EAQR4>
M%B.X1LS"_3TW'8>\XT->BC\: ?^4" ;1U8[,9.@+H3BHY/-LV;W>>2QN6%H^
MT;:C.(7\UH>Q!KX;"38>,N/LS176+"^"O29)&K0+HN;3*1&'')32ASP?+)UI
M?^5UQK$USE=$L"5G$@B5MFUPVUS98^(]9)*[%KZ/IPUDSV4UD:KM]!&S[>E5
MN;$\NV%%Q%UURF=(7FFI090 >T2WF7Z#W'$J,5*2"^\0)(&2@!MO&$-PYNI6
M&:[>23(UY2,[6'B4R-9+DY0#B0I>-XOU4I Y(&+;>\W\'DUP:]S%PMI[[==&
M]F\5.,^T0Y91;<CO!MV(B(/\WOT%_B/*$B@0(!=MG ,D4 TW[%1:"_GZX2C,
M;2W-)?P9 WWAK<9'E.,;B(;".*ASD#-PA@3ZLA%7F(R3B_&E!<-M>F!(/T$]
M($ ^?ENO7JP)A-S0^#O5(C (BD-DB]TK'$&=(-]O9+]:(2;%LXR?NE-,K 56
M4;,YUW;L^WNE+Z5%\^"U()D+#Y[@ R&WM*2+6@R4\RSJA&=WG6]WA+C#!$-!
MW#LTAC,@5>/+4O<%>:P%Q4;9KAQ#3WR.J,$& P]<XTUV4U3"M.^^N;_G/VHV
M=;BXUG[QSI+$4J 1H:YH-&4T,<8>*_+J4 4C>[A0JH1>';BS.-.JPHV%[Q6]
M9:,IBW91L79$F-R;)D/Z+"U@\JS8N,1AQF[6:RJA!\\'SZ"0:BO-IH!3C)%S
MY'L]+_M>E)$WC!ZR%_^DA&DX)% ,<<P3*B:<'$<U$&V@-!PP7#K2>0M[-D/D
MT':_%HL09QB*Q+MV^_" 5D5G<$;< M@'SW/VDA\\XZ.ROX?+&[*<J>),*-9U
M5VH]91=)'< ZMHV'KVHQ?L2*G*-KD$04'C8S#';'2\8[=3221E2U Z/=C(JE
M'R3T44L.%Z;QDV"[Y!PI/LF59*JFA @5AJL76*);]0QWD\!RU5YA#]2?:%\/
MI:9,7R"&J3+.-IW,J^FRI*VNE)=CO"#4JR5"U<;%(T,MW3K!8VRUFV+*5#H[
MYJ_Q=4Y:/.[L=Y!RD/C@LY(*A6 (ZZ(%]=0-G'F2*9V00#HI#@@*+E%-7:67
M\=MS_)!:\D&D[>ZD6("^T/D7&!.8:Z5/01>,R E'F3$H\0)#+VB _/#/7!<F
M 7<A)<Z422$'M-Q+TOA,PJ66I:3(J#9'<';FE#_MKC$]!'>,/_WM2_QI$'_Z
MVY?XTY\__C0[''!M=5@9H) BT^PT^Z6IJ-B"LUDBYBU,D34:4<+O1R /H@'P
MC'*W&XP,>U?[REBZ*3;IV&PU"4\AP8-QKSBI8AO,E;[J?0F*MG//41J2QKWQ
M/M[NXB+?$5J)H=LZ;;"3LK%1?C]^;\1<7"V*FIBP WX(?\'V>C>DZS0EU/V$
M.C0T@U*ZUHC1V6V][H^)6!HOTREA6:B\0QI#)T.7)WS%.P9R[BQ#>:BOH!^,
M@@G([8,IZV79BV.O"_QD#'/! U$L.E9&4)G@HM<C;QUJ4C=KIQU:@ BHPXK8
MK*A.UN0ZK1LF%]S?,X;!\8/[\-2FBS3Q@.7NX/BQ/"3..^8HI)M6$@M]%OW[
MC8$]^1IZW@Q7YP?L>\1SD=[.:6&1WS [$>^[H4!$-103$F8!_C7>&J[\Q#,%
M-!O!XWSZ$_&'7TN9D0"JZ>J,4'HS#0PE!VU\U(>#=1MQUKNB3G!UBE>%_.(8
M-2(!:1+OT*O:=+#JA/1BWWTTF71@B71?W[H'_4?1RS[A]QOM#_?]NF%6KZIU
MW8<.S8OKIG6N.?UL2LM>X^),<$-Q3EUG$OA2RW24O8BR2113M>4EW;R<.2);
M/.&K0<<(W@[N%)0DE^?-NI7B7CSOXO1 3IGR7?J+6.)^D?X3LHI/&#A[E+W1
MW \'RS*+OK\WWE<RY>$^F[.K-EY'*_!5[AT_PBB>;.?3]W S@LE/3K&M=1=4
M7^Y,VE@<SQL>C\F&F,AT/X7,7CN)!C]B-M#G3&8M0LXD07^'+"3D_HPSH[.W
MM)H4:71925S(U (HL:"+OY7(P_'@D6X<[R@SC#3ANJ*_O$:24$J^T&R&;*!X
M-(E($MN6;J4?H$\?.G%,Q5M32RZ)SG878?5P.47$']ZQ#4W%!<1B,AQ_](JI
MQF16^!+N!DWN.A0W 6=O._<26\'8QJ (:G*FD @NC'4%H\'+PD38+/<Q^>6C
M@BS;2X+8EG>T4Q_B3L4"5I=1*2T?<O !(%1I<\XH]R$+S[C,?^&P_'H3,E75
MY6734Z36K'(3%?V+(FNNUM:#M-8KG-$<[J:0 P_#ECC@SKJ^!J%4,O?E)C,M
M63!Q&)@:CS]**N+P&TW[&SLYYZQ*5"Y\J"%=T46F,_)$L#M62!7"$9+#36X-
MIT@$28*F<BZU,ZCRBY-"U,#)MLP-I!5@4JTB.)HL[J#\[HY.Q",\$69]J3S,
M,Y?+Y82W2\<=ZAIR53Z56!<S2J"/YSG"P;^Y]W\T-\SQ.'U8JJ>DD^0H,FU\
M=(3,MO,$&#TS7A@=U&NS5L;2[1.'50)QE3TGSZS6?V5UTX?X:5UUN.'M8PBK
MAU4>=*,:[+864=9)*V>!UI"/9+>#S6A]T084:CXW+(L]4OPK-W]C+52$F*E"
M$^8<:L''CBL^<G+A" ']Q[$(1U$:S/E-%5RF3*5%+TH55\2E8US5%"I0IP%Y
M0=$0+2D!.Y6P=^N.9"S1EKIJKG.:62C!0%5*@T[06_X.<>Y\?I)7W&NB&OME
MM1&%&(Z\]'YKES\QX(X8#%]EJ?$4->WV+Y219RF>O^0W;+=@@9@\7=KT]ZZA
M!*%X/#9]52YF3%ZQ*#;ES)6=T5"V*;X2X:>)?G1 U6Y$$E9<0%@3=\!%8%T*
MC7.)\6,T4)Z.VE4N2"]1$W&*W9:OFC)BF0(M$@D<X2N6(PO'8G++4\I1)@(L
M(1WY%)/XHAL7@QI<LPP_$-ZY>6*G*%V V3%#)@1AD"Z(:]FNV3 +#/T>-REY
MHE4<1G*W4M+E]E0:%T7U$AXAH LKF/;W_)V3NEZHG<FAYQ^@RD&W;];A_%JM
M)[&58]75;EPC^\?WK>G."FLJ4?#,) 9Q*64<S(YTE,>DHQB-2S%G;Q:%J/"O
M&NQFM71N5J6J$?+O@374M$8K&).<,9]%SA=V=):(O,3!P!V=++^BT3EEJMAH
M;4Q6(9FTIA/F)\>2"6)C AN.?[MJ*N326.'(#D+/=^ G%FA!X5*_/"+/)()C
MDO$]K'U.=(/L<6X#EF,3IVLS[Y<I9LVJ'TQD[G3^Z+Z;J@D@?&!X#J!CEW)3
MAIX.?\T-^Y/C%Z^KME_3EF6"$N.I]F9*4FT@2>9G7W@0W'&?E/T-4I[UD6X1
MGIZ[QAJ__A)K',0:O_X2:_PSQQI%1O^-2SG5]T9\??M[IZRQI13MR"!,4_M]
MG-60*[67X.PIMB9V5<J9"Q;QB/<P)H5SBG_5^_*5 ?N19XTB5G!FCJ(+2NYH
MQMN&N>(DN-EMUCH889(=CCKAJ4JZW-.IJ>EIU.A%55XSN81_WI< 3AN5>2;N
M#O&2L#D=QX"-\2H7J:]H2-)ZY?6_@!=1Y]/[AKPN ^]CL>'A6Y9^)C0);:$(
MV4+S"O<3@YE2QB+E72PVLDJ!-HXW&*^\OQ!)98^(5$8)N:!S@>HWX$84@YV)
MQFZW[RG$'!(&HLX]PF4B*Q'N9>&B&M_2R95%$X0)]I"+9+;F%)"8!BC.VO]D
MG@4^#<;#0$DAEK,(6\RH7\-.S%*=^"1]"*K.DT<<-1Q2.WDK::5;29:Z;85S
M0RZH6R5>BK9<,@6GS7*R :#]O<2F$TP@ZOSN$S%U79)<)A8NDA)A),?X=@WI
ML\>*5M..2(1N*V16*^JR67<:1J%)E&&D#*X0BR'>R/V]H3OR]Y0:V>U"@R(_
MXU)C-]?WUWA]OV4OC50S[\)[.X!^P+#1)!-N8;@TO\:'LZ+O"_Q=IG[7X<JN
MU7M14MR</N2Y!!,1 8?PW-_#X,!-T[ZC>2Y6%192UV#!CN;M&PXHA<69,*P6
M5ST\#R-EB<1-KX%\D\CBTP)0;)V@'1SO3245-F++R3)R/ZKYC,>W1-1G0!7G
M11M?"J2"'"C?:LAO)UCK.96U0A)@+/('=NPU+!^6KFP62H/#BA!^5W'/<)%5
M_8+!!8$OK,C(XG%T+?A42&]%O\*2TS1P;AKS8\6B[N+KZ\"X^!$=*ZX<%V@[
M?CR2*X>CUN5X<#\5OSQTR4K)^<["Z=;K8S#M=)7YF?\=ICO[@-EV3C\[W>X1
MF65RB&F9(ZV2;L#*?OK?H+_4PNA!BVB7I$\RSEU,;10+"^*)SEUY/[P7@K*'
M.?MW\+\- =4P;P??F!5+F%[Z?2<:C23D= %.$#[RRWIV*49!L42(-S(U5C/6
MXA0H32VMV]ZWAW>9RY0%$=>T=;EQU>/F>F3X><\<?FFT=.??B&:'X&+(U*U$
M4; -XQ(6!'[FNG.D!)*_%-I#:QB#&W,;[(FHY7+#*Y<;O:\Q+I"0]--%^5/D
M=5KVJ"?D9CK^AA"-R:%A0W0Y\QC)DO*"H6[SAI.\U2N-!6 PWABIBDLQ;T)U
MS>B!^WN8>H(S;>!!4?(WB@LMWAR1=B76AV8M%=FXG9UV:SU,+3#+F#:9I0X5
M1@5-%F9Y4QMGC(W0+C@)%[_FM_C)7/TPOR^:0;FS]!S1+B8+P=FI0\B5-.^J
MF'6).IC:'J$D)<5JA!%.NXM^ DQ*&V_,AYE$E05%HBW6LSR[;+$^3EU>@I0I
MJ50C7K7S]2(#G5(;IJ3*Q1PD (*X#@DH9S:WTP@G;;-&^DC=XJ%ESZ<] (-H
M ,PGN[G\4VHH!.940<)Y4I9$ 2Q3'ML<:E<;6Z\O^9L&*$/^,"[VT*V7$C0K
MYRA8V1& S&ZXW(8P0>L53J\:CO9OI8Z+^G^4G6 WTJ,:=HMO34^:K-T0(6*/
M%N474MF?:B68G,1H&&M+VGQ9"B&YWB3F$A3*/%?H6?"[_.#8<=5P93\TSK3$
M!H^'J\[*]$(#".)$G)44%J6K/RR?.[:^+H;EC'^L<%T0,DP<^I8!0BC#F[FC
M9Y%UYQ 13Y4@Y-WDNZ5O7<728.)I(%0;SN'MW >'/(0YX9/$$XAF&-B4O3)<
MN3]0!!VGQ?OM*>UJ""EV6]S^/;4ZJ?AP:+60Q=>!8.Y< GLX') IJ@?8/5,W
M6+F6D(V8C5=JDGZX9].U[;F&JRONE1 G:?*^@\TA$Q\+S?K"P;G3.Y.,U'(6
M!'$3:5_#H&[H6I4>V^ ]8S"BT/UWM%O^'05&^?!1)DGBC!2D'XH*J"H?MN.+
M>",/3\^Q,)VR<+@@68*+\].K3\GI'>A1=!-:16H;VB4N^[N%&.X;OU6U0WRF
ML<IOL0F0F*S]2D4@3,#SI0-\)<O^JHQ465K$.=/,%,) @"A06((%)\6XZ@$4
MPBM9H:5B(V8T?:!D.+9C3N:LS)6*HESJS.@1X.Q17+2I=DD#FWPS#* .O Q6
M\32^*%H )8K96.LCQ&+HS>R->'L[6^3U+0'";[X$" <!PF^^! C_!P0(OT5/
MV1D(U_;:P>T9:H\L!& HL)_L)%5A-A\H,BTUQ)3FB?N:?03KDHDIZ%%ZDD)*
MGD\?KQ9)^4#SD5+PX>LK%$XKIH0F* 5J)J:>EL^9EAQ^-Q3)&HC2I @OAS=B
M[ UW[""#%,/]/3(#I_[WBN9L2^4PQD_MR.UY?!]7\V75:5);8B6M3B.!)T]D
MAU(\3D\*,C,6VG:;P7W=%Y%^Y^=:// A9(H8"L2\(G8%(>)9;*AA21JCPG+N
M#SZFP+C E/>:RY*@R"?*+.Y;:;D$$SQDKK917'-=E.4([25L*&S$,?/:UAG9
M_O&(-,/SH2<_'J[:G.GJ9-GR.!&$0D^\G,X\"WI T3#/4:O*#A<W4NR@D)[@
MV[5#+CH[@J-;;,5]R#B#\K[</L)I#:I?47S,N!N4EV,EXV.^)_DWO,?<_IBY
MV0[FP"UXY]:;NH,U\]#,2)@%-$DT$MJ-4U$*G9$=#L,)P;'=0\)3.B/F>W"0
M:>E2^Y,Z0ZEM&TUKTVRV(#87%\[@[*!<<96>V,12E'M'%2>[D<;,.2"R'MLV
M+1_40)8P\5AEZ\\-Q#51X+=-#=JR8S;IK\BG0R]X<@]T?%IV#S*U>!0@T HM
M SQ=E$7+$4&X!%JMV;.]I ^J]9PY)BH[04]+SY&YM1MFB]W6DQ24EFERAO.P
MJSN&*E^<8N% 6/"RZ&4^AK&U5[37NVHFQ3)CE"25@3%E=\;BW8?>]* <)3["
M%")0"YP#+/@3)C+3SE3P*(6=B72*?/FICT8<C:G:,'Z')URTXC;F2.FR#$>]
MOX<V,*:>:^>Q1UZ("95JLBS5K9\^PN@YVM^M'Y2&7G-NSPV.BEVHLQ4U)W5W
ML(5&]+S<NRB"&2<L4G*%)-+-7#,+HIB*\P\*9MS"?+,:+YUYTX8F'*$SRAA7
M(07#86!2F]X[,\21>,.F'PVI77/!Q;B)J=:)Y4JU/*/8[B4(D)6DHL1US.3]
M7(JC5&K/7C>J5&VCH+"I(KLZH \^HIKC*"-)]@&$)-X3,PK$<Z$=Z$L*AM?<
MJ7JC*B>>0_>6HHU97+/1'RR';7,7H@EI;"W>Z&;"%S$<R@]3!#%@I7-8HA"#
M,@10AJVUFM;ODD^*FHD;9P-Z7)?G1PFMW;2M)G$AFT=;5OZ#N&BBI6<^@("#
M;VM@;F2H.DB+#HVDT<<,>A"HH<T4Z":):GJT5^Y8 \_9OQ8B*5JTX^L=2924
M-WVR9Z: GFZ0J20)C[ZTGBQ9B"FH-W%=O6$865-M$4T BFIH90DYV6+(*R]&
MB!2$'I $4$5B202R+ESGP=TP?DW 66*/NCQA=;F7]25Z6[8"/@N?PTU^PCCH
MX-+LQX_?7;;D!Y\^H9@?VXD4#PKFS(8VB"1(])VVH?394JB"_$S0-;IU-D@]
MBR)22*?7SCS1D4$LQC'=>9!D^]LF$:;C4\LPS0VCP%JP8)+<N21O#]9<)9"L
M5.\S^.XA;):3SPD^2MA1I9T9+?,[Y-,<H%O][)DRU+PN=Q/5G[PTKJFYNK^W
MZ]*XY*U R.YN2^-*1R7KTXFF/[(H;I:HB8N)Y!];%'='>BBQ>M#.?O9=]F2Q
MAIZ^VV3/R<>@*-:ABR D^N'7DY.[U>%C,U>%R=ME:T)[EMH82\>M-B[JEGLO
M'_EZM5!"',%*N3>\,TO5@"[AK32.H5F)*@1<R8&SBZ#(KH"L<-0$['CSAE.*
MX<]HB"N@Q+-UY(S9'5(;:+*#\#X,2,6MA -330"$NGJ:-LE0'^$;Z8FM3GYZ
M6],5131[XN<+\U^%W-MC,O3>V#;M1EK?-:3W[9>0WB"D]^V7D-[_@)#>,9''
MG#A-W3GHGE6+=4"OE"X7Y=0ZHZ98\<*$[H2#!;DTDT;UH6;=.P4E'8=S'!/N
M51_'QU>'*60NXC'H)D';DD[JD;3#H:=W?V]0O=TUZ$.!M]XXL>8Z\GW4?D'5
MU31**0-?3$"RK/O2V]PVEPC-)T51H![2S.>$AL8]K]@;1/$P)GG&%.)YQJD^
MY)J4M='\<9/9[9=/@)O8WA!EP8EF20RE$$!%G^)VKQ/U8=VN<NU*K+"Y0>S]
M5;5R6ZDG0'/ "_E9I.4<,_6!)XQZSI7(ZDM1:YYKYHR)EHM3Q/U6=7(RH&Y*
MM(6)>O'@P:-#IM%#NXA2$8O6N8'#8@=CJ3Q<ZV*YA/U1L2_'0/Q\;#?W/%MD
M%>K*W)F0:!!B)Z>H^?G4Y4-T[/L%Z^0J=)!+HJ#A5LAHLAQ3%/QT8%,9QN;=
MEP5PND81N7F0F>3]H2+F*#^P,O(MT7!<_2>P;K?E1:<:X^5BF!<C&CC3"A4^
M<9!SI+(MJHX2#AV/OB,_X%!'X]-0-!PFU$"(I5]*H9K4>#@DP&6_^6,*-3QD
MZ8- 13I]*[1.UEKO0PB<K/8:AQ33;$TC<S3:PT]VIN\?/?Z 4_T[W]BLH8 2
M@_7M Q6&XWE8]!4TWQ6<6-BK\-R3'[#$_=.7I_M[_SCZ_LD9=.OG%^>H)YV\
M.GW]]OS[KYZ )H.M_; +(?CXB.* %V2^!*2-E:TZIE=[+\]))9N0&\G45AJ:
MX_9V-^5Q:@E-:+B6W)1\U=R 8.T:=&-S10S<RZ:1;=0B0\<V]%;QM2(L9%][
M\JG*@C#$KD(P%$-O!9B[7BXY X4/K_ 0OI[V#6*6'A[GV8/[#QY\YS*!\^RJ
MN<$QY.;J[/UL>^=H88H*6:PE\V+1Q)8.>2SPVLF&.0XL@]9!XX:S&T:AQ\)8
MJXCM4T%L#Q)>O3LZ8CT?\ZD/G-LT"0&_6,%77A(N3N0/L^NJXYQ-CXOGBB0N
M95]B_/!FV_.6<-GNGJ#:-:P@7(=17@DR>4J.2.VTAEHE%=U5,\PQ&"%QI]RS
MZI-GHVPIZN!4]\ ;E/!;K(@=?1'79*').+@%&T'6.3WI'"[,RKHL[\V*#=]Q
MG3)MLO/9U;G)%F6/3E%/DABJ'G"7@T6P7&5]\;ZTD^Q_GJW948VDZ3/RG*2X
M#8-:)O7F5K10Z#79T7$@!]HI:(T@*=SZ&<?9B(G1-Y<E39()4 KS)KEC-)K$
MZ@5J@5I3D9[E[X51UPBK,* N)#^06"P@YW!)#7=R;_[=K3%)M9PQ5(K53P,[
MQT?"Y#94#PO*91$Y/$S]X_QE_JYCEK']-78C6QPDED$[9A^X7CXS/X?I&=O1
M/GC$)#YX^PBTYH3O+!#B? G@7QSV(&0W["3) [=_94\IBGO'*\>:H*.A\!>M
M1?U+$I-QZCD>L?T]+&'%<4]?X+*Q5=+(F<>\@LX&PGW%I:&(+")WQ)&JF$>#
M0>W5RXKKJLB0><,QWA>S&5X,8#):2@3:G##+14]<>@6%+D-*!&R 8FQB#3W^
M^\/[V>IH>90=X'K^JVG?94])$88E/0SQ=\\*D/%$*4C2^GWOP93/B@&_]^\S
MXNRV <-.B49,8Y@5&FV5Y%L[*LKD\64M[C G]2::E>FAALT:M"P>?'_^]LT/
M]>S[K_"_AY2K[+X6U:V3R<+!5E)0N).$J;='YT<9JT$$4<$*%I<U9=YA#*0F
M+0@S9K"P'*+,96*Q] ZG\4[[-3']$PN2RPIV&I,WH615J@&7.VUWODMU#>:*
M]=,#R49/<!9]@N)PS6#;;M^E2>JB3\XB0Y)T*XM,MI5$QMB_OY5+QOFAMI+)
M)*BM=R2HR2UT@A!$ND:^R_Y)N$/58%\U6Z&&8BH15A'T?T8JXK]\16I)X5JR
MKT#)=O$DJY'"RA5'OZ'#^'H8%R96S$+[F*?0?5'(2'DK8+,A97"?/3[^#Z)M
M1HM68C3&/=HC&-IZ@3$:-8A-,R(SC\Z>>ACI  I'J.)MG<N2)\A,)<PB)V=;
M\TD+1M&@_'!#_&<K_2" $;E%*& KE;A1;Y_A^N%/%<P/XJAM6!U-)L(2$C^/
MFS$IC!N3["8^P8W"8$P^Y%BCFNL@58Q4'A'.5O&M/-Q9.2_059,F?Y99R[T_
MAOW&OI:R;$UKQD?7O0C!0L'L!(?C/LA*S]<DQ\BU%_;.\.QK1Q-/B67J>DO0
MN'1W-6Z+&$.9(Z9QXRNL4>$1V\5@/K53I/3V#G:O]U2:WTR%&7"=JI:%M'O-
M[DEZ_8ZAR0?WOX0FX]#D@_M?0I-_^M#D8Z8C_:DDI:_S8<@K^8W+-2:,&.LD
MH&95C!>H%Z!2SAB5Y947K 95M'WB/@UQXX'L(@<&B1UVGAF]Q5. <6^:^8Z4
MB:\YQC1%[TDCV= G'5[J'CR30+LAYTG%%R_KNHC K]>M<UQ.RKJ<5WULT\O%
M7Y$.:[_IC<2"OSXH<\P\B_S7>!&4KYZYKYMVQ)][)ZKZ*)QS(*X@-$XF&S;G
MVT.8EY,@/DFE_[AOJJ4N'"V*]"M%V3!,+O%F@8E^\IP0&$>\9YWQ,%$J2B+_
M+>249.>NO(Z5USDATYC<?-].&NCHT/_A()B:@KJE5J13^(8US49\IV1D:((E
M/B>1..,>D\C;;L[)-^P=P<A#.[O'O )/:(]/V?I(GY8H*V7;T5 ?@3LAANCJ
MML.B&3!X0ESRB_\.:RVT18-$)/&8873.,^6GF.]+YQ7W)4H"K[BAHMB1(*,4
M\Q____:NM:>-)(M^1^(_E&9W1T&R\B"/V<VLHC70@&<<&]EFF&BU'SIN.^D9
MXT9V&\2_W_NLNM5N YEQ0LA8B@CX455=CUOW<>ZY;)G#5FZG5[(B33B'A/)2
MW/!0/J+:L[J)&^X2.LJ(?,Q:!2S;X'J]@ 6*<I'K][*7D!]H-#2I'/0T>424
ML"%S7H.39E@F](G8#8N#ZY?BLE#O2/"7L[T<2";1QW\AB9/*J,.0=:PT(>Y2
M2<U0PRBP 1,Q'[0X44I0X@"K3%\\+?/E>5.:I1K.M-O34"(^Q!5D:E<?V0N]
MQ, ECZ1^*$9*FR.56NZX.] X!K),3^08$0(SS:/)(I0<'K:@)XLY=#JY]A!O
M6D8J^2<49\0[B$Y%.-B24$86L^2%Z')'ZR48ZASD\64QI&@YV#WG>0A&^:[A
M\,SR>98/[?Y=-0HG@Z! 1]TH&FZO$#S V+U-IQ_1AS0-)6+3[+=%5LE_1,-T
M(3@5":_.*IFHOOZJH@PJ20>5+2./CY[G?#Y<4%U[4>T,GJ+N'JLQ^F\ZTD+X
MN3S=VUMD3PH$58Z/T$$C%GOF,PF;GK(F'*=&P$(ISDR%.'-LDM^Q4F:QNHYJ
M'%+$<%:&DAQTW==U2Y?2.3H)9 WP^L"(H*K!I8/_)9S+BHC_[FW;CZ=C>TO'
M'QRC8XW1*4K#ET73U]^/",W'U!Z6R:WV(5 72R63G+#5/@"$[FNN"(3>;$[3
MY8K7T"ZYM5%!]"Y<'[1[Q$7##')8W]KQR &1D[%;/-1,P1E3ORR"^DJC\UE'
M1RWUNDY5*&4FML>'HL@DK.5I2%;,JZ('5+AWBFI2%A\09?RKL5=,ZFMP65!=
M7B12T<YRR^L@_HN@EG U(T^7&(EB?3R6CN0HK%U@])WP,8VU%KK/V+R\ 0&)
M_L%&E42J"M*(87Y:]'*)BQDNN$O9:AH]OV%CFLRJ_/P]$FKY>#,YNJN-C?W=
M%/CD5A/-:NRM2G<; OU&?S#\75%47S,3YB:C=.4#W9,^QRPS_05L<U#+3*W6
M"DT;XW,"[VEUIVL@@!H:1? 93^)LPO;!Q7Q?S\W,!PJZN!'O))G)G&EY53#S
MP&RDJ%W<7W@UL2'* >LK)1&9A@B^45D8,4FD)2,_/T0WD)K<.A.9A7,\,K%8
M:MYV;R+A'"GP^?LB2DE)-,4K3='&"^%G+.5JD) ]2D.4FFSEJ/DTQ5(BA&EF
M_X!G2?!C 7$DD>++**X5XF%1%!1+T:5#(I@;5:*I^ B>*@,C67E4G$M,U\<7
MV5A36<1!80@V0J],I1+E>E/L476RI-\ZZFCMW=VG3Y^"YOGXP^,&(0FPF<?0
MP@[=<Z9FK?JCSV&-BTR2D4.G(H61% &=6V3YT&*H6\? TXVA>JUIZ(A9Q0Z)
MA)WXG"BSGC61:$9UD^Z$QZ.54=&NH7RT+O,Q9>0B<2B5 LL_4.6]\EY=9$QU
MT*>,=2:2$<M2;C?$RS7BD(>D\U$(@=-KZX-Q.9K]$T8K"O,X&6OG%R.*O4;*
M'GMG0*KC6L&QF)!Y!M;+99%GS-<L%R9>(GQU<<T0PX5-0%DSVBBKGD'V?L V
M>!P)4ZE$ O_&"_B3^A3.7/5TJH3($=&H/!JI8( ;$NK@0*,\4>J9N6J\(E']
MB'P6P<[=,NJ<X$+C?"J&-A/68D1R0B8UB2HL"D!:&@@<+(\4=B:IO3Y)9'(=
MWI&$E%34MJH!Z^&3C4I,J78_@#R2'<"9L&5^L>"F6"@BX8H/@JFU/:V>R-SD
MTEQ+T6N2N?YR"/N <_D_:0>H<R$FU5%]0?)(:7%#L4 _]*6]ZFJWZETC6L\V
M$:VEB-:S343K+Q#1XBSGWF@^- 5FS^!H9K/T"DNX45%4)<1:0<Q1P2?'1!V/
M+,R=#$$]ZTJQ&QE@.]9GLN2@,^5Q&Z02XMU92>C2 #?5N\#1-U@[$J#Q.1D[
M<&UQ*K*DI]1CC*HTH%G!7ABL-L-\:@Q5%C.+9:RU TVI&";@$=0JO&:A'J-I
M-2XC28K#G =[)2M"AB=V-L?J+.B<@DN,YH6+'0G).OU/X;-Z\']43@TK:5_B
M)<*?L7.D\\9,Y@57SL&Q8\12UQ2,)O+)8>O;6S@X 4]H9C2)?@I4W9>>]8(W
M.=RGP37'MEBL<(DW9RA%(@P829PWNG5OXM""B_<<]-@)JQU@$6)EA1(F3ZBN
MH<WB6M8]!I4AUQIF.Z!?B<@B13'#%^DLC;16$/MLWK,?1S+J&7Q,_*[H[I],
MM%*,Y*!5,$PR1OC(CI3WAM,Y6@C$JM(\-4)Y^2G80U>K)\HPKDL>O*_4Z/U?
M)@5K#@.8@S%$E<"K'"0P$#H5S-(.;XU+/X,+470(P,CI_U/VDMTR0#GP7'8A
MG\%!1WF&;C6#3[I0%Y7QG)04GV-3A;TDQC #<PFN+91]GHT<RX_/BR&SS 77
MB<E)9N2-V94W[*K[.CDO^>2<CS*-1**MJZXOTH;9A$;]L9R(I>V12:C2<X@Z
MPF83/X2G[&.?GJ4[0T2L^DU\)28EUJ_ ^PA';O>-UNJV(])*%U%NR2W)UKRY
M/+X 32M12XOIJ,2UEJ&1L*9; 2V1##0EKL)PC@ZTU!S/:]K*4>8,[S!UMX?J
M ?82J?!>W<2\Q1H_'& >K2#KU(&[,GA _OBZ*;(8,9M6_M'6.:%2"@AFR\B!
MC3% LA:B^;BO#4R0G1.A/>V#U=E$1Y3&U&\NI2KT7X$U=19J'BP5S[@3:)GD
MDU%5V%1AF$706PRRH_1!+2$CX5C!\GB4&UR+'ZI\B0)2H1/U&]%-KE<$"!H4
MN8IOI*"BL: KAB.5.UI,="#$(,X,5 TR[U.<Z(:>9>'](E[*#\5,2(2*F11X
MB,#IT!0^<M8@GVS*AEW !Z 96<Q"->"@S;@2R6M'W.M(.5.KJ -3MQWWZITR
MQ-ZGT]]GBXMR*+)JJ9 4O3KDW'%L%><:'HK+AE3J2^R(SA?7)(GPF/2(X;"%
MLT=;)5HU=6;1<D5IV'R[8G#*A XN<R6X5R;G+/:W+'O.HDWW,<U4V&$2$E6F
MG=7N-=@$Q7BL7W#%4*IVW),D^$&+:EZ,Z!TP>5%-)=Q"N$\T+M(U A@GA.P@
M@_FK1'LJV*ZPP^KM"O23,E&ERN;M+:*I-"25<0=F$\?TM"O)]WQ=(1-W\R4$
MK(R?<?@HO.39!V\?PRU/NCI.*"KGS3",AA**^-)/%%^HIF 'V>N/!)\.3 ZL
M"4>:"&A5F9@+OD.H/!KDVQ,]CGUN*?.)8B3;0\3]0_Q.]MJ8=0\N->@]X1A<
M6@@!UG(IYKE4M@DATD^E_ZU<TOY*^&,5[JO,JF$>K5Z5A^.$F 6X?4KUTFJ(
M-5QFM_*4EYH#CI.1<\[MH@X:B]?!HKR;EX! 5F6,I V$]N/X?@B,@R1 <:69
MFSD-2B^6!]9@K<2/-4+K<0U"8HUIW_$L8F(]"4X?;.1UT!IWGI*0$5*F_!R[
M&"YSD(R6POHVT)C$-FV5$[+J>?T\B1S,C=F*<3PE4&#4*YXJ5"*T\W+--+DT
M^"[$8$P:9W,*91H/+(/]7.A!7U+Z[^L*(:QF'Z^-++W&%D'ZX2_;6\?H[*77
M1N50["0>]23EFAY@I:+<@,?+C" &@692RT/Y*=8++O)9A'1BR(2=-+6A8O"%
M;//4[2W@%"&J@O(9@Z-).E)V"Y*JNG>YDQ ()GTQT\1,RA EU"AO>=O#7=WM
MNQMW^Y*[?7?C;O\KN-L)3+QOL,&&#Z'&U6!\'D1A_*2H*5:LEP0%Y_B*$ T?
M56\,=\=42/@1X5ZM%>BD=#6\ST\"OE-4#B=4,45POX$&0PT9PY7&>8OO\P\+
M9N-,9R-OW<%1)1O$5,_+9NFX#- E<8>*'!,XK/=_? IF6NYWGT+I:2,B1Y9X
METAO(<>36+/BU"; +@*?-2UZ186N?+I:Y_?ZDZ7&RW"WT-MCN@$I6Y-QL\7L
M"D'7Q![GYA>3G$A]^<\L)U]J-F_(^X9]S**Y-,(2J8#A:C8UE7#)R$"K2_B_
M?SK>EX]W";5UUFS]DO1<]]#]=-I[YP:]5K.M+OR.:W;>N>;^H-7M0(>GK4'#
M=7ONI-?=3Q*49DX^ E]M]0]:]$&WU^N>'AT/W-X[>N^DV1O ;T?-5J<_H%>Z
M@V/HD5Z'ISE.Z-=6TG=)<__8_=SIGD'3;?SV 70P2#K8;+/=?@>K->C2-XYZ
M27.00'O)K_B^.TEZ;UN#07) O9Z<M%O[)'G;S;.&@]X2?'FOWVV?#A)HQYUV
M]KN=@Y9OV+5ZO>27+GZ)^TU^/>DE_3[\11/4=X==^  ,FR9H>VN/'OK=YULZ
M3P_6>O.H[S$Z)^0=/21BA)U_/VFMA^FK*L%O43:>;Y2-)67C^4;9^.:5#1!V
M9ZU!!\2".T.9TCUL6&@/9X=JD3TRRC*GQ7^50ELMKCBK$'TIB\EUP &Q'R%6
M2DPY<0;M%5Q$("[$2844,!F$<CI0)T!V^B"GPB:QFZ*Z:98WB3^Z0Q ^Z<4<
M]J;^]AVMN#E^EQ@J'*83G5/8M]_IK@B[3!I_^>(?_LT_MS,.3KM]-TCVCSO=
M=O<(+Y0CN(I.0+AW]F4"UM"+W7]?7W-PH^]=O\8+?)U-DK@C1E4>K?ZR^?EG
M?JY[E0;H1-PLTX-9LG#TZ29=)2!?O%J7@&P:7BIFCWO]M<JQ'UZ]>NKV*2"
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MDGZ) H+_!@/+^#<8\10)DR:SIIXG'0R<[BS^"?:ENK=)Y-KN9C5.X,?SB@W
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MQI<N&5XYQFT&'@N<!+&T"G2[I3>"'Z]HT4!N"9C(9H#ZJ$7$1>^=2]N]%1,
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M=%\X:RYH=&U02P$"% ,4    " #&HV)56KEPO ^(  !^@ ( #P
M    @ 'V*P  9'5O=%]E>#$P>C$N:'1M4$L! A0#%     @ QJ-B5>8XL@62
M4P  R\<!  \              ( !,K0  &1U;W1?97@Q,'HR+FAT;5!+!08
1    !@ & '@!  #Q!P$    !

end
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
